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 Summary 
 
Dental pulp progenitor cells (DPPCs) are among many stem cell sources potentially 
beneficial for tissue engineering.  DPPCs offer advantages over other mesenchymal 
stem cell sources, due to their accessibility and multi-lineage differentiation.  
However, distinct DPPC clones exist within dental pulp, with contrasting 
proliferative/regenerative capabilities.  This is a key consideration for the 
exploitation of DPPCs, in terms of the abilities of isolated clones to undergo 
sufficient in vitro proliferative expansion, while maintaining their regenerative 
potential. 
 
This Thesis supports the heterogeneous nature of DPPCs, demonstrating 
significant variations in population doublings (PDs) and senescence, with highly 
proliferative clones exhibiting greater proliferation (>80PDs) under normal and 
oxidative stress (H2O2 treatment) conditions, compared to low proliferative clones 
(<40PDs) demonstrating altered morphology, increased SA-β-galactosidase staining 
and senescence marker (p53/p16) expression.  Although negative for human 
telomerase expression, highly proliferative clones possessed longer telomeres 
(>18kb); maintained stem cell marker expression (CD73, CD90, CD105) and 
osteogenic/chondrogenic differentiation in culture.  In contrast, low proliferative 
clones exhibited shorter telomeres (<6kb), reduced marker expression and increased 
adipogenesis. 
 
DPPC heterogeneity was further evident upon Raman Spectroscopy analysis, 
which distinguished between undifferentiated high and low proliferative clones and 
undifferentiated DPPCs and clones following chondrogenic differentiation. High and 
low proliferative clonal behaviour was also assessed in type I collagen gels, 
demonstrating increased contraction and reduced cell proliferation in detached versus 
attached gels, irrespective of clonal type.  Increased contraction was due to increased 
MMP-2 expression by both clonal types, while highly proliferative clones also 
expressed MMP-9, especially at late PDs. 
 
These findings indicate significant variations in DPPC clonal 
proliferative/differentiation capabilities, partly explained by telomere length/cellular 
ageing differences.  Identification of clonal populations with contrasting tissue 
regeneration capacities supports the development of screening strategies (e.g. Raman 
Spectroscopy) for the selective isolation of highly proliferative clones from dental 
pulp for therapeutic use, or assessing DPPC differentiation in 3D culture. 
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Chapter 1: 
Main Introduction 
 
 
1.1 Overview 
Tissue engineering is an emerging field in medicine, especially with ever-increasing 
ageing populations worldwide (Zippel et al., 2010). Tissue engineering is defined as 
a strategy based on combining cells with biomaterial scaffolds that aims to repair, 
replace, or regenerate dysfunctional cells, tissue or organs to restore function that has 
become dysfunctional (Sittinger et al., 1996; Daar and Greenwood, 2007). Due to 
ethical concerns with the clinical application of embryonic stem cells, adult 
mesenchymal stem cells (MSCs) are a vital tool in tissue engineering and 
regenerative medicine, due to their capacity for self-renewal, clonogenicity and 
ability to differentiate into various cell lineages (Gafni et al., 2004; Lin et al., 2008). 
As such, the use of stem cells in combination with appropriate biomaterial scaffolds 
is expected to offer significant potential in the development of cell-based therapies 
for the repair and replacement of numerous diseased and damaged tissues. 
 
MSCs were first isolated by Friedenstein and his group (1968) from the bone 
marrow as fibroblastic stromal cells that were able to form adherent colonies in 
culture (Friedenstein et al., 1987). Although bone marrow is the most exploited stem 
cell source, others including dental pulp progenitor cells (DPPCs), are increasingly 
being recognized as a viable alternative stem cell source for the development of 
effective cell-based therapies (Gronthos et al., 2000). These cells may be a better 
candidate for use in clinical applications in comparison with other MSCs isolated 
from bone marrow, adipose tissue or umbilical cord blood because they have similar 
gene expression profile to bone marrow stem cells (Huang et al., 2009b), high 
plasticity, good interaction with scaffold, very low morbidity and due to the ease of 
accessibility as they are discarded following tooth extraction (Graziano et al., 2008). 
Indeed MSCs have been demonstrated as a promising tool to support tissue 
engineering in many fields such bone repair (Quarto et al., 2001), cartilage repair 
(Centeno et al., 2008; Veronesi et al., 2013) and skin regeneration (Ma et al., 2009). 
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A significant limitation of stem cell therapy is that such cells exist in low 
abundance (Friedenstein et al., 1982). This means an extensive in vitro expansion is 
necessary to produce sufficient cell numbers for clinical use that influences their 
biological properties, which is accompanied by increased oxidative stress. Oxidative 
stress may lead to loss of their stemness and multipotency (Banfi et al., 2000; 
Siddappa et al., 2007), and eventually cellular senescence (Stenderup et al., 2003; 
Bonab et al., 2006). Another factor that may affect the use of these cells in tissue 
engineering, is the diversity of each clone isolated (Gronthos et al., 2002). 
Heterogeneous cells are expected to produce unwanted biological activity while 
homogeneous cells are more desirable to use in the clinic. However, this is not 
always the case, as a heterogeneous population from the dental pulp was found to be 
key in the success of clinical intervention for treating spinal cord injury (Sakai et al., 
2012). This thesis will focus on investigating homogeneous DPPCs clones. In order 
to investigate individual clones, a quick non-invasive method to characterise dental 
pulp progenitor cells prior to their use in stem cell based therapies is required, and 
will be looked at in this study alongside the effect of in vitro expansion in normal 
culture and senescent co-culture, with sub-lethal hydrogen peroxide (H2O2) doses. 
 
Furthermore, DPPCs behave differently in their natural niche than on in vitro 
culture plastic. In this study, type 1 collagen gels are used in order to imitate the 
natural niche environment of these cells. This will give a better understanding of 
DPPCs native interactions with the ECM, which will be beneficial for tissue 
engineering before application of DPPCs in clinical medicine. 
 
 Overall this study will investigate the effect of in vitro culture expansion on 
DPPCs stemness and to study the variations between clones and develop a screening 
strategy for the selective isolation of the efficacious DPPC clones for therapeutic use. 
 
1.2 Stem Cells 
Stem cells are unspecialized cells that are capable of differentiating into other cells 
and have the ability to self-regenerate, depending on the signalling pathway, which is 
believed to be controlled by different growth factors on the stem cell niche (Blau et 
al., 2001; Lin et al., 2008). Stem cells are present in most connective tissues and 
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believed to have an important role in replacement of injured and damaged tissue. 
Stem cells are considered to be a promising therapy to cure many diseases in the 
future (Denham et al., 2005) and even though stem cells are still in the research 
stage, some therapies arising from tissue engineering have already entered the 
clinical stage (reviewed in Atala, 2012). There are two main type of stem cells; 
embryonic stem cells (ESCs) and adult stem cells. 
 
1.2.1 Embryonic Stem Cells 
ESCs are cells that derive from one of the earliest stages of embryonic development. 
These are derived from the inner cell mass of the 5-6 day old human blastocyte 
(Bongso and Lee, 2005). The first human ESCs isolated from inner cell mass were 
performed by Thomson and his colleagues, in 1998. ESCs are pluripotent cells which 
mean they can differentiate into any of the germ layers that form the body; 
endoderm, mesoderm and ectoderm (Lin et al., 2008).  
 
Human ESCs show high telomerase activity. Telomerase acts as a shielding 
structure that protects both ends of the chromosome. These are composed of special 
DNA repetitive sequences of TTAGGG in association with a variety of telomere-
binding proteins including telomerase reverse transcriptase (TERT) that possesses 
reverse transcriptase activity and is used as marker to evaluate the telomerase 
activation. At the end of DNA strand there is an extension, due to the 3' strand being 
a little longer than the 5' strand (Serakinci et al., 2008). This process maintains a 
normal euploid karyotype in long term culture which make these cells unique and 
have favourable use in therapeutic applications (Hoffman and Carpenter, 2005).  
Telomeres protect the chromosomes from degradation or any actions that can lead to 
cell death. However, when cells replicate they cannot be completely replicated. They 
are slowly shortened until they reach a point called "replicative senescence" (Hiyama 
and Hiyama, 2007).  Furthermore, the high telomerase activation of ECSs decreases 
during differentiation. In addition, ROS can accelerate telomere shortening because 
telomeres are at least partially deficient for oxidative DNA damage (Saretzki et al., 
2008; Saretzki, 2009). 
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 ESCs have characteristic markers such as stage-specific embryonic antigens 
(SSEA-4), TRA-1-60, TRA-1-81(Hoffman and Carpenter, 2005). Octamer-binding 
transcription factor-4 (Oct4), Sox2 and Nanog are other transcription factors 
expressed in ESCs, which are essential to maintain the pluripotent phenotypes of 
these cells (Rodda et al., 2005). Oct4 is a transcription factor of the POU family, 
which is restricted to cells of early embryos and undifferentiated ESCs. Oct4 is 
rapidly down-regulated in gastrulation and for this reason a low level of Oct4 is 
essential for ESCs to differentiate into different cell lines. However, Oct4 remains 
expressed in embryonic neural crest (Guo et al., 2002) which means it may be 
expressed in the dental pulp (Huang et al., 2009b). On the other hand, Nanog over-
expression also maintains ESCs self-renew ability (Yates and Chambers, 2005). 
However, Nanog cannot function in the absence of Oct4 (Chambers et al., 2003). 
There are many signals and growth factors that regulate the ESCs self-renewal 
ability. Leukaemia Inhibitory Factor (LIF) activates Signal Transducer and Activator 
of Transcription 3 (STAT3) to support the undifferentiated phase of mouse ESCs. In 
addition to LIF, Bone morphogenic protein 4 (BMP4) extrinsic factor and Wnt 
pathway maintain mouse ESCs self-renewal (Ying et al., 2003). In humans, LIF and 
BMP4 are not enough to maintain ESCs pluripotency. Instead, growth factors such as 
fibroblast growth factor (FGF) signalling are considered to be essential to the self-
renewal of human embryonic stem cells. However, the mechanism of these processes 
is still unclear (reviewed in Pan and Thomson, 2007).  Furthermore, ESCs express 
some surface antigen that are found in adult stem cells such as Oct4, CD 117, CD 
135 and CD 91 (Hoffman and Carpenter, 2005) which indicates that adult stem cells 
have some similar characteristics to ESCs. As ESCs have the capacity to generate 
any type of cells in the body, they are a promising target for tissue replacement. 
However, the use of these cells has ethical challenges, with respect to their source 
where it may require the destruction of a human embryo. For this reason, using other 
types of stem cells for tissue replacement has been introduced (Liao, 2005; Lin et al., 
2008). 
 
1.2.2 Adult Stem Cells 
Adult stem cells, sometimes called somatic stem cells, are undifferentiated cells that 
are found in tissues throughout the body with renewal capacity after embryonic 
development (Lin et al., 2008). Stem cells generate intermediate cell type called 
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progenitor cells, before they achieve their fully differentiate state. Their main 
function is to replace cells that die because of injury or disease (Verstappen et al., 
2009). Adult stem cells are located in different adult tissues, including bone marrow, 
peripheral blood, the subventricular zone (SVZ) of the brain, dental pulp, blood 
vessels, skeletal muscle, epithelia of the skin, cornea, retina, liver, and pancreas 
(Bongso and Lee, 2005). These cells differentiate into specific tissues depending on 
their site where specific signals are taking within their niche. Adult stem cells have a 
more limited range of differentiation lineages but less ethical concerns compared 
with ESCs (Gafni et al., 2004; Lin et al., 2008). In the beginning, no one considered 
the possibility that stem cells in adult tissues could generate in vitro other types of 
tissue, different than the tissue in which they normally reside. Later, several studies 
showed that adult stem cells from bone marrow were able to differentiate into 
different cell linages such as mature cells of the liver (Theise et al., 2000; Alison et 
al., 2000) and neural cells (Sanchez-Ramos et al., 2000). Telomerase activity in adult 
stem cells is controversial. Even those adult stem cells tend to give rise to a high 
number of daughter cells but they do not express high level of telomerase like ESCs. 
In addition, some adult stem cells such as MSCs they do not express any telomerase 
which means there are other mechanisms to maintain the telomere other than 
telomerase (Hiyama and Hiyama, 2007; Saretzki, 2009). There are several types of 
adult stem cells. These types of cells are mostly classified according to their location 
in the body. 
 
1.2.2.1 Mesenchymal Stem Cells (MSCs) 
Friedenstein et al., (1968) was the first to discover MSCs in the bone marrow and 
defined them as osteogenic stem cells. However, the first person who called these 
cells MSCs, was Caplan in 1991. These cells were able to form colonies composed 
of fibroblastoid cells raised from one cell (Fridenstein et al., 1970). It has been 
noticed that MSCs are commonly associated with blood vessels, which means MSCs 
are found in many parts of the body, such as bone marrow, blood and dental pulp. 
MSCs are mononuclear cells with fibroblastic like morphology (Mareschi et al., 
2001). These cells are capable of differentiating into many types of cells, such as 
osteoblasts (Rickard et al., 1996), chondrocytes (Ashton et al., 1980) adipocytes 
(Bennet et al., 1991), and myoblasts (Wakitani et al., 1995) in vitro. In addition, 
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MSCs can form bone and cartilage in vivo, when seeded upon ceramic carriers 
(Friedenstein et al., 1987; Goshima et al., 1991). Some studies show that MSCs have 
the potential to differentiate into non-mesodermal lineages including skin (Sasaki et 
al., 2008) and neurons (Kopen et al., 1999; Zhao et al., 2002; Suon et al., 2004). Due 
to their diversity in differentiation, ease of handling and accessibility, such properties 
make MSCs an attractive target for tissue engineering. So far, MSCs in the tissue 
engineering facilitate studies in the growth of bone, cartilage, muscle, skin and neural 
tissue (Rosenbaum et al., 2008). 
 
In order to use these cells in tissue engineering, better understanding of how 
they behave and differentiate into specific lineages is required. Different signals and 
growth factors often lead to different MSC differentiation. The Mitogen-Activated 
Protein (MAP) kinase pathway is identified to control and regulate the proliferation 
and differentiation of MSCs. There are several growth factors and hormones that 
activate this pathway (Jaiswal et al., 2000). The differentiation of MSCs into 
osteoblasts is stimulated by introducing these growth factors such as epidermal 
growth factor (EGF), dexamethasone, and vitamin C into the culture medium 
(Maniatopoulos et al., 1988; Kratchmarova et al., 2005). Many in vitro studies show 
the ability of MSCs to differentiate into neural cells. When human or mouse MSCs 
are cultured with EGF and brain-derived nurotrophic factor (BDNF), the cells started 
to express neuroepithelial marker (nestin) and the neuronal nuclear protein (NeuN), 
which can be considered as evidence that MSCs differentiate into neural cells   
(Sanchez-Ramos et al., 2000). Another study by Woodbury et al (2000) was able to 
differentiate peripheral MSCs into neurons. In this study, cells were cultured in 
serum-containing medium supplemented with -mercaptoethanol. After 24 h, 
changes in the morphology were observed. The next step was culturing the cells in 
medium containing basic fibroblast growth factor (bFGF). These results 
demonstrated that MSCs exhibited the neuronal marker neuron-specific enolase 
(NSE) (Woodbury et al., 2000). Another study found that MSCs can express keratin 
14, a specific cell marker for keratinocytes, when cells were exposed to bone 
morphogenetic protein-4 (BMP-4) for 6 days in vitro while in vivo MSCs are 
recruited to the wound site by specific chemokine (SLC/CCL21) where they 
contribute in wound healing process and may differentiate into different skin cells 
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(Sasaki et al., 2008). MSC also have the ability to differentiate into endothelial cells 
(Reyes et al., 2002). By culturing MSCs in vitro with vascular endothelial growth 
factor (VEGF), CD34
+
 and fetal liver kinase
+
 (Flk1
+
), endothelial expressions were 
detected. These expressions would be expected for endothelial cells (Reyes et al., 
2002). Furthermore, mechanical loading plays an important role in MSCs 
differentiation. A study showed that MSCs lose their fibroblastic morphology and 
begin to show expression of chondrocytes, when grown in 3D culture, containing a 
serum-free nutrient medium, with addition of a member of the transforming growth 
factor (TGF) super family (Barry et al., 2001). All these studies into MSCs 
differentiation may help in tissue regeneration and cell therapy. 
 
Nowadays, there is a lot of debate over the identification of MSCs. Until 
recently, there are many techniques available but no single method is seen as ideal. 
These techniques include colony forming efficiency, gene expression and cell surface 
markers (Kuhn and Tuan, 2009; Morikawa et al., 2009). Another recent technique 
using collagen type II, alkaline phosphatase and Oil Red O staining assays, are 
applied to identify MSCs isolated from bone marrow. This technique depends on the 
ability of these cells to form osteoblasts, chondrocytes and adipocytes (Pittenger et 
al., 1999). With regards to identifying MSCs by using cell surface markers, many 
studies have shown that MSCs from different sources express several markers such 
as CD73, CD105, CD90, CD44, CD29, CD166 and CD271 (Bühring et al.,2009; 
Kuhn and Tuan, 2009; Market et al., 2009). Unfortunately, there are no specific 
markers for MSCs only (Javazon et al., 2004), but it is generally agreed that MSCs 
do not express CD34, CD45, CD14 or CD 11 which could help in identifying these 
cells (Chamberlain et al., 2007; Sasaki et al., 2008). Furthermore, several studies 
state that MSCs must express CD105, CD90 and CD73 or they cannot be considered 
to be MSCs (Rosenbaum et al., 2008; Kuhn and Tuan, 2009). CD105 or endoglin is a 
vital molecule in vascular development and angiogensis (Seon and Kumar, 2001; 
Takahashi et al., 2001; Wikstrom et al., 2002). Gene mutations in CD105 in humans 
are responsible for an autosomal dominant disorder, called hereditary haemorrhagic 
talengiectasia type 1, characterised by recurrent haemorrhage (Shovlin and Letarte, 
1999). Endoglin is a receptor for TGFβ1 and TGFβ3 where TGFβ signalling 
regulates cell proliferation and differentiation (Pepper, 1997). Studies have shown 
8 
 
that CD73 or ecto-5’-nucleotidase have many functions including adhesion of 
lymphocytes (Airas et al., 1995) and may play role in T-cell proliferation (Massaia et 
al., 1990). Studies have shown that CD90 or Thy-1 is expressed in human fibroblasts, 
neurons, blood stem cells and endothelial cells (Rege and Hagood, 2006). CD 90 is 
involved in many functions including T-cell activation (Barboni et al., 1991) and 
fibroblast proliferation (Silvera and Phipps, 1995). 
 
There are many methods available to isolate MSCs, including the fibronectin 
adhesion assay (Jones and Watt, 1993). This method depends on MSCs having a high 
surface expression of 1 integrins.  MSCs express three kinds of 1 integrins; 51, 
the fibronectin receptor, 21 which plays a major role in binding to laminin and 
collagen and 31 which is a receptor of laminin. For this reason, fibronectin, an 
extracellular matrix glycoprotein, is used as it strongly binds to 51 which is 
strongly expressed by MSCs. In the Jones and Watt study, they found that 1 
integrin density was directly proportional with colony forming efficiency which 
meant that 1 integrin density is increased in the cell surface of stem cells due to its 
proliferative potential.  Another way to isolate MSCs is through magnetic activated 
cell sorting (MACS). This method is based on the isolation of cells by magnetism by 
adding MACS microbeads, developed by Miltenyi Biotec. These microbeads have a 
biodegradable matrix and they do not change activity or the structure of the cells. 
This technology had been used by many research groups, such as Quirici et al., 2002; 
Huang et al., 2009a; Lu et al., 2009. Another method which could be used to isolate 
stem cells is fluorescence activated cell sorting (FACS) by flow cytometry. It has the 
same principles as MACS. In this method monoclonal antibodies are used for the 
selection of cell markers expressed by MSCs. It has been used in several studies, 
such as Schwab and Gargett, 2007. Both methods (MACS and FACS) sorted cells 
based on their cell surface receptors such as CD146, CD271, CD71 and CD34 
(Quirici et al., 2002; Schwab and Gargett, 2007; Huang et al., 2009a; Lu et al., 2009). 
 
MSCs are considered to be a promising tool for the future of tissue 
engineering and regenerative medicine. However, they are some drawbacks such as 
their rare population (Friedenstein et al., 1982). This means an extensive in vitro 
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expansion necessary to produce sufficient cell numbers for clinical use. This is going 
to influence their biological properties which will be investigated in this study. 
 
1.2.2.2 Hematopoietic Stem Cells (HSCs) 
HSCs are adult stem cells. Their main function is maintaining a functional blood 
system throughout life, by their differentiation and proliferation into many types of 
blood and lymphoid cells, such as erythrocytes, granulocytes, monocytes, T-cells and 
B-cells (Stocum, 2001). HSCs are believed to exist in few numbers of specialized 
niches within the bone marrow, about one cell in every 10
5
 bone marrow cells. They 
are also found in umbilical cord blood and the liver. HSCs are believed to be 
multipotent, because of their high plasticity and their ability to differentiate into 
many types of cells (reviewed in Stocum, 2001; Bongso and Lee, 2005; Forsberg and 
Smith-Berdan, 2009). HSCs are mainly isolated from bone marrow and are 
characterised by either FACS or MACS methods based on their surface markers, 
including CD34, C-KIT and CD90 (Stocum, 2001; Challen et al., 2009). 
 
HSCs are considered as the most successful type of stem cells for therapy. 
HSCs transplantation is used as standard of care for many patients with congenital or 
acquired disorders of the hematopoietic system, such as leukaemia and lymphoma 
from the mid-seventies until now (Hołowiecki, 2008). There are several sources of 
HSCs for transplantation. The main one is the bone marrow, where side- effects in 
the donor are rare, about 2 deaths in every 8000 cases (Anderlini et al., 2001).  
Allogeneic bone marrow transplantation has been used for many years to treat 
patients with genetic immunodeficiency, metabolic disorders, bone marrow failure 
syndromes or in patients who have undergone radiation or chemotherapy. However, 
the majority of patients cannot match with an appropriate donor which leads to many 
complications. Recently, another source of HSCs have been found, which can reduce 
these complications is umbilical cord blood (Stocum, 2001). The first use of this 
transplantation technique was performed in a child with Fanconi’s anemia 
(Gluckman et al., 1989). The following table was taken from Copelan, 2006 (Table 
1.1), which shows the most common diseases treated with hematopoietic stem cell 
transplantation. 
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Table1.1. The most common diseases with hematopoietic stem cell 
transplantation (Copelan, 2006). 
 
 
 
Autologous Transplantation Allogeneic Transplantation 
Cancers Other Diseases Cancers Other Diseases 
Multiple 
myeloma 
Autoimmune 
disorders 
Acute myeloid 
leukemia 
Aplastic anemia 
Hodgkin's 
disease 
Amyloidosis Acute 
lymphoblastic 
leukemia 
Fanconi's anemia 
Non-Hodgkin's 
lymphoma 
 
 
Chronic myeloid 
leukemia 
Blackfan-
Diamond anemia 
Ovarian cancer Hodgkin's disease Thalassemia 
major 
Neuroblastoma Non-Hodgkin's 
lymphoma 
Sickle cell anemia 
Acute myeloid 
leukemia 
Multiple  
myeloma 
Paroxsymal 
noctrunal 
hemoglobinuria 
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1.2.2.3 Other Types of Adult Stem Cells  
There are other type of adult stem cells that may contribute in the development of 
dental pulp based on their ectomesenchymal origins (Sinanan et al., 2004) such as 
endothelial stem cells (EnSCs), and neural crest stem cells. EnSCs were first isolated 
by Asahara et al (1997) from the human blood in the bone marrow. They expressed 
cell markers that were found in mature endothelium and HSCs including the vascular 
endothelial growth factor receptor-2 (VEGFR-2), CD34 and CD133 (Andreou et al., 
2006). The main functions of EnSCs are repairing of endothelial damage, formation 
of new blood vessels and paracrine signalling (Sen et al., 2011). Alterations in 
numbers and functions of EnSCs may associate with many diseases such as 
cardiovascular diseases, diabetes and hypertension (Sen et al., 2011). EnSCs play an 
important role in tissue engineering of blood vessels (Zeng et al., 2010) and because 
of their role in signalling they are considered as a good candidate to use in tissue 
engineering to enhance the function of other adult stem cells (Fedorovich et al., 
2010). For example, co-culture of DPPCs and EnSCs led to enhance the 
differentiation into osteogenic cell type when compared with culturing of DPPCs 
alone (Dissanayaka et al., 2012). 
 
The neural crest is considered as a good model in stem cell biology because it 
gives rise to cells that form most of the skeleton and connective tissues of the head, 
face, neck and teeth. They also give rise for most of the peripheral nervous system 
(Kalcheim and Burstyn-Cohen, 2005; Chung et al., 2009). During neural crest 
development, Snail family members including Snail and Slug transcription factors 
and Notch family members are among the earliest markers that are expressed and 
used as indication of the neural crest stem cells (Kalcheim and Burstyn-Cohen, 
2005). Neural crest stem cells are a heterogeneous population with different 
potentials of proliferation and differentiation (Lee et al., 2007). These cells can be 
isolated from many tissues such as skin, hair follicle and dental pulp and because of 
their differentiation capacity and high proliferative capacity without raising ethical 
concern they are a good candidate for clinical use (Ibarretxe et al., 2012). These cells 
have been successfully used to contribute in recovery of spinal cord injury in animal 
models (Hu et al., 2010).  
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1.2.3 Asymmetric Stem Cell Division 
Adult stem cells have the ability for self-renewal and differentiate into multiple cell 
lineages, with short life-spans. To achieve self-renewal capabilities and 
differentiation functions, stem cells divide slowly and symmetrically to produce an 
identical daughter cell with low proliferative capacity and multipotential 
differentiation. Some of these adult stem cells go on to divide asymmetrically and 
give rise to one identical daughter cell and another progenitor cell called a transit 
amplifying (TA) cell. TA cells have high proliferative potential and low 
differentiation ability and give rise to more committed progenitors with reduced 
proliferative potential (Figure 1.1) (Ho, 2005). Despite enormous progress in the 
stem cell field, there are still many unanswered questions about stem cell division 
(Inaba and Yamashita, 2012). Asymmetric stem cell division is controlled in the stem 
cell niche by a combination of intrinsic and extrinsic cellular mechanisms. These 
mechanisms are becoming elucidated with advancing technology. For example, time-
lapse microscopy has been used to demonstrate that neural progenitor cells in the 
cortex divided asymmetrically, to produce different cell lines (Ho, 2005).  One 
example showing the vitality of asymmetric stem cell division in humans is that 
asymmetry maintains long term haematopoiesis, by the formation of blood cellular 
content, derived from HSCs (Ho, 2005) (Figure1.1). It is noteworthy that even if both 
daughters of a stem cell division express stem cell markers after few times of 
division, it does not exclude the possibility that one daughter is less proficient as a 
stem cell than the other over the long period of culturing (Inaba and Yamashita, 
2012). This observation is important for tissue engineering field because it will take 
in consideration that these cells need more investigation to select the appropriate 
cells to use in stem cell therapy. 
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Figure.1.1. Asymmetric stem cell division (Ho, 2005). 
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1.2.4 Stem Cell Niches  
Generally, the word niche has several meanings according to the context in which it 
is used. For example, in ecology it refers to a habitat, while in French, it means a dog 
house (Scadden. 2006). In stem cell biology, the niche is a microenvironment place 
that contains elements which control stem cell differentiation, stem cell survival and 
stem cell renewal (Huang et al., 2009b). These elements include growth factors, cell-
cell interaction and adhesion between the extracellular matrix and the cells (Discher 
et al., 2009). Stem cells reside in a quiescent state within their special niche and they 
start to proliferate and migrate when they respond to injury or physiological changes 
to their niche by systemic signals such as Notch (Mitsiadis et al., 2007; Drummond-
Barbosa, 2008). The stem cell niche concept was first proposed in 1978 by Schofield, 
as a specialized microenvironment housing stem cells in mammalian haematology. It 
has been observed that adult stem cells behave slightly differently outside their niche. 
For example, HSCs, their niche is located in the bone marrow. In this niche, their 
main function is the maintenance of blood cells and immune systems throughout life. 
However, HSCs appear to have limited function when they are circulating freely 
outside their niche. The reasons why HSCs act properly inside the niche are specific 
signals provided by the niche (Scadden, 2006). 
 
Using stem cells as a successful treatment is still hindered by several 
challenges. One of these challenges is the complete control of stem cells growth and 
differentiation (Vazin and Schaffer, 2010). It is believed that a better understanding 
of the stem cell niche will provide a better control of stem cells behaviour (Voog and 
Jones, 2010). Studying the stem cell niche in vivo provides better control of stem cell 
survival and their behaviour, in response to injury (Bendall et al., 2008). Most of our 
knowledge about the stem cell niche comes from studying cells of Drosophila. These 
studies explain how the direct contact of adjacent non-stem cells to the stem cell 
niche, play an important role in stem cell behaviour (reviewed by Fuchs et al., 2004). 
Later, other studies in the Drosophila model showed that extracellular matrix 
molecules and cadherin molecules have an influence on stem cell niche (Vazin and 
Schaffer, 2010). In mammals, the study of stem cell niche in vivo is more 
complicated than in lower organisms, because of the diversity of their components. 
However, the knowledge gained from lower organisms provides an important 
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principle to understanding mammalian stem cell niche through signalling between 
cells or cells and the extracellular matrix (Vazin and Schaffer, 2010). A stem cell 
niche inside the bone marrow is surrounded by osteoblasts. Studies in mice models 
show that by increasing the quantity and activity of osteoblasts the number of HSC is 
increased (Calvi et al., 2003; Zhang et al., 2003; Lo Celso et al., 2009). The 
extracellular matrix (ECM) around the stem cell niche also plays a role in stem cell 
behaviour, due to its content of signalling mediators and growth factors. For 
example, osteopontin (OPN), an important gene in bone remodelling, plays a role in 
HSCs regulation by interacting with CD44, a receptor in HSCs. A study in animals 
shows that a deficiency in OPN will lead to increases in HSCs. This means that OPN 
acts as restraint on HSCs number (Scadden, 2006). Another factor which affects the 
stem cell niche is oxidative stress which is going to be explained in the next chapter. 
Another important factor inside the niche is signalling. Osteoblasts can maintain 
HSC self-renewal and prevent differentiation by expressing Notch ligands jagged 1 
to stimulate receptors on the HSC surface (Calvi et al., 2003). In addition, 
BMP/TGF superfamily may play role in the maintenance of HSCs in their niche 
(Zhang et al., 2003). 
 
MSCs niches are found in different locations. Bone marrow is believed to be 
a major site for MSCs as well as HSCs. Dental pulp is another possible niche for 
MSCs (Shi and Gronthos, 2003). MSCs in the dental pulp have been localised in the 
perivascular and perineural sheath regions, by using antibodies against STRO-1, 
CD146 and pericyte-associated antigen (Huang et al., 2009b). Other studies have 
localized MSCs in capillaries and nerve networks within the cell free zone (Lizier et 
al., 2012), and the subodontoblastic cell-rich layer in the dental pulp (Hosoya et al., 
2012). An example of the importance of signalling in the maintenance of the dental 
pulp stem cell niche, are ephrin (Eph) receptors which are components of signalling 
pathways involved in mammalian development. Eph receptors regulate the migration 
of DPSCs by several signalling pathway (Matsuo and Otaki, 2012). This finding 
suggests that Eph/Ephrin interaction may play a role in maintenance of DPSCs inside 
their niche (Stokowski et al., 2007). Another study by Bundesen et al., 2003 found 
that following spinal cord injury in rat, EphB/Ephrin-B expression is decreased and 
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cells subsequently migrate to the injury site. We can conclude from these two results 
that Eph receptors maintain the stem cell niche in the healthy phase. 
 
1.2.5 Stem Cell Senescence 
Ageing is a complex process that occurs due to cell damage which, leads to organ 
failure and eventually death. Every time the cell divides, it is susceptible to telomere 
shorting, which leads to cell senescence (Serakinci et al., 2008; Wagner et al., 2008). 
Cell senescence can be defined as the loss of a cell’s ability to divide (Hayflick and 
Moorhead, 1961), which is different from apoptotic cells, as senescent cells remain 
alive, despite a change in their function (Itahana et al., 2001). The majority of cells in 
the human body have a limitation in their replicative potential described as the 
Hayflick limit (Petersen and Niklason, 2007). At the end of every chromosome there 
is a region of repetitive DNA known as a telomere that consists of tandem chromatin 
TTAGGG. Importantly, telomeres protect the end of chromosomes from weakening. 
After each cell replication the telomere becomes shorter due to incomplete linear 
chromosomal replication, by DNA polymerase, which can lead to damage to the ends 
of the chromosomes leading to cell senescence. Additionally, the process of 
oxidative stress can also shorten telomeres (Flores et al., 2006; Serakinci et al., 
2008). 
 
MSCs exist for as long as the organ they reside in (Fehrer and Lepperdinger, 
2005). One of the reasons that make them survive this long is the telomeres which 
are required for both cell duplication and differentiation, which means  MSCs should 
at least express some telomerase, in order to achieve these features (Fehrer and 
Lepperdinger, 2005). However, some MSCs show no or low level of telomerase 
activity (Zimmermann et al., 2003), which suggests there are other mechanisms 
within these cells, which are enable them to keep proliferating or maintaining their 
multipotent potential (Hiyama and Hiyama, 2007). Altogether, this suggests that 
MSCs in vivo are subjected to little or no telomere erosion. Therefore, if telomere 
maintenance can be achieved in vitro, this would mean huge benefits to tissue 
engineering (Fehrer and Lepperdinger, 2005). 
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MSCs exist in very low populations in their niche. In order to study these 
cells, it is essential to culture them for proliferation. For this reason, it is important to 
understand the process of aging during their proliferation in culture (Bonab et al., 
2006). Population doubling (PD) is considered as a simple method to help estimate 
cell growth in vitro and the most obvious marker for cell senescence. Earlier studies 
have shown that human MSCs are more likely to lose their proliferative potential 
during expansion in vitro (Mets and Verdonk, 1981; Digirolamo et al., 1999; 
D’Ippolito et, al 1999). The number of days of culturing or passages of MSCs in 
vitro varies between studies depending on many factors, including the components of 
the medium are used, the cell source and the age of the donor. Bonab et al., 2006, 
expanded MSCs from the bone marrow of healthy individuals which showed a mean 
long-term culture of 118 days, the mean passage number was 9 and the average of 
PD declined from 7.7 to 1.2 in the 10th passage. Another study suggests that MSCs 
cannot be expanded beyond 7 passages (Market et al., 2009). Several studies show 
that donor age affects the rate of in vitro senescence in MSC (Stenderup et al., 2003; 
Mareschi et al., 2006). In the Mareschi study, it showed that PDs are almost doubled 
from paediatric donors, compared with adult donors. During passaging studies, 
MSCs were also show to be subject to molecular changes. During ageing, it has been 
suggested that MSCs decrease osteogenesis and chondrogenesis, while they increase 
their adipogenesis ability (Murglia et al., 2000; Moerman et al., 2004; Wall et al., 
2007). These changes may affect the benefits of MSCs on cell therapy. Another 
criterion that distinguishes senescent cells is morphology. As cells progress through 
their proliferative lifespan, morphological changes take place. In early stage, cells 
tend to be bipolar and spindle shaped. However, cells are larger, wider, flattened and 
irregular in shape when they senesce (Sethe et al., 2006). They are also become 
multinucleated with loss of polarity (Matsumara et al., 1980). Furthermore, it is been 
found that there is correlation between increasing of cell size and increasing of actin 
microfilaments organisation (Wang and Gundersen, 1984). Another marker for cell 
senescence is -galactosidase activity. This enzyme is easy to detect by using 
histochemical stain in senescent cells, but not in quiescent or immortal cells (Dimri 
et al., 1995). 
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1.3 Tissue Engineering and Regenerative Medicine 
There is a growing need for tissue engineering because of increasing in life 
expectancy which is accompanied with elderly diseases such as osteoporosis (Kanis 
et al., 1994) and Alzheimer's disease (Pouryamout et al., 2012). Moreover, a wide 
range of diseases cause organ failure which often cannot repair itself. The accepted 
treatment of these conditions in the past 50 years was to remove the injured part and 
replace it with different types of structure, either synthetic such as knee replacement, 
intraocular lens and prosthetic heart valves or natural such as an organ from donor 
(Williams, 2006). However, there are limitations of these replacements including 
shortage of donor organs, rejection, the need of life-long immunosuppressants and 
biocompatibility (Williams, 2006). Therefore, the development of regenerative 
medicine has been promoted to outcome these shortcomings. Tissue engineering and 
regenerative medicine are aimed to restore normal structure and function through the 
production of new tissue that regenerates exactly that which has been lost by using 
combination of cells, and tissue inducing substances such as growth factors placed 
within matrices such as collagen (Langer and Vacanti, 1993).  
 
1.3.1 Role of Biomaterials in Tissue Engineering 
The purpose of using scaffolds in tissue engineering along with desired seeded cells 
is to imitate the biologic and mechanical function of ECM that naturally occurs in the 
human body to help deliver these cells to the desired sites in the body and therefore 
restore the damaged tissue (Kim and Mooney, 1998). Scaffolds have been used for a 
long time in the tissue engineering field (Ma et al., 1999; Altman et al., 2002; Li et 
al., 2006; Tai et al., 2010). Significant efforts have been made to construct scaffolds 
that are similar to the natural extracellular matrix. These scaffolds are made from 
different type of material that can be divided into two main types: synthetic and 
natural. Natural biomaterials used in scaffolds for stem cell cultures are either made 
from ECM components (collagen or hydroxyapatite) or other natural sources (silk, 
fibroin or chitosan). Synthetic materials include polyglycolide and polylactide 
(Dawson et al., 2008; Vazin and Schaffer, 2010; House et al., 2010). The ideal 
biomaterials to use in tissue engineering field should be biodegradable, bio-
resorbable and has good mechanical properties without inducing any unwanted 
response such as inflammation or swelling (Bergsma et al., 1995; Atala, 2012). 
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Moreover, a combination of adhesion peptides such as Arg-Gly-Asp (RGD) and 
fibronectin, which are naturally found in collagens and growth factors, enhanced cell 
adhesion and migration inside biomaterial scaffold (reviewed in Gurtner et al., 2007). 
Many extracellular matrix components such as collagen, fibrinogen, hyaluronan acid, 
glycosaminoglycans (GAGs) have been used as scaffold materials (Dawson et al., 
2008). These components provide a physical structure and natural signals which 
control stem cells behaviour (Vazin and Schaffer, 2010). For example, a 
collagen/hyaluronan matrix was found to be enhanced neural stem/progenitor cells 
differentiation (Bränvall et al., 2007). 
 
Collagen is the most common protein found in the human body (Karamichos 
et al., 2007). Collagen type I is most commonly used in scaffolds because of its 
abundance, ubiquity and biocompatibility (Glowacki and Mizuno, 2008). Also, 
collagen contains cell adhesion domain sequences (e.g., RGD) that may contribute in 
maintaining the phenotype and activity of many types of cells, including fibroblasts 
(Silver and Pins, 1992). Primary hepatocytes have a low proliferation ability and 
gradual loss of function by expressing low albumin level when they are grown in 
vitro. However, when they are grown on collagen type I modified scaffolds they 
show higher albumin levels which exhibit that they are functioning better on collagen 
scaffold (Tai et al., 2010). It is also highly desirable to use collagen gels for the 
culture of BMSCs because it maintains cell attachment and proliferation (Hesse et 
al., 2010). DPSCs have almost same properties with BMSCs (Huang et al., 2009b) 
and for this reason collagen type I will be used to culture DPSCs in this study. 
Collagen type I is the most abundant protein in dentine and a major component for 
primary and reparative dentin formation (Linde, 1989). Collagen type I scaffold with 
other components including dentin matrix protein-1 and BMP-7 with DPSCs have 
been used in tissue engineering of the tooth in order to attempt to form hard tissue 
and it has been shown that these elements enhance DPSCs differentiation (Prescott et 
al., 2008; Wang et al., 2010). In the present study cultures these cells and imitates 
compromise tissues in the collagen gel are to be investigated. 
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1.3.2 Mesenchymal Stem Cells and Tissue Engineering 
Tissue engineering is defined as the use of combination of living cells with 
biodegradable material to regenerate the affected tissue in the patient (Lanza et al., 
2007). Recently, many aspects of tissue engineering have been investigated including 
methods of cell isolation, expansion, differentiation and transplantation 
(Khademhosseini et al., 2009). Cells can be used for therapy via injection with 
carriers such as hydrogels or even alone without a carrier (Atala, 2012). Many types 
of stem cells have been used for tissue engineering purposes such as embryonic stem 
cells (Hwang et al., 2006), hematopoietic stem cell (Copelan, 2006), Bone marrow 
progenitor cells (Cho et al., 2006), adipose derived stem cells (Bunnell et al., 2008), 
neural stem cells (Olson et al., 2009), dental follicle stem cells (Honda et al., 2010) 
and DPPCs (Arthur et al., 2009). 
 
MSCs are considered as promising tools in the tissue engineering field since 
they have the ability to give rise to progenitor cells. These cells can be expanded in 
culture and differentiate into specific cell lineages to replace the damaged cells. 
Many research groups have isolated MSCs from different tissues and characterised 
them to find the best conditions to grow them in order to use in numerous medical 
applications. Culture medium, addition of growth factors, mechanical stimuli and 
oxygen levels are examples of conditions that influence MSCs stemness, 
proliferation and differentiation capacity (reviewed in Lavrentieva et al., 2013).  
 
DPPCs have been suggested for use in bone tissue engineering because they 
have the ability to differentiate into osteocytes in vitro and in vivo. Osteogeneses has 
been confirmed by Alkaline Phosphatase, Van Kossa staining and reverse 
transcription-polymerase chain reaction (RT-PCR) analysis of osteogenesis-specific 
genes (Li et al., 2011; Khanna-Jain et al., 2012; Akkouch et al., 2013). Furthermore, 
DPPCs showed better osteogenesis differentiation in compare with BMPCs in terms 
of expression of bone markers which make them a good candidate to be used in bone 
tissue engineering applications (Alge et al., 2010). 
 
Conversely, the use of MSCs in tissue engineering is hampered by large donor 
variability and the loss of stemness during in vitro expansion which eventually leads 
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to cell senescence (Alves et al., 2013). In order to investigate the correlation between 
the age of donor or in vitro expansion with MSCs differentiation capacity, a number 
of studies have been performed (Bonab et al., 2006; Siddappa et al., 2007; Agata et 
al., 2010; Kim et al., 2012). A specific study compared the effect of in-vitro culture 
by time with increasing passage number, and found that the former has more effect 
on MSCs than the latter (Stenderup et al., 2003). It showed that increasing the 
number of in-vitro passages led to a decrease of their ability to differentiate into 
osteogenic and adipogenic lines while the donor age did not affect the differentiation 
ability between young and old groups (Stenderup et al., 2003). However, this is not 
always the case. There are many conflicting results about the age effects which may 
be due to age of the donor or the ageing within the in vitro culture. These conflicting 
results were showing that this aging either has no effect on differentiation ability of 
the cells (Justesen et al., 2002;  Scharstuhl et al., 2007) or it affects the differentiation 
into either adipocytes or osteoblasts or even both ( Wall et al., 2007; Stolzing et al., 
2008; Kretlow et al., 2008). Nonetheless, most of the studies demonstrated changes 
in cell proliferation and cell senescence during ageing (Stenderup et al., 2003; 
Mareschi et al., 2006; Kretlow et al., 2008). In this study, the effect of in vitro culture 
in term of cell senescence, differentiation capacity and telomere length will be 
studied upon different clones of MSCs. Cellular senescence during in vitro expansion 
of MSCs could be the result of intrinsic (telomere length) or extrinsic (oxidative 
stress, DNA damage) factors (Ben-Porath and Weinberg, 2005). Accumulation of 
DNA damage during in vitro culture, which could be induced by oxidative stress due 
to the presence of hydrogen peroxide, has been linked to the loss of differentiation 
potential of human MSCs (Alves et al., 2010).   
 
1.4 Oxidative Stress 
Oxidative stress is induced as a consequence of the generation of reactive oxygen 
species (ROS) which is a collective term including; oxygen-derived free radicals, 
such as the superoxide radical (O2
.-
) and hydroxyl (
.
OH) radical species, and non-
radical derivatives of oxygen, such as hydrogen peroxide (H2O2) and hypochlorous 
acid (HOCl) (reviewed in Waddington et al., 2000). ROS are produced naturally 
through a variety of cellular processes. However, excessive production of ROS 
contributes to severe damage to cellular components, loss of cell function, and 
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ultimately apoptosis. The free radical is defined as any species capable of 
independent existence that contains one or more unpaired electrons in an outer orbit 
(Halliwell et al., 1992). They are generated as by-products of metabolism in cells and 
react indiscriminately with organic molecules due to their instability. These 
molecules include proteins, lipids, carbohydrates and nucleic acids (reviewed in 
Waddington et al., 2000).  Oxidative stress occurs as a result of biochemical 
disequilibrium, between ROS production and antioxidants, which cause 
accumulation of oxidative stress leading to oxidative damage (reviewed in 
Waddington et al., 2000).  This has led ROS to be involved in a variety of disease 
states, including AIDS, cancer, atherosclerosis, chronic inflammatory conditions, 
diabetes mellitus and in the ageing process (Halliwell et al., 1992; Ames et al., 1993; 
Beckman and Ames, 1998; Evans et al., 2004; Moussa, 2008).  Under normal 
conditions, cells lose about 90pb each population doubling, while when they 
subjected to oxidative stress they lose more than 500pb each population doubling 
(Von Zglinicki et al., 1995). Their influence on stem cells may vary between 
inhibition of self renewal ability and at the same time, serving as a signal stimulating 
stem cell differentiation based on their concentration (reviewed in Dayem et al., 
2010). 
 
 H2O2 is a type of ROS that exists in almost all human cells with mitochondria 
being the main source during metabolism (Halliwell et al., 2000; Giorgio et al., 
2007). H2O2 is believed to be cytotoxic and cause damage to the DNA (Ballinger et 
al., 1999). However, studies have revealed that H2O2 can also be used as a signalling 
molecule involved in many different cellular processes (Rhee, 2006; Veal et al., 
2007). For example, H2O2 appeared to be a key messenger for cell adhesion by 
activating tyrosine kinases (Giannoni et al., 2005). Both positive and negative effects 
depend on H2O2 concentration and cell type (Rhee, 2006; Veal et al., 2007). Indeed, 
human tissues are exposed to different concentrations of H2O2 which varies from less 
than 1mM in blood plasma (Frei et al., 1988) to more than 100mM in the oral cavity 
(Long et al., 1999). It is noteworthy to know that damage to DNA and other cellular 
components does not come directly from H2O2 but from its ready conversion to the 
indiscriminately reactive hydroxyl radical (OH) which is the result of reduction of 
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H2O2 by ferrous or cuprous ion known as Fenton reaction (Martins and Meneghini, 
1994; Halliwell et al., 2000) :- 
Fe2
+
    +    H2O2          .OH    +    OH-    +    Fe3
+
 
Human cells protect themselves against this danger by a network of endogenous 
antioxidant defences (reviewed by Waddington et al., 2000).   
 
1.4.1 Antioxidants 
Antioxidants are exogenous or endogenous molecules, which have the ability to 
prevent or slow the oxidation of other molecules.  Antioxidants prevent oxidation by 
scavenging ROS or their precursors.  These are very important for human health, for 
the prevention of oxidative damage to cellular components, such as proteins, lipids 
and DNA (reviewed by Waddington et al., 2000; Andriantsitohaina et al., 2012).  
There is a wide diversity of antioxidants in the human body, which may be 
enzymatic or non-enzymatic in nature (Sies, 1997). There are many compounds of 
non-enzymatic antioxidants including ascorbic acid, lipoic acid and carotenoids 
(Andriantsitohaina et al., 2012). Their activity as antioxidant is low and acts mostly 
due to their metal ion binding capacity (Lee et al., 2008).  For enzymatic 
antioxidants, there are three main enzymes which play a role in protecting cells 
against oxidative stress. These include Superoxide dismutases (SODs), catalase and 
glutathione peroxidases. SODs are the most important antioxidants in mammalian 
tissues, because they defend against oxidation in almost all cells.  There are three 
major SOD types which have been identified in humans to date, SOD1 or CuZn-
SOD contains a copper and zinc containing homodimer (Zelko et al., 2002).  It is 
located in the cytoplasm. SOD2 or Mn-SOD exists as a tetrameter and is located in 
the mitochondria (Zelko et al., 2002).  SOD3 or EC-SOD is found in the extracellular 
space and forms a glycosylated homotetrameter (Fattman et al., 2003). Catalase is an 
enzyme found in most living organisms which are exposed to oxygen.  Mainly, it is 
found in the peroxisomes. These enzymatic antioxidants work in collaboration to 
protect human body against oxidative stress, where SODs catalyze the dismutation of 
O2
.-
 into H2O2 and O2 and then H2O2 reduced to H2O by catalase (Andriantsitohaina 
et al., 2012). Although antioxidant seems important in scavenging ROS, that cause 
diseases such as atherosclerosis, it has been found to be non-effective to apply it in 
vivo because of the complexity of their reactions (reviewed by Halliwell, 2012). 
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Stem cells have shown a high ability to resist oxidative stress by increasing their 
antioxidant capacity (Dernbach et al., 2004; He et al., 2004). This will support using 
stem cells in tissue engineering and regenerative medicine as it has been shown that 
using muscle-derived stem cells increased antioxidant-resistant capacity which led to 
enhance regenerative capacity in skeletal and cardiac muscle (Urish et al., 2009).  
 
1.4.2 Oxidative Stress and Stem Cells 
     Imbalance between ROS and antioxidants will result in accumulation of oxidative 
stress inside the cells. This could cause damage to cell components, including 
proteins, lipids and nucleic acids which may result in adverse biologic effects, such 
as changes in the signalling pathways or gene expression (Camargo et al., 2009). For 
example, a study showed that endothelial progenitor cells (EnPCs) lose their function 
in response to oxidative stress (Case et al., 2008). Moreover, H2O2 treatment for 
endothelial progenitor cells reduced their clonogenic capacity and impaired the 
ability of them to form blood vessels in vitro and in vivo (Ingram et al., 2007).   Also, 
in a rat model of myocardial infarction, increased production of ROS has been linked 
with reduced EnPC levels (Thum et al., 2006).  Although, ROS are toxic, they also 
function as signalling molecules inside the stem cells niche, controlling apoptosis, 
proliferation, self-renewal, senescence and differentiation (Case et al., 2008). One 
ROS that plays a role in activation of several cell surface receptors is H2O2. For 
example, neutrophils are activated to engulf and kill foreign bodies depending on 
NOX (a subunit of NADPH Oxidase) which release very small amount of H2O2 as 
signals (reviewed in Rhee, 2006). Also, p38 MPAK pathway, which is involved in 
cell differentiation and apoptosis, is activated when oxidative stress increases in 
HSCs. This shows that the regulation of oxidative stress is vital to maintain HSCs 
quiescence (Arai and Suda, 2007). Furthermore, another study found that BMSC 
niche for HSCs is believed to be a hypoxic environment. This environment maintains 
the stemness of the cells and protects the stem cell against ROS, as low oxygen 
results in decreased respiration by mitochondria and prolonged cell lifespan 
(Eliasson and Jönsson, 2010). 
 
Furthermore, it has been proved that stem cells can resist oxygen overload 
more than other cells. This has been shown in endothelial progenitor cells which 
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demonstrated more resistance to oxidative stress than mature umbilical vein 
endothelial cells by revealing higher production of antioxidative enzymes (Dernbach 
et al., 2004). 
    
1.4.3 Oxidative Stress and Dental Pulp Progenitor Cells 
In the dental pulp, there are many different sources of oxidative stress. These sources 
could be divided to internal and external. Accumulation of oxidative stress with 
aging is one of internal sources. This accumulation causes damaging to the DNA, 
which eventually leads to cell death (Rossi et al., 2008). Another internal source is 
inflammation. A recent study showed that the development of pulpitis accompanied 
with a decrease of monoamine oxidase (MAO), which catalyzes the oxidation of 
monoamines, and increase in the amount of semicarbazide-sensitive amine oxidase  
(SSAO), which is involved in the inflammation and oxidative stress in other tissues 
(Vavilova et al., 2009). Finally, diabetes is also could be another internal source of 
oxidative stress. Several studies have demonstrated that the levels of all ROS 
increase during diabetes (Alp et al., 2003; Sadi and Guray, 2009).  Hyperglycaemia 
increases the production of O2
.-
, H2O2 and 
.
OH, by the mitochondrial electron 
transport chain, which inhibits GAPDH activity (Góth, 2008).  Such events can 
induce mutations in mitochondrial DNA, which cause the major overproduction of 
ROS (Kowluru and Chan, 2007). A recent study showed that diabetes causes 
modification in the structure of the dental pulp by inducing the expression of 
inflammatory mediators which eventually increase the amount of oxidative stress 
(Leite et al., 2008). 
 
 Several types of dental materials and treatment techniques are the main 
external sources that could cause oxidative stress in the dental pulp. Dentin bonding 
agents, such as HEMA and TEGDMA, used to improve the contact between filling 
materials and the prepared cavity of the dental wall. These materials are believed to 
be cytotoxic and cause the formation of ROS which eventually may lead to cell death 
(Demirci et al., 2008). Some dental treatment techniques such as magnetostrictive 
ultrasonic scalers and high speed handpieces could also generate heat to the tooth 
surface and so raise the temperature of the dental pulp (Nicoll and Peters, 1998; 
Cavalcanti et al., 2003). Changing the temperature of the dental pulp can induce an 
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inflammatory reaction. A number of studies in animal models found that applying 
heat to the dental pulp will increase interleukin (IL-1) and tumor necrosis factor 
(TNF-α) expression (Chang et al., 2009). TNF-α is known to induce ROS and 
decrease antioxidant enzymes which leads to elevation of oxidative stress (Dhingra et 
al., 2007). Dental bleaching is based on H2O2 applied to the enamel surface which 
may traverse dentinal tubules that will affect the pulp cavity (Ubaldini et al., 2013). 
For this reason and because cells investigated in this study are located in several 
niches in the dental pulp (Sloan and Waddington, 2009), an introduction about the 
tooth structure and the development of these cells will help for more understanding 
of these cells and their markers. 
 
1.5 Tooth Development 
The first arch epithelium, which gives rise to the maxilla and mandible, has a main 
influence on the induction of tooth development (Mina and Kollar, 1987). The dental 
pulp is created of ectomesenchymal components, resulting from interaction between 
ectoderm and mesoderm layers, during the six week of embryogenesis (Sinanan et 
al., 2004). Ectomesenchyme cells participate in tooth development, from the cranial 
neural crest cells which later form dental papilla. Other studies have demonstrated 
that the dentine matrix, odontoblasts and most of the pulpal tissue are of cranial 
neural crest origin (Chai et al., 2000; Sloan and Smith, 2007).     
Primary odontoblasts differentiate from dental papilla cells, in response to signals 
derived from the inner dental epithelium and mediated by the basement membrane. 
These dental papilla cells come into contact with the basement membrane at the last 
line of division, resulting in two daughter cells. One of these cells becomes 
terminally differentiated odontoblast after it responds to the molecular signals 
mediated through basement membrane. The other one remains in the cell-rich zone 
where cells are kept in the undifferentiated state (Ruch et al., 1995; Sloan and Smith, 
2007). These cells are called undifferentiated mesenchymal cells. 
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1.6 Dental Pulp 
Dental pulp is soft tissue, arising from ectomesenchymal and mesenchymal origin 
which develops from the dental papilla. It consists of connective tissue, water, blood 
vessels, nerves, lymphatics, fibroblasts, immune cells and odontoblasts (Trowbridge, 
2003). Dental pulp contains a heterogeneous cell population. The majority of these 
cells are fibroblast-like cells, with inflammatory, immune and DPPCs (Goldberg et 
al., 2008). Indeed, it is proposed that DPPCs exist in several niches within dental 
pulp. However, the nature and origins of these DPPC clones with contrasting 
proliferative capacities have yet to be elucidated. This is because DPPCs have two 
origins; one is neural crest and the other is mesoderm and it is difficult to distinguish 
between them (Komada et al., 2012). Mostly they have been reported that they reside 
in the perivascular/pericyte zone (Alliot-Licht et al., 2001; Shi and Gronthos, 2003; 
Téclès et al., 2005). Others suggested that DPPCs could be located anywhere in the 
coronal pulp, such as subodontoblastic layers controlled by Notch signalling 
molecules (Løvschall et al., 2005) or in the capillaries and nerve networks in cell 
free zone (Lizier et al., 2012). In mouse incisor teeth, the cervical loop was suggested 
to be another location where DPPCs reside because this where odontoblast 
differentiation begins (Feng et al., 2011). During tooth eruption and before the 
completion of root development, odontoblasts are responsible for the secretion of the 
primary dentin which comprises most of the tooth mass surrounding the pulp (Smith 
et al., 1995). After the completion of root development, secondary dentin is secreted 
at a much slower rate than primary dentin throughout life (Smith et al., 1995). 
Reactionary dentin is secreted from surviving post mitotic odontoblast cells in 
response to mild injury. During severe trauma to the tooth, such as excessive caries 
and fracture, the death of several odontoblasts will occur and then DPPSCs may 
differentiate into odontoblasts like cells which are responsible for the secretion of 
tertiary dentin called reparative dentin (Smith et al., 1995; Duque et al., 2006). The 
isolation of pulp cells, from different species, has been achieved in many studies. 
However, Gronthos et al., 2000 were the first group to characterize a unique 
population of postnatal human dental pulp stem cells (DPSCs), these cells 
demonstrating an ability to self-renew using colony forming efficiency assay and 
differentiation into odontoblasts-like cells (Sloan and Smith, 2007, Gronthos et al., 
2000).  
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1.7 Dental Repair  
Unaffected odontoblasts protect the dental pulp by producing a reactionary dentin, in 
response to mild caries or pathological abrasion or superficial tooth preparation in 
the dental clinic (Lesot et al., 1993). On the other hand, severe injury to the dental 
pulp, such as severe caries or trauma may cause death of odontoblasts by bacterial 
toxins. In this case, a subpopulation of pulpal cells, DPPCs, which is believed to 
reside in the cell rich subodontoblast layer of Höehl are recruited to proliferate and 
differentiate into odontoblast like cells. A recent study suggested that DPPCs niche 
reside in the perivascular regions of the pulpal cavity, from which they migrate to the 
site of injury (Tecles et al., 2005). DPPSCs produce an extracellular matrix to act as 
dentinal reparative bridge. However, this matrix is permeable which makes it unable 
to protect pulp against bacteria. For this reason, studying these cells may be help to 
find new therapeutic agents to protect the pulp (Tziafas et al. 2000; Goldberg et al., 
2008). 
 
 During dental repair, growth factors play a role in recruitment of DPSCs. 
The main growth factors that are believed to be responsible to control DPSCs 
proliferation and differentiation are transforming growth factor beta (TGF) 
superfamily including BMPs, platelet-derived growth factor (PDGF) and insulin-like 
growth factor (IGF) (King et al., 1997; Iohara et al., 2004; Saito et al., 2004). The 
BMPs family and their receptors are understood to influence DPSCs, by causing 
them differentiate into odontoblast like cells to secrete dentin (Satio et al., 2004). 
Several studies have found that BMP-7 TGF-1 and –2 stimulate the secretion of 
extracellular matrix by odontoblasts in a rat tooth slice model and in vitro (Sloan and 
Smith, 1999; Sloan et al., 2000). Following pulpal injury, an inflammatory response 
develops which could harmfully affect the growth factors such as BMP-7 which is 
found to be insufficient to induce dentin with inflamed pulp compared with healthy 
pulp (Rutherford and Gu, 2000).  
  
1.8 Dentine Matrix 
Bone and dentin are mineralized tissues that have close organic matrix composition, 
which are mostly made of type 1 collagen (Qin et al., 2007). The main function of 
dentin is to protect the pulp and to provide support for overlying enamel and 
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cementum. The mature dentin consists of 70% mineral, 20% organic matrix and 10% 
water (Kim and Simmer, 2007). During dentin formation, odontoblasts secrete 
unmineralized type 1 collagen called predentin, with other molecules such as 
glycoproteins, sialoproteins and phosphoproteins (Silva et al., 2004). After that, 
predentin is mineralized by the deposition of hydroxyapatite crystals onto the fibrous 
matrix. The dentin molecules become trapped in the mineralized phase, bound to 
matrix components (Silva et al., 2004).  
 
 The dentin matrix includes different type of collagens mainly type 1 (86%) 
and type 3. It also contains different types of non-collagenous proteins (NCPs) with 
other proteins such as proteoglycans. SIBLINGs (small integrin binding ligand, N-
linked glycoprotein) family is one of important class of non-collagenous proteins, 
consisting of dentin matrix protein1 (DMP1), osteopontin (OPN), bone sialoprotein 
(BSP), matrix extracellular phosphoglycoprotein (MEPE) and dentin 
sialophosphoprotein (DSPP). These proteins could be used as markers to confirm the 
differentiation of DPPCs into odontoblasts. SIBLINGs proteins are secreted by 
odontoblasts or osteoblasts during formation and the mineralization of both dentin 
and bone. These proteins are also found to be expressed in soft tissues, such as 
kidney and salivary gland (MacDougall et al., 2006).  
 
 DMP1 was first identified in odontoblasts and later in some soft tissues, 
including different types of tumours. It is an acidic phosphorylated protein, rich in 
phosphoserine, glutamic acid and aspartic acid that regulates apatite crystals in 
mineralising tissues and mediates cell attachment through RGD domain. In DMP1 
knockout mice there is defective dentin development which shows the important of 
this protein in dentin formation (Von Marschall and Fisher, 2008).  
 
 Dentin phosphoprotein (DPP) and DSPP are the most abundant dentine 
specific proteins, related to dentin nucleation and mineralisation. It is found in bone 
but in much lower concentration than in dentin. Both of these proteins are found to 
be encoded in one gene. DPP and DSPP functions are still unclear. However, as they 
are expressed primarily in odontoblasts and predentin, before the beginning of 
mineralisation it may be further involve in dentin formation. Also, DSP is found to 
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have a slight effect on the formation of hydroxyapatite which has a role in 
dentinogenesis. A tooth defect was found in DSPP null mice similar to human 
dentinogensis imperfecta III with hypomineralization suggesting that DSPP has a 
role in dentin formation (MacDougall et al., 2006; Maciejewska et al., 2006; 
Yamakoshi et al., 2005).    
 
 In addition to these proteins, the dentin matrix has been identified to have 
many molecules, including TGF-s, fibroblast growth factors, insulin like growth 
factors and BMPs which are considered to play an important role in odontoblast 
differentiation (Sloan and Smith, 2007).  
 
1.9 Aims 
The four main aims in this study of human DPPCs are: 
 
1- To investigate the effect of in vitro expansion of DPPC clones isolated from two 
different patients by investigating proliferation and differentiation. In addition, the 
effect of age-related changes on telomere length that occurs in DPPCs will be 
investigated, followed by oxidative stress induced senescence and the effect on 
telomere length. 
 
2- To identify differences between individual clones in terms of proliferation rate, stem 
cell marker expression, differentiation capacity, resistance to oxidative stress and 
telomere lengths.  
 
3- To research the most convenient method for identifying the preferable clones for use 
in tissue engineering and regenerative medicine.  There is still no single easy 
technique to investigate the clones that are most convenient for use without the need 
for in vitro expansion and other multiple methods. For this reason, Raman 
spectroscopy will be used as a suitable identification method.  
 
4- To investigate the interaction of DPPCs with collagen matrices, to evaluate whether 
type 1 collagen could be used to imitate the natural niche of DPPCs, which will give 
better understanding of these cells for use in tissue engineering. 
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Chapter 2: 
Effects of In Vitro Expansion and Oxidative Stress on Dental Pulp Progenitor 
Cells Proliferative Lifespan 
 
 
2.1 Introduction 
Dental pulp progenitor cells (DPPCs) are an adult stem cell population that express 
similar markers as other mesenchymal stem cells (MSCs) (Huang et al., 2009b). 
Gronthos et al (2000) first reported the identification and isolation of DPPCs. DPPCs 
are described as having a typical fibroblast like morphology with a high clonogenic 
ability, rapid proliferation rate, and capacity to form mineralized tissue that express 
alkaline phosphatase, osteocalcin (OCN), and osteopontin (OPN), both in vitro and 
in vivo. DPPCs are proposed to be better candidates for use in clinical applications 
compared with other MSCs isolated from bone marrow, adipose tissue, and umbilical 
cord blood, because they have minor ethical issues, are easily accessible, and 
produce very low morbidity as these cells are obtained from extracted teeth 
(Nakashima et al., 2009). DPPCs are easy to harvest from extracted teeth, mainly 
third molars since their extraction is a common procedure. Third molars extracted at 
an early stage of their development make them a rich source for isolation of DPPCs, 
and they interact with biomaterials making them ideal for tissue reconstruction 
(reviewed in Graziano et al., 2008; Nakashima et al., 2009; Sloan and Waddington, 
2009; Atari et al., 2012). In addition, they have extensive differentiation capabilities, 
including a high potential for neural differentiation (Sakai et al., 2012). 
 
DPPCs isolated using the single colony method, is demonstrated to isolate 
highly proliferative clones with the capacity for multiple differentiation (Sloan et al., 
2009). However, the pulp tissue is heterogeneous, and many papers suggest that 
clones are located in different niches within the pulp (Section 1.6). Fitzgerald and 
colleagues showed that undifferentiated DPPCs reach synthesis phase (S-phase) at 
different times i.e. proliferation, but differentiation occurs at the same time for all 
cells. The differentiation synchronisation could be due to the establishment of cell-
to-cell communication (Fitzgerald et al., 1990). Therefore, DPPCs exhibit different 
behaviour in different studies, according to the method of isolation, age of the donor, 
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the condition of the pulp and other reasons. So far, at least two different stem cell 
populations have been identified; one arising from the neural crest and the other from 
mesenchymal origin (Waddington et al., 2009). Stem cells from both origins exhibit 
similar cell surface marker expression in terms of adult stem cells, such as Stro-1. 
However, cells of mesenchymal origin strongly express  integrin which binds to 
fibronectin of  the extracellular matrix in the dental pulp, while neural crest cells 
strongly express neural crest-associated markers such as low affinity nerve growth 
factor receptor (LANGFR) (Waddington et al., 2009). In general, both these cell 
subsets express numerous markers, including CD13, CD29, CD44, CD59, CD73, 
CD90, CD105, CD146 and STRO-1, but do not express haematopoietic markers such 
as CD14, CD24, CD34, CD45, CD19 (Lindroos et al., 2008, Huang et al., 2009b, 
Karaöz et al., 2010). Although there are many studies on DPPCs, the stemness ability 
of these cells is still unclear which hinder their ability to be applied clinically. 
Another one of these drawbacks is the cell senescence induced during in vitro cell 
culture. 
 
2.1.1 Factors Influencing Mesenchymal Stem Cells Behaviour Which May 
Affect Their Quality Implication for Cell Therapy 
After many years of research on MSCs, work has now developed towards the 
assessment of MSC therapies in clinical trials for multiple medical applications. 
However, their status as being true stem cells and their ability to differentiate to 
highly specialized cells, such as cardiomyocytes and neurons are still not satisfactory 
(Brooke et al., 2007). One of the drawbacks of using these cells in medical 
application is that the number of cells for prospective isolation is very low, estimated 
at 0.01%- 0.001% of the total number cells within bone marrow (Friedenstein et al., 
1982). This means that these cells will require extensive in vitro expansion before 
sufficient cells are obtained for possible clinical use. However, expansion may have 
an effect on the quality of the cells eventually obtained. It has been shown that MSCs 
from human bone marrow tend to lose their multipotentiality, proliferation rate and 
ability to differentiate to bone, during expansion in vitro (Banfi et al., 2000). Indeed, 
cell senescence is a key factor that affects cells in culture, as described below. Also, 
another factor that may affect the use of these cells in tissue engineering is the 
diversity in each clone being isolated. Heterogeneous cells are expected to produce 
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unwanted biological activity while homogenous cells more desirable to use in the 
clinic (Karystinou et al., 2009).  The claim of clonal variation was supported in the 
dental pulp MSCs clones by several studies. One of these studies found that only 
three clones out of twenty clones derived from dental pulp have the ability to 
proliferate over 20PDs (Gronthos et al., 2002). In the bone marrow, only four clones 
out of fifty grow beyond 50PDs and some clones take 44 days to reach 20PDs while 
others take 130 days to reach the same milestone (Karystinou et al., 2009). Also, 
these variations have been shown in many levels such as the site they have been 
isolated (Huang et al., 2009b) the donor age (Gala et al., 2011) and even variations 
from the same site of the same donor (Karystinou et al., 2009). Huang et al., 2009b 
have shown that the PD of DPPCs varies between one site to another. For example, 
progenitor cells from dental pulp varied from 60-120PDs and from deciduous teeth 
were over 140PDs while from bone marrow it varied between 30 and 50PDs.  It has 
been shown that Progenitor cells from bone marrow are age dependant (Pittenger et 
al., 1999) 
 
2.1.2 Telomeres and Telomere-independent Senescence 
Telomeres are believed to predict the future life of cells. Telomeres are special 
regions at the ends of eukaryotic chromosomal DNAs. Human cells contain 92 
telomeres but controversy surrounds whether it is the average telomere length or the 
shortest telomere that decides the cell age (Brandl et al., 2011). Loss of telomeric 
DNA has been observed in vitro for each population doubling in same matter in vivo 
when cells divided which is estimated 50bp after each cell passage (Harley et al., 
1990). This process of telomere shortening as consequences of repeated cell division 
is called replicative senescence (Hayflick and Moorhead, 1961). Telomeres are 
protected by ribonucleoprotein enzyme telomerase. It has been reported that lack of 
telomerase cause shortening of telomeres (Yu et al., 1990). It is known that 
telomerase is required for both cell duplication and differentiation which means 
MSCs should at least express some telomerase in order to achieve these targets. 
Altogether, this suggests that MSCs in vivo are subjected to little or no telomere 
erosion. Therefore, if telomere maintenance can be achieved in vitro, this would be 
beneficial from a tissue engineering point of view (Fehrer and Lepperdinger, 2005). 
However, there are several immortalised in vitro cell lines that have long telomeres 
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without expression of the telomerase (Bryan and Reddel, 1997). Therefore we could 
hypothesis that the telomere length maintenance is not only protected by telomerase 
but there are other factors that protect the telomere length to maintain the cell 
proliferation. When cells senesce due to telomere shortening it is referred to as 
telomere-dependent senescence. On the other hand, when cells become senescent for 
reasons other than telomere shortening it is referred to as telomere-independent 
senescence (reviewed in Reddel, 1998). One of the causes of cell ageing is 
accumulation of oxidative stress resulting from cellular metabolism (Harman, 1956). 
All actions that cause cell senescence will activate various signaling pathways. These 
signals include p53, p21
Cip1/Waf1
 and p16
Ink4a
 (Campisi et al., 2007). DNA damage 
mediated by tumour suppressor gene p53 protein initiates growth arrest and cell 
senescence by inducing p21, which subsequently increases p16 (Chen and Ames, 
1994; Itahana et al., 2001). Under condition of stress, p16 inhibits formation of active 
cyclin D-CDK complex, preventing Retinoblastoma protein phosphorylation, to 
block the cells to transfer from G1 into S phase (Sharpless and DePinho, 1999). In 
addition, p53 has a role in mediating apoptosis in cells (Huang et al. 2011). Another 
factor, is expression of certain oncogenes such as Ha-Ras, which causes senescence 
in active telomerase cells (Wei et al., 1999). In conclusion, the telomere is affected 
by several factors such as the telomere attrition that is generated during cell 
proliferation by either the end replication problem or oxidative stress activity (Flores 
and Blasco, 2010). For this reason, telomere shortening could be considered as a 
marker that indicates of cell senescence. 
 
 There is no one way to determine cell senescence. This study investigated 
telomere length, expression of -galactosidase enzyme (-gal), population doubling 
level (PDL) and cell morphology. Indeed, the gradual loss of the telomere length has 
been confirmed to be contributed to cell senescence (Harley et al., 1990). In human 
diploid cells, the average of the telomeres lengths varys between 0.5kb and more 
than 20kb (Reviewed in Aubert et al., 2012). Cells in different organs have different 
telomere length. For example, cells in fetal liver (~13kb) have longer average 
telomeres length than in cord blood (~12kb) and bone marrow (~8.5kb), respectively 
(Vaziri et al., 1994). Also during aging, the telomere length in humans shorten by 20-
60bp per year depending in the location of the cells. These differences in telomere 
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attrition may be explained by cellular environment, the mechanisms that maintain the 
telomere length and the proliferative capacity of cells (Takubo et al., 2002). Also, 
cells tend to lose their telomere length each population doubling when they cultured 
in vitro (Zglinicki et al., 1995). Telomere lengths are not restricted to tissues only but 
also between cells from same origin in the same individual (Rufer et al., 2001; Weng 
et al., 1997). Terminal restriction fragment (TRF) was the first technique used to 
measure telomere length (Moyzis et al., 1988). It calculates approximately the 
average of telomere length within a population of cells which found a correlation 
between telomere length and replicative capacity of different populations of cells 
(Allsopp et al., 1992). In terms of tissue engineering, cells with longer telomere 
length show better response to regenerate tissue after injury (Montgomery et al., 
2011). 
 
Another criterion that distinguishes senescent cells is morphology. As cells 
progress through their proliferative lifespan, morphological changes take place. In 
early stage, cells tend to be bipolar and spindle in shape. However, when they 
senesce they become larger, wider, flattened and irregular in shape (Bayreuther et al., 
1988; reviewed in sethe et al., 2006). Also they become multinucleated with loss of 
polarity (Matsumara et al., 1980). Furthermore, it has been found that there is 
correlation between increase in cell size and increase of actin microfilaments 
organisation (Wang and Gundersen, 1984). Another marker for cell senescence is -
gal enzyme. This enzyme is easy to detect by using histochemical stain in senescent 
cells but not in quiescent or immortal cells (Dimri et al., 1995).  
 
The most obvious marker for cell senescence is PDL. MSCs in vitro show 
different population doublings according to the site they have been derived from. For 
instance, the average population doublings from human dental, bone marrow and 
deciduous teeth MSCs is between 60-120, 30-50 and over 140PDs, respectively 
(Huang et al., 2009b). However, there are conflicting results in term of the 
proliferation rate. Gronthos et al., 2000 showed that human DPSC proliferate faster 
than BMMSC while it was the opposite in another study (Jo et al., 2007). Indeed, 
before using these cells in therapy, techniques for generation of large numbers of 
MSCs should be established without affecting their differentiation potential.  
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However, this study aims to highlight factors that lead to senescence of these cells 
during expansion in vitro such as H2O2. 
 
2.1.3 Stem Cells and Hydrogen Peroxide 
ROS are considered as a crucial determinant of cellular ageing (reviewed in Giorgio 
et al., 2007). However the main cause of cell damage by ROS, is when hydroxyl 
radical (
-
OH) species react with other components in the cell (Ueda et al., 2006). 
Stress-induced senescence can happen after a few cell divisions which seem to be 
independent of telomere status. However in some cases, oxidative stress is believed 
to be telomeres dependant. Oxidative stresses have been suggested to be a major 
cause of telomere shortening in cultured cells (Von Zeglinicki et al., 2003). Rubio et 
al (2004) found that cells with longer telomeres are more sensitive to H2O2 than cells 
without telomeres or are short telomeres.  Interestingly, H2O2 induced senescence in 
these cells without affecting telomeric length, which makes one speculate that there 
are another aspects of telomeres rather than length which could affect the response of 
these cells to ROS. Indeed ROS are more likely to attack the GGG sequence of 
telomeres (Henle et al., 1999). Also the amount and the time of exposure of H2O2 are 
other factors that determine the influence on cell senescence. Low dose of H2O2 for 
long period had no effect on cell proliferation or morphology of MSCs from bone 
marrow while increasing the H2O2 amount to over 100μM, accelerated telomere 
attrition occurred (Brandl et al., 2011).  In terms of telomerase, there are conflicting 
results on whether telomerase protects cells from H2O2 or not (Rubio et al., 2004). 
 
Cellular responses towards different H2O2 concentrations vary depending on 
many factors, such as cell type and origin of these cells (Veal, 2007). There is much 
evidence to show that stem cells can resist oxygen overload more than other cells by 
regulating their own antioxidant defence systems (Lekli et al., 2009). For example, 
endothelial progenitor cells show more resistance to death than mature umbilical vein 
endothelial cells, when subjected to oxidative stress. In addition, cells produce more 
antioxidant enzymes in comparison with other cell types, at the same site (Dernbach 
et al., 2004). Under normal conditions cells lose about 90bp each population 
doubling, while when subjected to oxidative stress, cells lose more than 500bp with 
each population doubling (Zglinicki et al., 1995). 
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2.2 Aims  
Dental pulp may provide a potential source of progenitor cells for tissue engineering 
purposes. However, these would require considerable in vitro expansion before use, 
potentially leading to loss of proliferative lifespan and cellular senescence, which 
may be accompanied by increased oxidative stress, altered cellular responses and 
differentiation. The aim of this chapter, therefore, was to examine the effect of 
oxidative stress on DPPCs, in terms of population doubling levels (PDLs) and 
senescence. 
 
2.3 Materials and Methods 
 
2.3.1 Isolation of Dental Pulp Progenitor Cells 
Normal human wisdom teeth were collected from three adult patients at the School 
of Dentistry, Cardiff University with informed patient consent and ethical approval 
by the South East Wales Research Ethics Committee of the National Research Ethics 
Service (NRES), UK. A copy of the patient information sheet and consent form is 
included at the appendix. Teeth were sterilised by soaking in 70% ethanol and the 
attached soft tissue removed using a paper towel, prior to dissection. Teeth were 
grooved in the centre of three areas (mesial, distal and occlusal) with a rotary bone 
saw. On a dissection board, a chisel and hammer were used to separate each tooth 
into two halves and the pulp removed with a forceps and placed into universals filled 
with culture medium to maintain hydration. Pulp tissues were minced on a glass slide 
and cells were placed into 5ml bijoux tubes containing 1ml of 4µg/µl 
collagenase/dispase enzymes (Roche, Welwyn Garden City, UK). Pulps were 
incubated for 1 h, with regular agitation every 20 min, to increase cell dissociation. 
Pulpal tissues from individual patients were prepared separately. The contents of 
each bijoux were passed through a 70µm mesh cell strainer into a 50ml Falcon tube 
(BD Falcon, UK), to obtain a single cell suspension. The cell strainer was washed in 
10ml medium. Cells were centrifuged at 1,800rpm (Labofuge400, Thermo Scientific, 
USA) for 5 min and further resuspended in 1ml medium. Cell numbers were 
calculated using 0.4% trypan blue vitality stain (Sigma, UK) for monolayer cell 
culture. A 10µl aliquot of each cell suspension was diluted in a known amount of the 
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stain and cells counted in a Neubauer Haemocytometer by light microscopy (Nikon 
eclipse TS100, UK). Cells were subsequently seeded in fibronectin coated 6 well 
plates (Sarstedt, Leicester, UK) at 4000/cm
2.
 
 
2.3.1.1 Fibronectin Adhesion Assay 
Following the protocol of Waddington et al., (2008), 10µg/ml fibronectin, derived 
from human plasma (Sigma) was reconstituted in 0.1M PBS at pH 7.4 containing 
1mM Ca
2+
 and 1mM Mg
2+
. Fibronectin (1ml/well) was pre-coated onto wells of 6-
well plates overnight. The fibronectin pre-coated wells were seeded with the cell 
suspension at 4,000 cells per cm
2
 (40,000 cells/ well). Cells were allowed to adhere 
at 37
o
C, 5% CO2 for 20 min. Following adhesion, the culture medium and non-
adherent cells were removed and the wells refilled with 2ml fresh culture medium. 
Cells were fed every 2 days with 2ml of fresh working medium each time. 
 
During the culture, the isolated DPPCs were monitored using an inverted 
light microscopy (Nikon Eclipse TS100, Tokyo, Japan) at x10 magnification and the 
number of cells per colony recorded. Jones and Watt (1993) defined a colony as a 
cluster with a minimum of 32 cells. By day 12, identifiable colonies were isolated by 
using 1ml sterilised pipette tips with the ends trimmed off leaving a cylindrical tube; 
with its edges smeared with petroleum jelly; and placed onto the wells to form an 
isolated water-tight seal around the marked colonies. Pre-warmed accutase (100µl, 
PAA, Velizy-Villacoublay, France) was added at 37
o
C, 5% CO2 and the isolated 
clones were then expanded until the numbers were sufficient for seeding into T-75 
flasks. 
 
2.3.2 Cell Culture 
Cell culture was performed under sterile conditions, using sterile tissue culture plates 
and flasks (Sarstedt, Leicester, UK). All procedures were performed in aseptic class 
II tissue culture hoods (Astec Microflow, Andover, UK). Cells were maintained in a 
5% CO2 in a humidified chamber at 37°C. Medium and accutase were pre-warmed to 
37°C in a water bath, prior to administering to cells. When cells were approximately 
80% confluent in T-75 flask, cells were washed with 0.1M phosphate buffered saline 
(PBS, pH 7.4) before being treating with 2ml of the pre-warmed accutase. Incubation 
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was performed at 37°C until the cells had become detached from the culture vessel 
(approximately 5min). The accutase was subsequently inactivated by the addition of 
serum-containing in the culture medium before centrifugate at 1800rpm. The 
resulting pellet was resuspended in the culture medium before cell counting and 
reseeding as described before.  
 
2.3.2.1 General Media 
Cells were maintained in α-modified Minimum Essential Medium (αMEM) 
containing ribonucleosides, deoxyribonucleosides, L-glutamine and phenol red, in 
addition antibiotics (100 units/ml penicillin G sodium, 0.1µg/ml streptomycin 
sulphate and 0.25µg/ml amphotericin; Invitrogen, Paisley, UK). Working medium 
for cell culture consisted of αMEM with 20% foetal calf serum (FCS, Invitrogen, 
UK), 4mM L-glutamine (Invitrogen, UK) and 100µM L-ascorbate 2-phosphates 
(Sigma-Aldrich, UK), except where stated. 
 
2.3.2.2 Freezing and Thawing Cells 
To cryopreserve cells, cells were centrifuged, counted with trypan blue (Sigma, UK) 
and resuspended in 1ml freezing mix containing 10% Dimethyl Sulfoxide (DMSO) 
(Sigma, UK) and 90% FCS. Freezing mix was added to the cryovials placed in 
freezing pot at -70°C. After 24 h, cryovials were transferred to liquid nitrogen for 
long term storage. When cells were required, cells were rapidly thawed by 
transferring to a 37°C water bath. The cells were immediately resuspended in 5ml 
medium and centrifuged as stated above. Cells then were rewashed with medium and 
expanded in culture. 
 
2.3.3 Population Doubling 
 To determine the rates of cell proliferation of each DPPC clone, cumulative PDs 
were plotted against time. The total numbers of viable cells during the cell counts 
from each passage were obtained using a haemocytometer and the number of cells 
reseeded was recorded. The PD of each cell population was calculated using the 
following formula: 
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PD = log10(total cell count obtained) - log10(total cell count re-seeded) 
              log10(2) 
 
2.3.4 Extracting mRNA from Isolated Clonal Cultures 
An RNeasy Mini Kit (Qiagen, Manchester, UK) was used to extract mRNA 
following the manufacturer’s protocol. Cells were initially cultured in 6-well plates 
(Sarstedt, Leicester, UK) until 90% confluence. Each well of cells was then lysed 
with 300 μL of Buffer RLT lysis buffer (Qiagen, UK) supplemented with 10 μL/mL 
of β-mercaptoethanol (Sigma-Aldrich, UK). The lysate was transferred to a 
QiaShredder column (Qiagen, UK) 600 μL at a time for centrifugation at 13,500 ×g 
for 2 min (Spectrafuge 24D, Jencons, UK) to shear cellular components, including 
DNA, and separating cellular debris. Subsequent, cell lysate was treated with 1:1 
volumes of 70% molecular-grade ethanol (Sigma-Aldrich, UK) and mixed 
thoroughly by pipette action. The sample was then transferred into an RNeasy Mini 
Kit column (Qiagen, UK) and centrifuged at 10,000 ×g for 15 s. The flow-through 
was discarded and the column was washed with 350μL of Buffer RW1 (Qiagen, UK) 
and centrifuged again at 10,000 ×g for 15 s. The flow-though was discarded and the 
column was treated with a mixture of 10μL of DNase I stock and 70μL Buffer RDD 
(both Qiagen, UK). This was incubated at room temperature for 15 min for on-
column digestion to remove any contaminating genomic DNA. 350μL of Buffer 
RW1 was added to the column and then washed by centrifugation at 10,000 ×g for 
15 s. A further 2× 500μL of Buffer RPE was added and centrifuged for 1 min each 
time with the flow-through discarded after each spin. The column insert was then 
transferred into an RNase-free 1.5mL eppendorf (Fisher Scientific, Loughborough,, 
UK) and 40μL DNase free water (Promega, Southampton, UK) was added for eluting 
the RNA by centrifuging at 10,000 ×g for 1 min. The eluate was pippetted back into 
the column and centrifuged again to maximise yield. Total RNA collected in the 
eppendorf was stored at -80C. 
 
To quantify the amount of RNA in each sample a NanoVue (GE Healthcare, 
Amersham, UK) was used. The NanoVue was standardised with 2μL of DNase free 
water as a blank before using 2μL of RNA sample to quantify. The absorbance ratio 
at 260:280 nm between 1.7 and 2.2 indicated sufficient RNA purity. 
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2.3.5 PCR Methods to Characterise Cell Marker Expression 
 
2.3.5.1 Reserve Transcription (RT) PCR 
RT-PCR was performed using the Moloney murine leukaemia virus (M-MLV) 
reagents from Promega. 1 g of total RNA was treated with 0.5g of Random 
Primers (Promega) with the addition of DNase free water to adjust to a final volume 
of 15 L. This mixture was then placed in a G-storm™ GS1 thermal cycler (Genetic 
Research Instrumentation Ltd, Braintree, UK) and incubated at 70C for 5 min to 
unravel RNA. The product was immediately cooled and stored on ice before 5μL of 
5M-MLV buffer was added along with 0.625μL of RNasin, 1.25μL of 10mM 
dNTPs, 1μL of M-MLV reverse transcriptase (all Promega) and the addition of 
DNase free water brought the final volume to 25L. The sample was gently mixed 
with a pipette and placed into a thermal cycler at 37C for 1h, followed by 95C for 5 
min. The newly generated cDNA was stored at -20C until the next use of PCR 
reaction. 
 
2.3.5.2 Polymerase Chain Reaction (PCR) 
All PCR reactions were set up by the addition of 1μl of cDNA/control generated by 
reverse transcription to 5μl 5x Green GoTaq™ Flexi Buffer (Promega), 1μl 25mM 
MgCl, 0.5μl 10μM PCR Nucleotide Mix, .0.25μl 5U/μl GoTaq™ DNA Polymerase, 
1.25μl 0.04μg/μl Forward Primer (Table2.1), and 1.25μl 0.04μg/μl Reverse Primer 
(Table 3.1). All reaction volumes were made up to 25µl with nuclease free water. 
Reactions were run on a G-storm™ GS1 thermal cycler (Genetic Research 
Instrumentation Ltd) with an initial denaturing step of 95ºC for 5 min, followed by 
35-40 cycles of a 1 min 95ºC denaturing step, a 1 min 55-62ºC annealing step (as it 
stated in table) and a 1 min 72ºC extension step. A final extension step at 72ºC for 5 
min was run, ending the reaction. All PCR products were loaded in agarose gels to 
visualise by Gel Doc 2000 (BioRad, Hemel Hempstead, UK). 
 
Positive human controls, human embryonic stem cell (HuES09), was supplied 
by Dr. Lindsay Davies, (Cardiff University, UK) for embryonic and neural crest 
markers. Total human RNA purchased from stratagene (Invitrogen, UK) was used as 
positive control for hemapiotic marker CD45.  Positive controls of MSCs markers 
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were performed on total human RNA (Howard-Jones, Thesis). For negative controls, 
water and RT-negative controls were used. The PCR was carried out with primers for 
mesenchymal markers, neural crest markers, embryonic markers, and hematopoietic 
markers with the housekeeping gene β-actin. Details of the markers are shown in 
Table 2.1  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
43 
 
Table 2.1: Human gene markers used for PCR amplification. β-actin was used 
as a housekeeping gene. 
 
 
 
Gene 
Marker 
Primer sequence Annealing 
Temperature 
o
C 
Cycles Source 
CD73 F:5'GTCGCGAACTTGCGCCTGGCCGCCAAG-3' 
R: 5'-TGCAGCGGCTGGCGTTGACGCACTTGC-3' 
65 35 Amr Alraies 
Cardiff 
University 
CD90 F:5'- ATGAACCTGGCCATCAGCATCG-3' 
R:5'- CACGAGGTGTTCTGAGCCAGCA-3' 
55 35 Amr Alraies 
Cardiff 
University 
CD105 F:5'-GAAACAGTCCATTGTGACCTTCAG-3' 
R: 5'-GATGGCAGCTCTGTGGTGTTGACC-3' 
65 35 Amr Alraies 
Cardiff 
University 
CD45 F:5'-GTGACCCCTTACCTACTCACACCACTG-3' 
R:5'-TAAGGTAGGCATCTGAGGTGTTCGCTG-3' 
65 35 Amr Alraies 
Cardiff 
University 
Oct4 F:5'-AGGAGTCGGGGTGGAGAG-3' 
R:5'-CGTTTGGCTGAATACCTTCC-3' 
55 35 Lindsay Davies 
Cardiff 
University 
Slug F:5'- CATACAGCCCCATCACTGTG3' 
R:5'- CCTGGAGGAGGTGTCAGATG-3' 
55 35 Lindsay Davies 
Cardiff 
University 
hTERT F:5'- CGGAAGAGTGTCTGGAGCAA-3' 
R:5'- GGATGAAGCGGAGTCTGGA-3' 
55 40 Mantripragada 
et al., 2008 
p53 F:5'- AGACCGGCGCACAGAGGAAG-3' 
R:5'- CTTTTTGGACTTCAGGTGGC-3' 
55 35 Huang et al., 
2011 
p21
WAF1
 F:5'- GGATGTCCGTCAGAACCCAT-3' 
R:5'- CCCTCCAGTGGTGTCTCGGTG-3' 
60 35 Mergui et al., 
2010 
p16
INK4A
 F:5'- CTTCCTGGACACGCTGGT-3' 
R:5'- GCATGGTTACTGCCTCTGGT-3' 
55 35 Wang et al., 
2012 
β-actin F:5'-AGGGCAGTGATCTCCTTCTGCATCCT-3' 
R:5'- CCACACTGTGCCCATCTACGAGGGGT-3' 
65 35 XQ Wei 
Cardiff 
University 
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2.3.5.3 Agarose Gel Preparation 
To visualise PCR products a 10µL of sample was loaded on to 1-3 % agarose gels. 
To prepare agarose gels, 1.4g of agarose powder (Invitrogen, UK) was added to 
70mL of 0.5xTBE buffer. Subsequently, agarose was dissolved by microwave 
heating for 20 s at a time swirling in between until the agarose solution was clear, 
prior to the addition of 7µl ethidium bromide 10mg/ml (Promega). The gels were 
poured into a casting tray containing a comb and allowed to set at room temperature, 
for 30 min. Once set, gels were placed in an electrophoresis tank containing 0.5x 
TBE buffer.  The comb was carefully removed and then 10µl of PCR reaction added 
to wells, in addition to a 10μl 100 base pair (bp) DNA step ladder (Promega). Loaded 
gels were subjected to electrophoresis, at 80mV for approximately 45 min, in 1x 
TBE running buffer.  The gel images were captured under UV light (312nm) and 
analyzed, using the Geldoc programme (BioRad).  
 
2.3.6 Cell Morphology and Determination of Cell Size throughout Their 
Proliferative Lifespan  
The relative cellular morphology and surface areas of DPPCs were compared at early 
PD, mid PD and at late PD (the total PD achieved by each clone was divided by 
three, to determine the three PD groups). Serial images of the cells were obtained 
throughout their proliferative lifespan using a digital camera (Canon PC1234, Tokyo, 
Japan).  The cells were outlined along their peripheral borders and perimeter and the 
surface area of the cells calculated using ImageJ) processing software.  Cellular 
surface areas was analysed using Excel to identify and compare the variations in the 
mean cellular surface area throughout the proliferation of DPPCs, and also to assess 
whether the mean cell area measurements were a true reflection of the overall 
distribution of cell sizes.  The results were presented for individual clones at the three 
PDs (early, mid and late PDs). 
 
2.3.7 Oxidative Stress Assay 
 
2.3.7.1 Cell Culture 
DPPCs at early passage; two clones from patient A, called A31 (the experiment 
started after 31 days of normal culturing) and A11 (the experiment started after 14 
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days of normal culture), and one clone from patient B, called B11 (the experiment 
start after 25 days of normal culture) were seeded at 1x10
5 
in T-25 flask and 
maintained in the absence/presence of sub-lethal doses of H2O2 (5, 10, 25, 50, 100, 
200μM). Culture medium was changed every two days. Cells were grown to 80–90% 
confluence and re-plated as described above, until senescence occurred. PDs 
throughout the culture duration were monitored. Senescence deemed to be achieved 
when PD <0.5 / week.  In addition, images were taken every two days of the 
morphological changes. mRNA was extracted from each group treatment at early, 
mid-point, and late stage PDs to assess their triplicate expression of stem cell 
markers. 
 
2.3.7.2 β-galactosidase (β-gal) Assay 
A Senescence Cell Histochemical Kit (Sigma-Aldrich) was used to detect β-
galactosidase activity in senescent cells. Cells at selected PDs were seeded in 6 well-
plates at 5000/cm
2
 and cultured for 24 h in culture medium. The culture medium was 
aspirated and the cells washed (x2) with PBS (provided in the Kit) diluted 1:10 in 
ultrapure water. 1:10 diluted Fixation Buffer (1.5 ml/well) in ultrapure water was 
added for 7 min at room temperature. Meanwhile 10 ml of Staining Mixture was 
prepared by mixing 1 ml of prewarmed Staining Solution (in Kit), 0.125ml of 
Reagent B (in Kit), 0.125ml of reagent C (in Kit), 0.25ml of X-gal solution (in Kit), 
with 8.50ml of ultrapure water. Following incubation with Fixation Buffer, cells 
were rinsed (x3) with PBS (1ml/well). Then, Staining Mixture (1ml) was added to 
each well and incubated at 37
o
C at 5% CO2 overnight, with the plate sealed with 
parafilm to prevent drying out. Cells were subsequently observed under a light 
microscope (Nikon eclipse TS100) and blue-stained cells were counted. Finally, the 
percentage of cells expressing β-galactosidase activity was calculated. 
 
2.3.7.3 DNA Extraction for Telomeres Length Assay 
Genomic DNA was isolated using QIAmp
®
 DNA Mini Kit (Qiagen). Firstly, cells 
from different treatment groups were seeded at 5000/cm
2
 density in T-75 flasks at 
two different PDs (early and late) and cultured to confluence. Cells were detached 
from the flask with accutase and centrifuged (1800rpm/5min). The supernatants were 
discarded and the pellets resuspended in PBS (200ml) and mixed with proteinase K 
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(20l) and buffer AL (200l). Samples were incubated for 10 min at 56oC in a water 
bath. After incubation, mixtures were briefly centrifuged. 100% ethanol (200ml) was 
added to each sample and mixed by brief centrifugation for 15 s. The mixtures were 
transferred to QIAamp Mini Spin Column (in a 2ml collection tube) and centrifuged 
at 8000rpm for 1min; and the spin column placed in a new 2ml collection tube. 
Buffer AW1 (500l) was added to the column and centrifuged at 8000rpm for 1 min 
and again placed in a new 2ml collection tube prior to addition of buffer AW2 
(500l) to the column and centrifuged at the highest speed (13,300 rpm) for 3 min. 
The column was placed in new 1.5ml microcentrifuge tube and buffer AE (200l) 
was added and left for 1 min at room temperature and then centrifuged at 8000 rpm 
for 1 min. Finally, DNA yields were measured by absorbance at 260nm in Nanovue 
(GE. UK). For long-term storage of DNA, the samples were stored in freezer 
(Indesit, UK) at -20
o
C.    
 
2.3.7.4 TRF Assay 
To determine the telomere length of each DNA samples, Telo TAGGG Telomere 
Length Assay Kit (Roche, Burgess Hill, UK) was used. Following manufacturer’s 
instructions, each sample of DNA (1g) was digested with of Hinf1/Rsa1(1l) and 
x10 digestion buffer (2l) in a final volume of 20l. In addition, a control genomic 
DNA digest was also established. The DNA samples with enzymes and digestion 
buffer were incubated at 37
o
C for 2 h and the reactions terminated by 4l gel 
electrophoresis loading buffer. Digested DNA samples were separated by agarose gel 
electrophoresis with 0.8% gel (highly pure, nucleic acid grade agarose-Agarose MP, 
Geneflow, UK) in 1x Tris-acetate-EDTA (TAE) buffer containing 0.2g/ml of 
ethidium bromide.   
 
 For gel electrophoresis, 1g of DNA digest and 10l of Digoxigenin (DIG) 
molecular weight marker were loaded onto each gel and run at 20V, overnight, until 
the bromophenol blue had separated about 10cm from the starting wells and the gels 
were removed to perform several treatment processes. The gel was submerged in 
hydrochloric acid (HCl) solution (Table 2.2) for 10 min, with agitation at room 
temperature. Gels were rinsed twice with water before being submerged in 
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Denaturation Solution (Table 2.2) (x2) for 15 min at room temperature; and again 
rinsed (x2) with water. Finally, the gel was submerged in Neutralisation Solution 
(Table 2.2) (x2) for 15 min at room temperature, before performing Southern 
blotting.   
 
 For Southern blotting, two pieces of Whatman 3MM paper (Sigma, UK) were 
used to make a wick gradient. The two pieces of Whatmann paper were placed over a 
plastic support platform, and wetted with 20x standard sodium citrate (SSC) buffer 
(Table 2.2). The gel placed face down on the wet Whatmann paper, and covered with 
SSC-soaked positively charged nylon membrane (Roche). The nylon membrane was 
covered by 4 pieces 2x SSC-soaked Whatman paper. Finally, a 15cm tall stack of dry 
cut paper towels was topped with a 100g weight. The entire apparatus was covered to 
prevent any evaporation and left overnight at room temperature. 
 
The following day, the nylon membrane was fixed by UV-crosslinking for 10 
s x2 (Stratalinker, USA) and washed with SSC (Table 2.2) (x2) prior to 
hybridisation. For hybridisation, all steps were performed in a hybridisation oven 
(VWR, UK) with the membrane placed in a hybridisation bottle and rotated gently 
on a rotisserie. Firstly, membranes were placed side up in a hybridisation bottle with 
25ml of DIG Easy Hyb (Table 2.2) for 1 h at 42
o
C, with gentle rotation. This solution 
was replaced with pre-warmed hybridisation solution (10ml) mixed with 2l of 
Telomere probe; and incubated at 42
o
C for 3 h. Afterwards, the membrane was 
washed with 25ml of Stringent Wash Buffer I (Table 2.2) (x2) for 5 min at room 
temperature. Another washing step was performed with 25ml of Stringent Wash 
Buffer II (Table 2.2) (x2) for 20 min at 50
o
C, and was lastly washed with 25ml of 
washing buffer 1x (Table 2.2) for 5 min at room temperature. Subsequently, the 
membrane underwent several incubations for 30, 30, 15, and 5 min in 25ml: 1x 
blocking solution, anti-DIG-AP working solution, washing buffer (2x), and 1x 
detection buffer (Table 2.2) respectively, at room temperature (all solutions provided 
in the Kit). Finally, the membrane was incubated for 5 min in Substrate Solution 
(provided in the kit) at room temperature before the membrane was removed from 
the hybridisation bottle and blotted to remove excess liquid onto 3M Whatman paper 
and wrapped in Saran. The membrane was inserted in a cassette (Hypercassete,UK) 
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and exposed for 30 s to a High Performance Chemiluminescence Film (GE,UK). The 
film was developed using CURIX 60 (AGFA, Mortsel, Belgium). 
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Table 2.2. Solutions used for TRF assay. Bottles with numbers provided in the 
kit 
 
 
 
TAE Buffer 0.04M Tris-Acetate, 0.001M EDTA pH 
8.0 
HCl Solution 0.25M HCl 
Denaturation Solution 0.5M NaOH, 1.5M NaCl 
Neutralisation Solution 0.5M Tris-HCL, 3M NaCl pH7.5 
20X SSC 3M NaCl, 0.3M Sodium citrate pH7.0 
2X SSC Dilute 20X SSC 1 :10 with autoclaved 
distilled water 
DIG EasyHyb Reconstitute the granules (bottle-9-kit) 
with 64ml of autoclaved distilled water 
and incubate at 37
o
C overnight 
Stringent wash buffer I 
2X SSC, 0.1% Sodium dodecyl sulfate 
(SDS) 
Stringent wash buffer II 0.2X SSC, 0.1% SDS 
Blocking Solution 1X Dilute 10X (bottle 13) 1:10 with malic 
acid buffer 1X 
Malic Acid Buffer 1X Dilute 10X (bottle 12) 1:10 with 
autoclaved distilled water 
Anti-DIG-AP, Working Solution Dilute (bottle 14) 1:10,000 with blocking 
solution 
Detection Buffer 1X Dilute 10X (bottle 15) 1:10 with 
autoclaved distilled water 
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2.3.7.5 Densitometry Analysis  
To convert the telomeric specific smear on the Southern blot image into mean TRF, 
the southern blot image was opened using ImageJ software and the image rotated to 
align vertically and then the colour was inverted to enable analysis. Each lane 
containing a different DNA sample was analysed separately, before overlaying a box 
on the image to measure mean density of the telomere specific smear. The size of the 
box was determined so that it only encapsulated the signal from the individual lane 
and to allow approximately 30 boxes of the same size to be fitted to each individual 
lane (Figure 2.1). The background density was calculated using the average density 
of several boxes that did not contain a telomere specific signal, and subtracted from 
each box that did have a signal. For each box containing DNA, the mean density 
(ODi) and corresponding length (Li) using the molecular weight ladders (in kb)  at 
the mid-point of the box was calculated and then substituted into the formula Σ (ODi) 
/ Σ (ODi /Li) to obtain mean TRF length (Kimura et al., 2010). 
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Figure 2.1. The Southern blot is shown with the telomere specific smear in 
white. Lane MW contains the size standard ranging from 21.2kb to 1.1kb. The 
other lanes contain different genomic DNA samples. Lane A31 at 55PDs showed 
the principles of how the analysis is performed using the ImageJ software. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
52 
 
2.4 Results 
 
2.4.1 Characterisation of Cells 
 
2.4.1.1 Cell Colonies 
After 6 days of culturing cells on fibronectin pre-coated well, several clones were 
observed (6 clones from patient A, 1 clone from patient B and 4 clones from Patient 
C). At day 12, 5 Clones were successfully isolated from patient A, 1 clone from 
Patient B and 3 clones from patient C). Each clone at day 12 showed crowded, 
fibroblast cell morphology (Figure 2.2) After isolation, each clone was transferred to 
be cultured further in 96 well-plates for expansion by transferring to a larger culture 
vessel at each passage until able to be cultured in T-75 flasks. Several colonies were 
continued culture and the remainder were cryopreserved until require uses. Cells 
were cultured until senescence-associated features appeared, as described above. 
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Figure 2.2. An example of a single clone colony formed after 12 days. The colony 
was compact and consisted of >32 cells. ×10 magnification, Scale bar 100μm. 
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2.4.1.2 Population Doublings (PDs) 
There were marked variations in the proliferative capacity between individual clones. 
Each clone showed significant differences in PDs, when comparisons were 
performed between clones from the same patient or from different patients. Three 
separate clones were further cultured until senescence from patient A and one clone 
from patient B (Figure 2.3). One clone demonstrated a high population doubling 
(A31) extending beyond 80PDs (almost 300 days), while the other clones from this 
first patient (A11, A51) demonstrated less than 25PDs under less than 70 days. In 
contrast, clone B11 from the second patient did not persist beyond 36PDs with less 
than 85 days in culture.   
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Figure 2.3. PDs of 4 different clones; 3 clones from patient A (A11, A31, and A51), and one clone from patient B (B11). A31 
demonstrated a high population doubling extending beyond 80PDs, while the other clones A11, A51 and B11 demonstrated less 
than 36PDs. 
 
 
 
        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Days 
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2.4.1.3 Gene Expression 
MSC markers CD105, CD90 and CD73 were analysed in three selected clones, two 
from patient A (A11 and A31) and one clone from patient B (B11) during different 
periods of their proliferative lifespan. These markers were expressed in all of these 
clones at early culture (1-10PDs). All markers were lost gradually during their in 
vitro culture expansion. CD105 was the first marker to be lost after 11PDs in clone 
A11 and after 24PDs in clone A31. Clone A31 all MSCs markers after 60PDs while 
B11 lost MSCs expression after 24PDs. Further analysis for clone A11 after 24PDs 
and for clone B11 after 35PDs was not performed as both clones senesced at these 
time points. Total human RNA was used as a positive control for MSC marker 
expression of CD73, CD90, and CD105 (Howard-Jones, Thesis). The water and RT-
negative experimental controls had no expression (Figure 2.4). 
 
At early culture time points (1-10PDs) other cell markers were also analysed 
including the hematopoietic cell marker (CD45), an embryonic stem cell marker 
(Oct4), and the neural crest marker (Slug). CD45 expression was negative while 
Oct4 and slug were weakly expressed in all clones (Figure 2.5), compared with MSC 
gene expression (Figure 2.4) and lost completely after 11PDs in all clones. Controls 
of embryonic markers (HuES09) expressed Oct4, slug and TERT markers. The water 
and RT-negative experimental controls had no expression. 
 
Expression of the tumour suppressor genes p16, p21 and p53 were 
investigated at early culture (Figure 2.6) to investigate their effects on cell cycle and 
proliferation at this stage. p21 gene expression was intensely positive in all clones. 
The expression of p16 gene was intensely positive in clones; A11 and B11 but was 
weakly expressed in clone A31. p53 gene was not expressed at all in clone A31 but 
was strongly expressed in the other 2 clones. Water and RT-negative experimental 
controls demonstrated no expression. 
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Figure 2.4. Mesenchymal stem cell gene expression for clones A11, A31, and B11 at specific culture time points. CD105, CD90 
and CD73 were gradually lost over 60PDs. -actin was used as the housekeeping gene. NC refers to no cell available due to cell 
senescence. Water and RT-negative experimental controls showed no expression. 
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Figure 2.5. Heamapoitic, embryonic and neural crest gene expression for A11, A31, and B11 at early culture (1-10PDs).  
Hematopoietic cell marker (CD45) was not expressed in all clones. Oct4 and Slug gene expressions were weakly expressed in all 
clones. -actin was used as a housekeeping gene. Water and RT-negative experimental controls showed no expression. 
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Figure 2.6. Gene expression for tumour suppression markers p16, p21 and p53 in clones A11, A31, and B11 at early culture (1-
10PDs). p21 was strongly expressed in all clones. P16 and p53 were expressed intensely in clones A11 and B11 while in clone 
A31, p16 was weakly expressed and p53 is not expressed at all. -actin was used as housekeeping gene. Water and RT-negative 
experimental controls showed no expression. 
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2.4.2 Cellular Morphology of DPPCs throughout Their Proliferative Life Span 
To support the PD data, microscopic analysis of DPPC morphology was undertaken 
throughout proliferation from early PD until senescence. In all clones (A31, A11 and 
B11) at early PDs (A), cells were morphologically similar with the characteristic 
long, spindle, bipolar shape as typical fibroblast appearance. Clones A31, A11, B11, 
are shown in figures 2.9-2.11 respectively. As the cells continued to undergo more 
PDs, their morphology began to change such that the cells became wider and larger 
in size, although still maintaining their spindle and bipolar shape at early and late 
middle PDs (B and C). At the senescence level (D), cells showed a distinct difference 
in their morphologies. Cells became larger, wider and irregular in shape with loss of 
polarity and with appearance of stress fibres (stress fibres, shown with arrow). 
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Figure 2.7. Comparison of the morphological appearance of clone A31throghout 
its proliferative lifespan, until senescence. A represents early PD, B represents 
early mid PD, C represents late mid PD and D represents late PD (stress fibres 
and wide cells shown with arrow. ×10 magnification, Scale bar 100μm. 
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Figure 2.8. Comparison of the morphological appearance of clone A11 
throughout its proliferative lifespan, until senescence. A represents early PD, B 
mid PD and D represents late PD (stress fibres and wide cells shown with 
arrow).  ×10 magnification, Scale bar 100μm. 
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Figure 2.9. Comparison of the morphological appearance of clone B11 
throughout its proliferative lifespan, until senescence. A represents early PD, B 
represents early mid PD, C represents late mid PD and D represents late PD 
(stress fibres shown with arrow).  ×10 magnification, Scale bar 100μm. 
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2.4.3 Determination of Cell Size of DPPCs throughout Their Proliferative 
Lifespan 
Cell size for all the clones and therefore, their surface area were observed to increase 
with in vitro expansion as was visually clear from the images (Figures 2.7-2.9). This 
was clearly shown as the cells were narrow and spindle shaped at early PD but 
became wider and larger when reaching senescence. Cell areas (m2) were calculated 
for 20 cells from different areas in T75 flask (5 images taken from random areas in 
the T75 flask) (Figure 2.10) and then the mean and standard error mean (SEM) 
calculated for each individual clone at three PDs (early, mid, and late PDs).  
 
In clone A11, the mean cellular surface area at early PD (4PDs) was 803µm
2
 
(mean ± 108), which increased at mid PD (15PDs) to 5,060 µm
2
 (mean ± 476). At 
late PD (22PD), the surface area gradually increased so that the mean cellular surface 
area was 9,885µm
2
 (mean ± 1005). In clone A31, the mean at early PD (3PDs) was 
815µm
2
 (mean ± 51), this mean was increased at mid PD (21PDs) to 4,483µm
2
 
(mean ± 310). At late PD (85PDs), the surface area gradually increased so that the 
mean cellular surface area was 9,935µm
2
 (mean ± 843). B11 clone demonstrated 
similar trend of increasing of cell size as the previous clones with the mean cellular 
surface area at early PD (4PDs) was 813µm
2
 (mean ± 56), at mid PD (18PDs) to 
1,893µm
2
 (mean ± 164) and at late PD (35PDs) was 4,458µm
2
 (mean ± 407).  
 
Since there were variation in surface areas between early, mid and late PDs in 
all clones but no particular pattern, analysis was undertaken by combining the data to 
identify if each stage of these PDs data (early, mid, late) could have a distinguishing 
range of surface area. Six different groups of surface areas were established to make 
a distribution of the cells in all the clones at the three different PDs (Figure 2.11). It 
was clear that cells from all clones (A11, A31 and B11) at early PD were less than 
1500µm
2 
surface area. Cells at mid PD from all clones varied between 1500µm
2
 to 
10,000µm
2
. Finally, cells from all clones at late PD contained cells over 1000µm
2
 in 
size.  
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Figure 2.10. Comparison of the cellular surface areas of DPPCs clones 
throughout their replicative lifespan. At early PD cells were bipolar and narrow 
with a small surface area. With progressive proliferation, the cell surface area 
gradually became larger with a wide and irregular shape. Cells seen were 
outlined along their peripheral borders to exemplify surface analysis using 
ImageJ. ×10 magnification, Scale bar 100μm. 
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Figure 2.11. The distribution of cell surface area throughout replicative life span 
of cells. Clones A11, A31, and B11 were analysed collectively. The surface area 
was obtained from three defined phases (early, mid, and late PDs), with 60 cells 
were measured for each phase. Cells with <1500µm2 surface area were 
collectively at an early PD; cells 1500µm
2
-10,000µm
2
 surface area were cells at 
mid PD, and cells > 10,000µm
2
 surface area were senescent. 
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2.4.4 Cell Senescence by -gal staining 
-galactosidase enzyme is an enzyme associated with cellular senescence and is 
considered as an indicator of senescent cells if positive staining observed. X gal at 
pH 6 is converted to blue staining by - galactosidase that can be visualised using 
light microscopy. -galactosidase was performed at early PDs (11PDs for clone A11, 
12PDs for clone A31 and 12PDs for clone B11) to confirm their negative expression 
at this stage, and at very late-stage of culture, when cell PD was less than 0.5 per 
week. Late-stage was considered after 23PDs for clone A11, 85PDs for clone A31 
and 36PDs for clone B11. All the images for the three clones showed a positive 
staining at late-stage PD for almost 100% of cells and no staining at early PD (Figure 
2.12). 
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Figure 2.12. senescence- associated -gal activity in populations of clone A11 (11 
and 23PDs), A31 (12 and 85PDs), and B11 (12 and 35PDs) suggested all clones 
have almost 100% positive staining. (-gal staining shown with arrow) ×10 
magnification, Scale bar 100μm. 
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2.4.5 Telomere Length of DPPCs Clones 
 
2.4.5.1 Southern Blot  
The average telomere length of 3 selected clones (A11, A31 and B11) was measured 
using terminal restriction fragment (TRF). Analysis of telomere length was 
undertaken by southern blots for these clones at mid-early PD (8-14PDs). In 
addition, clone A31 (55PDs) telomere length was measured at late PD to investigate 
the effect of aging on telomere length. The southern blot suggested that the highly 
proliferative clone (A31) had higher smear band than the other clones, and results 
were quantified by densitometry analysis. Clone A31 at early PD suggested that its 
smear band started at the same height as the later PD, but the length of the smear 
band was longer for the later PD, indicating a more heterogeneous population for 
these cells (Figure 2.13). 
 
2.4.5.2 Densitometry Data Analysis 
After determining the mean TRF (Figure 2.1) by using the equation Σ (ODi) / Σ (ODi 
/Li), the results is shown in Table 2.2. It is clear that clone A31, the highly 
proliferative clone, had a much longer telomere length, with 18.3Kb compared with 
clones A11 and B11. Clone A31 at 55PDs appeared to lose significant telomere 
length compared with its original length at 9PDs with a 11.9Kb shortening.      
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Figure 2.13. Representative southern blot for three clones (A11, A31 and B11) 
including Clone A31 at two different PDs (9 and 55PDs) in addition to the kit 
control (Ctrl) and molecular weight marker (MW). 
 
 
 
 
 
 
 
Table 2.2. The mean of telomere length for DPPCs clones calculated from 
southern blot (Figure 2.15) 
 
Clone Mean of TRF by Kb 
A31 9PDs 18.3 
A31 55PDs 6.4 
A11 8PDs 5.9 
B11 14PDs 5.6 
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2.4.6 Oxidative Stress Results 
 
2.4.6.1 Population Doublings 
The population doubling of DPPCs throughout their proliferative lifespan was also 
assessed in different H2O2 concentrations. At low concentrations of H2O2 (5-25M) 
population doubling levels for clone A31 were assessed. Based on the resistance of 
clone A31 to cellular senescence (Figure 2.14), higher H2O2 concentrations (50-
200M) were used to assess the susceptibilities of all 3 clones (A31, A11 and B11) 
to oxidative stress-induced senescence. For the lower concentration, there was almost 
no difference in the population doubling between controls and the other 
concentrations as cells in all conditions continued growing for more than 300 days 
without senescence (Figure 2.14). For the higher concentrations, there were variable 
differences in each clone but in general, 200M demonstrated significant reduction 
and early senescence of all clones. Clone A31 demonstrated more resistance to H2O2 
at 200M than other clones. Cells senesced before 100 days in 200M and then after 
160 days for other concentrations (50 and 100M) (Figure 2.15). On the other hand, 
clone A11 showed no diversity in population doublings between the different H2O2 
concentrations (Figure 2.16). Clone B11 at 200M H2O2 senesced after 50 days in 
culture while cells at 50 and 100M concentrations senesced after more than 80 days 
which was similar to the untreated cells (Figure 2.17).  
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Figure 2.14. Clone A31 at low H2O2 concentrations (0, 5, 10, 25M). All the 
treatments including the control exhibited almost the same PD throughout 
proliferative lifespan until they reach senescence at over 300 days in culture. 
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Figure 2.15. Clone A31 at high H2O2 concentrations (0, 50, 100, 200M). 
Reductions in PD at 100M and 200M H2O2 concentrations were clear after 50 
days, compared with the untreated controls and cells treated with 50M H2O2.  
PD of cells treated in 50M only declined compared to untreated control cells at 
>100 days in culture. Cells cultured in 200M H2O2 senesced at less than 100 
days in culture, while cells exposed to other H2O2 concentrations maintained 
proliferative capabilities for more than 150 days. 
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Figure 2.16. Clone A11 at high H2O2 concentrations (0, 50, 100, 200M). There 
were no differences in PD between the H2O2 concentrations during the short 
period in culture less than 30 days, due to its early senescence. This was also 
evident with the untreated control. 
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Figure 2.17. Clone B11 (from the second patient) at high H2O2 concentrations (0, 
50, 100, 200M) compared to untreated controls over 60 days in culture. The 
higher concentration (200M) significantly decreased proliferative capabilities, 
as cells exhibited lower proliferation within 20 days in culture, and senesced by 
50 days. The 100M H2O2 concentration showed a reduction of PD after 30 
days, while 50M concentration has no major effect on PD. 
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2.4.6.2 Gene Marker Expressions in DPPCs at Different H2O2 Concentrations 
MSC markers CD105, CD90 and CD73 were analysed in clones A11, A31 and B11 
in different concentrations of H2O2 (0, 50, 100, 200M) at the middle period of their 
treatments 18PDS, 38PDs and 18PDs for A31, A11 and B11 respectively (Figure 
2.18). No differences were detected at the MSCs gene expressions in the different 
concentration of H2O2. Water and RT-negative experimental controls demonstrated 
no expression. 
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Figure 2.18. Mesenchymal stem cell gene expression for A11, A31, and B11 in different concentrations of H2O2 (0, 50, 100, 
200M) at the middle period of their treatments. No differences were detected for MSC gene expression in the different 
concentrations of H2O2. -actin was used the housekeeping gene. Water and RT-negative experimental controls had no 
expression. 
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2.4.6.3 Cell Morphology 
Microscopic analysis of cellular morphology of the monolayer culture of DPPCs was 
undertaken throughout proliferation at different concentrations of H2O2. At early 
stages of culture with H2O2 treatment, cells did not show any noticeable difference in 
their morphology at differing concentrations. In later cultures, changes in 
morphology and size became more apparent between the different concentrations of 
H2O2 figures 2.19 to 2.29. For clone A31, no noticeable difference in cell 
morphology was observed in cells cultured in all low concentrations of H2O2 (0, 5, 
10, 25M) after 1 day, 100 days or 221 days in culture (Figures 2.19 to 2.21), 
However, cells exhibiting ageing in all concentrations after 221 days became larger, 
wider and irregular in shape with loss of polarity and with appearance of stress fibers 
(Figure 2.21). 
 
Clone A31 cultured in higher concentrations of H2O2 (0, 50, 100, 200M) did 
not show any differences in cell morphology between all these different 
concentrations after 1 day in culture (Figure 2.22). After 90 days, cells cultured in 
200M H2O2 appeared larger with the appearance of stress fibers (Figure 2.23), 
while after 146 days of culture, cells in the presence of 50 and 100mM H2O2 
appeared to be more irregular in shape and larger in size compared with non- treated 
cells which contained few numbers of larger cells (figure 2.24). 
 
Clones A11 and B11 demonstrated similar results as clone A31 at day 1 
where no differences appeared in cell morphology between all H2O2 concentrations 
(Figure 2.25 and 2.27). Clone A11 did not show any differences on cell morphology 
between high H2O2 concentrations at day 30, although cells demonstrated senescence 
morphology (Figure 2.26) as seen in A31 clone (Figure 2.21). For clone B cells in 
200M H2O2 after 40 and 60 days, there tended to be more elongated and stressed 
compared to the other concentrations (Figure 2.28 and 2.29). 
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Figure 2.19. Comparison of the morphological appearance of clone A31 at 
different low H2O2 concentrations (0, 5, 10, and 25M) at day 1. All images 
showed the same size and morphological appearance of cells, with the 
characteristic long, spindle, bipolar shape.×10 magnification, Scale bar 100μm. 
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Figure 2.20. Comparison of the morphological appearance of clone A31 at 
different low H2O2 concentrations (0, 5, 10, and 25M) at day 100. All the 
images showed the same size and morphological appearance, with cells started 
to be wider and larger in size, although still maintaining their spindle and 
bipolar shape. .×10 magnification, Scale bar 100μm. 
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Figure 2.21. Comparison of the morphological appearance of clone A31 at 
different low H2O2 concentrations (0, 5, 10, and 25M) at day 221. All the 
images showed the same size and morphological appearance, with cells became 
larger, wider and irregular in shape with loss of polarity and with appearance 
of stress fibers. ×10 magnification, Scale bar 100μm. 
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Figure 2.22. Comparison of the morphological appearance of clone A31 at 
different high H2O2 concentrations (0, 50, 100, and 200M) at day 1. All the 
images showed the same cell size and morphological appearance, with the 
characteristic long, spindle and bipolar shape. ×10 magnification, Scale bar 
100μm. 
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Figure 2.23. Comparison of the morphological appearance of clone A31 at 
different high H2O2 concentrations (0, 50, 100, and 200M) at day 90. The 
images for 0, 50, 100M showed similar size and morphological appearance of 
cells but cells in 200M were larger, wider and irregular in shape with loss of 
polarity and appearance of stress fibers. ×10 magnification, Scale bar 100μm. 
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Figure 2.24. Comparison of the morphological appearance of clone A31 at 
different high H2O2 concentrations (0, 50, 100, and 200M) at day 146. Most of 
the cells in the control treatment showed a fibroblastic appearance while cells in 
50M and 100M H2O2 showed more irregularity in shape and increased cell 
width with more cell fibers visible. ×10 magnification, Scale bar 100μm. 
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Figure 2.25. Comparison of the morphological appearance of clone A11 at 
different high H2O2 concentrations (0, 50, 100, and 200M) at day 2. All the 
images showed the same size and morphological appearance of cells, with the 
characteristic long, spindle, bipolar shape. ×10 magnification, Scale bar 100μm. 
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Figure 2.26. Comparison of the morphological appearance of clone A11 at 
different high H2O2 concentrations (0, 50, 100, and 200M) at day 30. All the 
images of the all different concentrations showed that the cells increased in size 
in very short period, 30 days. ×10 magnification, Scale bar 100μm. 
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Figure 2.27. Comparison of the morphological appearance of clone B11 at 
different high H2O2 concentrations (0, 50, 100, and 200M) at day 1. All the 
images showed the same size and morphological appearance of cells, with the 
characteristic long, spindle, bipolar shape.. ×10 magnification, Scale bar 100μm. 
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Figure 2.28. Comparison of the morphological appearance of clone B11 at 
different high H2O2 concentrations (0, 50, 100, and 200M) at day 40. The 
images of 0, 50, and 100M H2O2 concentrations showed similar size and 
morphological appearance, but cells in 200M H2O2 became elongated and 
stressed. ×10 magnification, Scale bar 100μm. 
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Figure 2.29. Comparison of the morphological appearance of clone B11 at 
different high H2O2 concentrations (0, 50, 100, and 200M) at day 60. The 
images of 0, 50, 100M H2O2  showed elongation of the cells while in 200M 
H2O2 the cells became more stressed. ×10 magnification, Scale bar 100μm. 
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2.4.6.4 Oxidative Stress on Cell Senescence by -gal Staining     
The number of positive (blue) cells for clones A31, A11, and B11 in different H2O2 
concentrations (0, 50, 100 and 200M) were counted from 15-20 different areas, 
seeding triplicate repeats of 38x10
3
 cells in 9.6cm
2
. The triplicate average percentage 
of positive cells was calculated (Figures 2.30 to 2.34). 
 
50M and 100M H2O2 appeared to have negligible effect on cell senescence 
in clone A31, with 45% of cells stained positive with -gal compared with the 
control (28% positive -gal staining). 200M H2O2 demonstrated the largest positive 
staining, with 61% of cells positive after 128 days of culture (Figure 2.30). In the 
same conditions after 196 days, there were no cells in 200M treated cultures as all 
cells had already senesced. Cells with no treatment or cultured in 50M H2O2 
demonstrated similar levels of cell senescence, with 27% of cells -gal positive, 
while cells in 100M H2O2 were 53% positive (Figure 2.31). 
 
More than 90% of cells of clone A11 were positively stained following 50 
days of culture in different H2O2 concentrations (Figure 2.32). Clone B11 showed 
similar results to Clone A11 after 70 days of culture in the same conditions (Figure 
2.34). 
 
 
 
 
 
 
 
 
 
 
 
 
 
91 
 
Figure 2.30. Comparison senescence- associated -gal activity in population of 
clone A31 in different H2O2 concentrations (0, 50, 100, and 200M) after128 
days (46PDs). (-gal staining shown with arrow). ×10 magnification, Scale bar 
100μm. 
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Figure 2.31. Comparison senescence- associated -gal activity in population of 
clone A31 in different H2O2 concentrations (0, 50 and 100M) after 196 days 
(59PDs). (-gal staining shown with arrow). ×10 magnification, Scale bar 
100μm. 
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Figure 2.32. Comparison senescence- associated -gal activity in population of 
clone A11 in different H2O2 concentrations (0, 50, 100 and 200M) after 50 days 
(23PDs). (-gal staining shown with arrow). ×10 magnification, Scale bar 
100μm. 
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Figure 2.33. Comparison senescence- associated -gal activity in population of 
clone B11 in different H2O2 concentrations (0, 50, 100 and 200M) after 50 days. 
(-gal staining shown with arrow). ×10 magnification, Scale bar 100μm. 
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Figure 2.34. Comparison senescence- associated -gal activity in population of 
clone B11 in different H2O2 concentrations (0, 50, 100 and 200M) after 70 days. 
(-gal staining shown with arrow). ×10 magnification, Scale bar 100μm. 
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2.4.6.5 Oxidative Stress on Telomeres Length 
 
2.4.6.6 Southern Blot   
The average telomere length of 3 selected clones at early PD (A11 at 15PDs, A31 at 
18PDs and B11 at 18PDs) in differing H2O2 concentrations (0, 50, 100, 200M) was 
measured using terminal restriction fragment (TRF) as described in section 2.3.7.5 . 
Analysis of telomere length was undertaken by southern blots after 30 days of culture 
in the presence of H2O2 which suggested that the density of the smear band in all 
clones was been affected by different H2O2 concentrations. Only clone A11 at 
200M H2O2 demonstrated a shorter smear band at the bottom end (Figure 2.35). 
 
2.4.6.7 Densitometry Data Analysis 
After determining the mean TRF as shown in figure 2.1 by using the equation Σ 
(ODi) / Σ (ODi /Li), the results are represented in Table 2.2. The densitometry 
analysis suggests that clones A31 and B11 have minor differences in telomere length 
between the different H2O2 concentrations, with the maximum difference being less 
than 1Kb.  
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Figure 2.35. Representative southern blots for three clones (A11, A31 and B11) in different concentrations of H2O2 treatment 
after around 30 days. The table represents the number indication of each lane. 
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Table 2.2. The mean of telomere length for DPPCs clones calculated from 
southern blots (Figure 2.35) 
 
Clone A11 A31 B11 
H2O2 
concentrations 
by M 
0 50 100 200 0 50 100 200 0 50 100 200 
Telomere 
length by Kb 
4 4.2 4.4 5 17.4 17.6 17.5 17.5 6 5.4 5.5 5.7 
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2.5 Discussion 
Only clone A31 was highly proliferative compared to clones A11 and B11 in this 
chapter. Proliferation was linked with telomere length, as A31 was highly 
proliferative and demonstrated longer telomere length. In vitro expansion of the 
clones showed that cultures altered their stemness by loss of stem cell markers, and 
eventually replicative senescence occurs due to progressive telomere shortening as a 
result of decreased telomerase activity (Sharpless and DePinho, 2007). Loss of 
telomerase leads to telomere dependence-senescence of cells. However, when these 
cells underwent induced senescence by H2O2, they showed high resistance. Telomere 
length was not affected by H2O2, and cells underwent telomere independent 
senescence. The cause of senescence in this situation could be caused by several 
factors such as DNA damage, accumulation of abnormal protein, or mitochondrial 
changes (Itahana et al., 2001). The results are explained in detail in the following 
sections. 
 
 Progenitor clones were isolated from human dental pulp based on their 
adherence to fibronectin. Clones were confirmed as mesenchymal stem cells based 
on their fibroblastic appearance, expression of triplicate stem cell markers (CD73, 
CD90 and CD105), lack of expression of haematopoietic antigen CD45 and their 
ability to differentiate into osteogenic, chondrogenic and adipogenic lineages 
(Rosenbaum et al., 2008; Kuhn and Tuan, 2009). A total of four clones from two 
different patients’ wisdom teeth; patient A (A11, A31, A51) and patient B (B11) 
showed different growth kinetics that was represented by PD data until senescence. 
These variations of PD from the same teeth of the same patient have been reported 
before (Waddington et al., 2009). Three DPPC A11, A31, and B11 were chosen for 
further investigation due to their differences. These 3 clones showed different 
telomere length and ability to resist oxidative stress, which has never been 
investigated before for this type of cell in the same study. They also exhibited the 
loss of embryonic and mesenchymal stem cell markers after long-term culture. 
 
In order to use MSCs for clinical therapy they will require considerable in 
vitro expansion, which is shown to be an important factor for the success of the 
clinical application in bone repair (Quarto et al., 2001) and cartilage repair (Centeno 
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et al., 2008; Veronesi et al., 2013).  However, studies investigating the effect of in 
vitro expansion on MSCs showed that their proliferation capacity and differentiation 
ability declined with passaging (Banfi et al., 2000; Min et al., 2011) as is shown in 
this study. 
 
Investigation of the PDs demonstrated that of five different clones, four of 
them showed less than 36PDs and senesced after less than 85 days, while only one 
clone (A31) had a high proliferation rate with over 85PDs that senesced after more 
than 300 days. It has been reported that MSCs from bone marrow are only capable of 
a maximum 50PDs (Huang et al., 2009b; Tamaki et al., 2012) and they proliferate 
slower than MSCs from the dental pulp (Alge et al., 2010). These data emphasise the 
great proliferation rate of DPPCs when compared with other MSCs from other 
sources that give these cells a potential advantage. 
 
After investigation of mesenchymal, embryonic stem cell and neural markers 
at different stages during the life span of these 3 clones (A11, A31 and B11), the 
PCR results showed the expression of these markers during early culture as at 10PDs 
in clone A31. These markers were gradually lost until they completely disappeared in 
all the clones. As clone A31 had the longer life span, it also had the longer period of 
expression of these gene markers with Oct4 being lost first after 10PDs and then 
CD105 after 24PDs and finally CD73 and CD90 after 60PDs, while for other clones, 
these markers were lost after short periods of time. It should take in consideration 
that these clones only survived less than 30PDs. It has been shown before that the 
level of stem cell markers reduce with time (Patel et al., 2009). Specifically, a study 
of human MSCs from bone marrow, after culturing for 10 weeks, showed a 
regression of CD105 and CD73, while CD90 expression stayed constant (Rallapalli 
et al., 2009). Dental pulp tissues are considered to derive from the cranial neural crest 
cells (Chai et al., 2000; Miletich and Sharpe, 2004). These cells during embryonic 
development are associated with embryonic stem antigen, which may explain the 
ability of the isolated dental pulp progenitor cells (DPPCs) in this study, to express 
embryonic stem cell markers such as Oct4 (Huang et al., 2009b; Kawanabe et al., 
2012). Embryonic stem cell marker Oct4 and neural marker Slug were expressed in 
the three clones (A11, A31, B11) but were lost at very early stage with less than 
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10PDs for clone A31. These results are in line with others, where Oct4 is expressed 
at very low levels in early passage MSCs and disappears at late passage (Boroujeni et 
al., 2012). However, the real function for Oct4 in MSCs is still debatable, whether it 
is essential for stemness or it has another function that is different from that in 
embryonic stem cells (Ulloa-Montoya et al., 2007; Zangrossi et al 2007; Lengner et 
al., 2008). Furthermore, it has been proposed that detection of Oct4 expression by 
using RT-PCR is not reliable because it might be a false expression, which is called 
pseudogene (Liedtke et al., 2007). The expression of neural stem cell markers by 
these cells wasn’t a surprise, taken into account that DPPCs is derived from the 
neural crest (Chai et al., 2000). Neural markers expression in these cells is proof of 
successful differentiation into neural lineages (Karaöz et al., 2010; Abe et al., 2012). 
Also, expression of different markers could be changed during in vitro culture due to 
the components of the culture media. For example, DPPCs cultured in serum-free 
medium with addition of vascular endothelial growth factor, leads to DPPCs 
expressing endothelial markers (Karbanová et al., 2011). 
 
The niche of these clones is located or what stage in stem cell development 
they are could be one of the reasons that explains their different growth kinetic 
profiles and differentiation ability. It is still not fully known whether these clones are 
derived from one pluripotent stem cell niche or whether they derive from committed 
progenitors into specific lineages, due to the lack of specific gene markers of 
mesenchymal stem cell development (Shi and Gronthos, 2003). It has been suggested 
that DPPCs are derived from the perivascular niche because they display similar 
characterisation of pericytes such as expression of CD146 and lack of expression of 
CD34 in human, the same fibroblastic morphology and their ability to differentiate 
into osteoblasts, adipocytes and chondrocytes as shown in clone A31 (Shi and 
Gronthos, 2003). However, it seems not all the dental clones are derived from the 
perivascular niche. It is suggested, based on staining localisation of embryonic stem 
cell and mesenchymal stem cell (MSC) markers, that the dental pulp has other 
locations of DPPCs including; nerve networks in the cell free zone, the innermost 
pulp layer in the cell rich zone and within outermost pulp layer where all cells from 
these locations have fibroblast morphology and are positive for the neural marker 
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nestin (Lizier et al., 2012). The aforementioned may explain the origin of clones A11 
and B11 that express CD271 neural marker. 
 
Unlike embryonic stem cells, the MSCs in this study showed a defined 
proliferation capability with shortening of telomere length. This type of senescence 
is called replicative senescence (Campisi, 1996). Telomere length is one of the 
important factors that controls replicative senescence (Harley, 1991). Shortening of 
telomeres has been linked to the absence of the enzyme telomerase (Zimmermann et 
al., 2003; Baxter et al., 2004; Parsch et al., 2004). Cellular senescence is also 
regulated by several tumour suppressor genes including p53, p21 and p16 (Pearson et 
al., 2000). p53 is activated in response to short telomere length and other stimuli such 
as DNA damage (Itahana et al., 2001). This explains the positive expression of p53 
in the short telomere clones such as A11 and not in the long telomere clone, A31. 
Also p16 was only expressed in low a proliferative clone that is in line with data 
from Molofsky et al., (2003). On the other hand, p21 was positively expressed in all 
the clones; p21 may be considered as a marker of cell senescence and is regulated by 
p53 or independently of p53 by growth factors and cytokines (El-Deiry et al., 1993). 
However, p21 appeared to have a dual role in stem cells. In addition to the role of 
p21 in inducing stem cell senescence in culture, it is also required to maintain stem 
cell self-renewal because of its positive effects on the cell cycle (Kippin et al., 2005; 
Ju et al., 2007) and could explain the expression of p21 in all clones at the gene 
transcription level. 
 
Telomere length varied among the clones with 18.3kb for clone A31, 5.9kb 
for clone A11 and 5.6kb for clone B11 at early stages of their PD. Telomere length is 
known to decrease with age, and the telomere length of A31 clone exhibited this 
decrease during in vitro culture being 18.3kb at 9PDs and then 6.4 kb at 55PDs. This 
shortening in telomere length, which correlated with reduction of proliferative 
capacity, has been demonstrated in human mesenchymal stem cells from bone 
marrow (Baxter et al., 2004) and from dental pulp (Mokry et al., 2010). 
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  Telomere length was measured by terminal restriction fragment (TRF), which 
estimates the average genomic telomere length within a population of cells (Harley et 
al., 1990; Allsopp et al., 1992). Although TRF is the most widely used method to 
determine telomere length, there are limitations of this technique such as it only 
measuring the mean of telomere length of a cell population, and since the telomere 
length in human cells is extremely heterogeneous, the technique is less sensitive by 
showing a large area of smear (Aubert et al., 2012).  This heterogeneity in smear 
band was clear in later PD of clone A31 as cells became more heterogeneous, which 
made it more difficult to estimate the average telomere length. Other disadvantages 
of TRF was it being  labour intensive, costly and it required great amounts of DNA 
compared with other methods (Kimura et al., 2010). For this reason, extraction of 
minimal amounts of DNA was difficult at later PD when the proliferation rate was 
slow, that prevented the comparison of early and mid PDs with late PD. To 
overcome this problem, single telomere length analysis (STELA) is to be considered 
for the future work, with picogram range of DNA being enough to evaluate of each 
single telomere of cell individually  (Baird et al., 2003).   
 
Clones are considered senescent when their cell proliferation is less than 
0.5PDs per week (Stephens et al., 2003; Dell'Orco et al., 1974). This was confirmed 
by production of SA -gal that is used as a marker for aged cells (Dimri et al., 1995). 
At mid PD (46PDs) and mid-late PD (59PDs) for clone A31, the percentage of cells 
with positive staining for SA β-Gal was less than 30%. At very late PD (over 85PDs) 
when cells were considered senescent, the percentage of cells was positive for SA β-
Gal increased dramatically to be almost 100% (Figure 2.14). This was similar for the 
other two clones at this stage when PD was less than 0.5PDs per week with the 
positive staining of -gal was almost 100% (Figure 2.14). However, -gal has been 
considered a controversial marker to confirm cell senescence because of an increased 
activity of the enzyme under different conditions other than replicative senescence 
such as in confluent culture or in cells under serum starvation (Severino et al., 2000; 
Yang and Hu, 2005). For this reason, -gal has not been used in this study as an 
exclusive senescence marker but as co-marker with other cell senescence markers. 
The morphology of DPPCs throughout their proliferative lifespan was also a useful 
indicator to assess these cells’ senescence. The difference in cellular morphology 
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was objectively quantified by determining the surface area of the cells by drawing 
around the cell periphery and calculating the surface area using ImageJ software. In 
vitro aged DPPCs appeared to be bigger in size and more flattened than their 
ancestors in early passage, this enlargement of cells has been linked with cell ageing 
(Angello et al., 1989; Karystinou et al., 2009).   
 
Taken together both the telomere smear band and cell size results at late PD, 
it has been noticed a heterogeneous population of cells where cell size at late PD 
showed variety of surface areas by displaying a small number of cells with small 
surface area (less than 3000 m2) compared to the majority of cells (more than 5000 
m2) (Figure 2.13), which indicate that these cells proliferate asymmetrically. This 
means some cells in the same population reached senescence before others (Ho, 
2005), and was supported by telomere lengths when the smear length band was 
longer indicating various telomere lengths in each cell of clone A31 after 
considerable time of expansion, 55PDs (Figure 2.15). 
 
Fehrer and Lepperdinger, (2005) reported that stem cells appear to be 
protected against damage from oxidative stress but without providing experimental 
data to support this. In this study, data will be provided in terms of proliferation rate, 
-gal staining and telomere length. Oxidative stress is continuously produced during 
the metabolic process of aerobic cells and neutralised by endogenous antioxidant 
defence system. However the balance between oxidative stress and antioxidant could 
change due to several causes (Halliwell and Gutteridge, 1990). The increase of 
oxidative stress is implicated in the cause of diseases and the process of ageing 
(Finkel and Holbrook, 2000; Valko et al., 2007).  Oxidative stress has been linked to 
cellular ageing by showing decrease in tissue function such as arteries (Brouilette et 
al., 2003), decrease in proliferation rate, enlargement and flattening of cell 
morphology; and eventually cell senescence at low doses of H2O2 (50-100 M) in 
human fibroblast, cell apoptosis at higher doses (300-400M) (Chen and Ames, 
1994; Bladier et al., 1997), and acceleration of telomere attrition in MSCs (Brandl et 
al., 2011). As has been described, cellular senescence could be telomere-dependent 
due to the end-replication problem of DNA synthesis that causes telomere shortening 
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(Harley, 1991). However, in some cases cellular senescence might be independent of 
telomere length. This could happen due to external causes such as oxidative stress 
and antioxidant defences system (Von Zglinicki et al., 2000). Cells introduced to 
mild stress, which still allows cell proliferation, can lead to telomere shortening (Von 
Zglinicki et al., 1995; Vaziri et al., 1997; Lorenz et al., 2001).    
 
In this study, sub-lethal H2O2 (200 m) insult accelerated the ageing process 
in A31 and B11 clones. Cell senescence occurred after 50 days in cells cultured in 
200m of H2O2 compared with almost 200 days for the non-treated, at 50m and 
100m concentrations of H2O2 in the highly proliferative clone, A31. In B11 clone, 
cell senescence occurred after 20 days cultured in 200m of H2O2 compared to 
around 60 days of non-treated cells. In the A11 clone, no obvious difference was 
observed that is possibly because of the short life of these cells, less than 30 days 
after the treatment started, which did not give enough time for H2O2 to show its 
effect. Equivalent doses of H2O2 have been applied in a previous study with MSCs 
from human bone marrow but their negative effects were faster compared to the 
DPPCs (Brandl et al., 2011). Long period treatments of low dose H2O2 showed no 
effect on proliferation rate or cell senescence that is line with the finding in this study 
(5-50m H2O2) (Figure 2.16).  
 
Sub-lethal H2O2 doses (100m-200m) in A11 clone seemed to cause effect 
only in cells with shortest telomere length (Figure 2.37), but this did not cause a 
difference in the time of cell senescence between the non-treated and 200m H2O2.  
It is still not clear whether it is the shortest telomere or the mean telomere length that 
causes cell senescence (Brandl et al., 2011). In A31 and B11 clones the difference in 
telomere length between the sub-lethal concentrations and non-treated cells was 
minimal. This in line with the data of PD (Figure 2.17 and 2.18) that shows these two 
clones after 30 days, did not reveal any difference between the 0M H2O2 and 
200M H2O2, Unfortunately, because the TRF technique required a huge amount of 
DNA, telomere length could not be calculated due to low amounts of cells at later 
stage of H2O2 treatment. Although, literature suggests that there are other mechanical 
reasons that could make H2O2 in 200mm concentration cause cell senescence before 
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non-treated cells after prolonged days of culture rather than telomere length. Indeed, 
it has been proven that H2O2 causes cellular senescence without reducing the 
telomere length, which could be explained by the effect of H2O2 on cell cycle by 
increasing p16 protein level (Chen et al., 2001; de Magalhães et al., 2001) or 
distribution of telomere structure, telomere dysfunction (d'Adda di Fagagna et al., 
2003). This confirms that telomere length is not the only reason for cell ageing 
(Blackburn, 2000).  
 
Cells protect themselves against oxidative stress by several mechanisms. The 
main mechanism is the antioxidant defence systems including; superoxide dismutase 
(SOD) (Serra et al., 2003), catalase, and glutathione peroxidase enzymes (Dorval and 
Hontela, 2003). This was proved by antioxidative in hMSCs, reduced the oxidative 
stress levels by restoring the antioxidant levels of these cells (Ebert et al., 2006). The 
work in this chapter demonstrated the remarkable resistance of DPPCs to H2O2 
compared with other human cells such as fibroblasts (Duan et al., 2005), 
chondrocytes (Brandl, Hartmann et al., 2011), and MSCs from bone marrow (Brandl 
et al., 2011). Due to high resistance of DPPCs it could be hypothesis that these cells 
produce large amounts of catalase or glutathione peroxidase, since it was proven that 
both enzymes has been increased by H2O2 stimulation (Seo et al., 2004). Another 
reason these cells are resistant to oxidative stress, could be the expression of PPAR 
in these cells. PPAR is believed to act as an anti-inflammatory by removing the 
activity of ROS (Kim et al., 2012b). 
 
Overall, this chapter showed that DPPCs undergo telomere-dependent 
senescence. When H2O2 was used to induce DPPC senescence however, they were 
highly resistant to H2O2 and the telomere length was not affected.  Furthermore, this 
study showed variations in proliferation capacity of isolated clones from the dental 
pulp, which could be linked to telomere length, and possibly the different niches that 
they come from. Further investigations into the aforementioned are in the following 
chapters.  
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Chapter 3: 
Effects of In Vitro Expansion and H2O2 on Differentiation Ability of Dental Pulp 
Progenitor Clones 
 
 
3.1 Introduction 
The multi-potential differentiation capacity of MSCs is the basis for their use in 
tissue engineering and clinical therapy. However, these cells behave differently in 
terms of proliferation and differentiation despite their same origin (Liu and Xiao, 
2011). Indeed, the previous chapter showed that DPPC clone A31 was highly 
proliferative, while clones A11 and B11 had low proliferation. This chapter will 
investigate if there is a connection between differentiation ability and the 
proliferative capacity, and therefore telomere length. In addition, here a proposed 
theory will try to explain the reason behind these variations. 
 
 The differentiation capacity of dental pulp progenitor cells has been well 
investigated in the literature. It has been reported that these cells can differentiate 
into osteoblasts (Zhang et al., 2006; Jo et al., 2007; Graziano et al., 2008; Mangano 
et al., 2010), adipocytes, chondrocytes (Zhang et al., 2006; Jo et al., 2007; Koyama et 
al., 2009), oligodendrocytes (Sakai et al., 2012); and along the myogenic pathway 
(Zhang et al., 2008). To regard the progenitor cells from the dental pulp as 
mesenchymal stem cells (MSCs), they should differentiate into at least 3 different 
lineages (osteoblasts, adipocytes and chondrocytes) under standard in vitro 
differentiating conditions (Dominici et al., 2006). The ability of MSCs to 
differentiate into specific mature cell types is influenced by many factors, such as 
transcription factors, cytokines, growth factors and extracellular matrix molecules 
(reviewed in Baksh et al., 2004). 
 
For osteogenic differentiation, the presence of ascorbic acid-2 phosphate, -
glycerophosphate, dexamethasone and foetal bovine serum are required to obtain 
osteoblastic cell morphology, with the upregulation of alkaline phosphate activity 
and the deposition of a calcium mineralized extracellular matrix (Barry and Murphy, 
2001). In addition, adding growth factors, such as basic fibroblast growth factors 
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(bFGF) induce osteogenic differentiation by enhancing bone nodule formation 
(Hanada et al., 1997). There are several markers considered significant for 
osteogenic differentiation. Runt-related transcription factor 2 (Runx2) is considered 
the main transcription factor for osteogenic differentiation (Komori, 2010). This has 
been demonstrated by the absence of bone formation in Runx2 knockout mice 
(Komori et al., 1997). Other examples of typical bone matrix proteins of osteoblast 
are; osteocalcin (OCN), osteonectin (ON) and osteopontin (OPN) (Mizuno and 
Kuboki, 2001; Mori et al., 2011). OCN and OPN are non-collagenous protein, where 
the former is considered a late marker and the latter as an early marker of osteoblast 
differentiation (Mizuno and Kuboki, 2001; Vater et al., 2011).  
 
For chondrogenic differentiation, cells must be grown in 3D culture, in 
serum- free medium with the addition of transforming growth factors- (TGF- 
super-family members. Under these conditions, cells lose their fibroblastic 
appearance and form a matrix containing aggrecan, type II collagen and the ratio of 
sulphated glycosaminoglycans is increased. All of these components are observed in 
the development of human articular cartilage (Barry et al., 2001). One of the main 
regulators for chondrogenesis is SOX9, which controls the expression of COL2A1 
(Lefebvre et al., 1997). 
 
To stimulate MSCs to differentiate into adipocytes, they have first to be 
grown until confluency in culture medium with serum. At this point, cells begin to 
change their morphological appearance from fibroblastic to a more spherical shape. 
Culture medium containing the glucocorticoid dexamethasone, in addition to insulin 
and indomethacin is required. Dexamethasone induces the accumulation of 
peroxisome proliferators-activated receptor  (PPAR), a major transcription factor 
in the adipogenesis process, while insulin accelerates triglyceride accumulation (Cui 
et al., 1997; Shugart and Umek, 1997; Kubo et al., 2000). Under these conditions, 
several ECM components re-organise and remodel including fibronectin and laminin 
to form fat cell clusters (Kubo et al., 2000). Lipoprotein lipase (LPL) is then 
expressed by the mature adipocytes (Goldberg, 1996), which eventually leads to 
accumulation of intracellular lipid-rich vacuoles that can be stained with oil red O. 
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Runx2 and PPAR are the key transcription factors responsible for the 
osteogenic and adipogenic differentiation. During ageing, the number of bone 
forming osteoblasts is decreased while the number of adipocytes is increased in the 
bone marrow. Runx2 is decreased in aged MSCs from bone marrow and leads to 
negative effect on osteoblast differentiation while PPAR expression and 
adipogenesis is increased (Moerman et al., 2004; Huang et al., 2010). Also, it has 
been shown that, culturing osteoprogenitor cell in serum from postmenopausal 
women, leads to differentiation of these cells into adipocytes. This suggests that there 
are components in the serum when women age, which have the ability to influence 
progenitor cell differentiation to an adipocyte lineages rather than an osteoblast one 
(Stringer et al., 2007).  Determining what factors cause this alteration would be 
beneficial from tissue engineering point of view in treatment of osteoporosis. 
 
CD73, CD90 and CD105 are the minimal criteria of stem cell markers 
expression to identify cells as MSCs. However, these markers may not have a direct 
link with MSC differentiation capacity (Pittenger et al., 1999).  Therefore, there are 
other markers which seem to have a role in the differentiation of progenitor cells 
such as CD271 (low-affinity nerve growth factor receptor) and CD146 (melanoma 
cell adhesion molecule). However it is not known if they identify the same cells or a 
subpopulation of these cells (Tormin et al., 2011). CD146 was linked with progenitor 
cells that have ability to differentiate into three different lineages (osteogenic, 
adipogenic and chondrogenic) (Xu et al., 2009). Mikami et al., (2011) showed that 
CD271 was found in progenitor cells that were not cable to differentiate into these 
three lineages which may make CD271 marker an important marker to determine 
differentiation ability of cells. 
 
3.2 Aims 
This chapter continues form the data obtained in the previous chapter in terms of the 
unique character of each clone which has been isolated. In the previous chapter it 
was found that different clones have different PDs and they responded differently to 
the oxidative stress, showed different expression markers of cell senescence and 
different telomere lengths. The effect of aging on these clones in term of 
proliferation and stem cell marker expressions was also demonstrated. This chapter 
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will investigate the differentiation ability of each clone; A31, A11 and B11 into 
osteoblast, chondrocytes and adipocytes and the effect of aging and hydrogen 
peroxide induced oxidative stress on the osteogenic differentiation for the highly 
proliferative clone, A31. This assessment will facilitate the process of isolating the 
best clone for use in tissue engineering.  
 
3.3  Materials and Methods 
 
3.3.1 Cell Source 
The isolated DPPC clonal population, A31, A11 and B11 at early PD (30PDs, 
17PDs, 25PDs, respectively) in addition to late PD of A31 (75PDs) clones were 
cultured in adipogenic, chondrogenic and osteogenic induction media, to evaluate the 
potential of DPPC clones to differentiate along these mesenchymal lineages. 
 
3.3.2 Culture Media 
The medium used was the NH stem cell media AdipoDiff, OsteoDiff and 
ChondroDiff media (Miltenyi Biotec, Surrey, UK) for osteogenic, chondrogenic and 
adipogenic differentiation, respectively. The medium was thawed and supplemented 
with 1% antibiotics (100 units/ml penicillin G sodium, 0.1µg/ml streptomycin 
sulphate and 0.25µg/ml amphotericin; Invitrogen, Paisley, UK). and then aliquoted 
into samples 20ml for storage at -20
o
C. 
 
3.3.3 Differentiation Induction Procedures 
Details of clonal differentiation into osteogenic, chondrogenic and adipogenic cells 
are described below. Controls were also performed consisting of DPPCs plated into 
2x 6-well plates (Sarstedt, Leicester, UK). These were maintained in culture medium 
for the same period of differentiation to be used for total RNA extraction and reverse 
transcription-polymerase chain reaction (RT-PCR). All differentiation studies were 
performed in triplicate. 
 
3.3.3.1 Adipogenic Differentiation 
For the analysis of clonal adipogenic capacity, cells were seeded at 7.5x10
3 
cells/cm
2
 
in 6-well plates and 12-well plates. Cells in 6-well plates were used for RT-PCR and 
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in 12-well plates for the oil red O analysis. Cells were cultured with AdipoDiff 
medium and incubated at 37
o
C, 5% CO2 for 21 days (as stated in Miltenyi Biotec 
protocol). The medium was changed every 3 days. On day 21, cells were processed 
for analysis.  
 
3.3.3.2 Osteogenic Differentiation 
For the analysis of clonal osteogenic capacity, cells were seeded at 4.5x10
3 
cells/cm
2
 
in 6-well plates and 12-well plates. Cells in 6-well plates were used for RT-PCR and  
in 12-well plates for alizarin red staining (Sigma, Dorset, UK) analysis (section 
3.2.4.?). Cells were cultured with OsteoDiff medium and incubated at 37
o
C, 5% CO2 
for 18 days (as stated in Miltenyi Biotec protocol). The medium was changed every 3 
days. On day 18, cells were processed for analysis.  
 
3.3.3.3 Chondrogenic Differentiation 
For the analysis of clonal chondrogenic capacity, a single cell suspension with 2.5x 
10
5
 cells in 1ml was centrifuged at 150x g for 5 min, to produce a cell pellet in a 
15ml polypropylene conical base tube in triplicate (Falcon tube, Sarstedt, Leicester 
UK). The medium was completely aspirated and replaced with 1ml of ChondroDiff 
medium before re-centrifugation. The caps of the conical tubes were loosely placed, 
and the pellets incubated at 37
o
C, 5% CO2 for 24 days (as stated in Miltenyi Biotec 
protocol). The medium was changed every 3 days following centrifugation. On day 
24, the pellets were processed for analysis. 
 
3.3.4 Histochemical Analysis 
For osteogenic analysis and control cultures, one 12-well plate was washed twice 
with phosphate buffered saline (PBS) before being fixed with 4% paraformaldehyde 
(PFA) (Santa Cruz, Texas, USA) for 10 min at room temperature. The PFA was then 
removed and the fixed cells were washed with PBS (x2). Adipogenic culture analysis 
and control cultures were washed with 60% isopropanol (x1) for 5 min with gentle 
agitation. For chondrogenic differentiation, pellet cultures and their controls were 
washed with PBS (x1), before fixation overnight in 3.7% neutral buffered formalin 
(in PBS) with gentle agitation. After formalin aspiration, each cell pellet was 
carefully removed from the conical tube using a thin tip, wrapped in filter paper and 
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inserted into embedding cassettes for automatic processing (Leica ASP300 S, Leica 
Microsystem, Milton Keynes, UK). This passed samples through increasing 70%, 
90% and 100 % concentrations of ethanol. Samples were paraffin wax embedded and 
cut into 5m sections using a sliding microtome (Leica SM2400, Leica 
Microsystems). Sections were collected on to poly-L-lysine coated glass slides 
(SuperFrost, Thermo Fisher Scientific, Loughborough, UK) and allowed to dry 
overnight at 60
o
C in an incubator (Binder, Germany). Sections were deparaffinised 
and rehydrated by washing for 10 min with xylene, 5 min with industrial methylated 
spirits (IMS) and 5 min with water. Sections were circled with immiscible ink using 
a paraffin pen (Sigma, UK) prior to staining.  
 
3.3.4.1 Alizarin Red S Staining 
The osteogenic cultures and its controls were stained with 0.5 ml/well alizarin red S 
(20g/L dissolved in double distilled water, pH 4.2 for 3 min with gentle shaking. 
Wells were subsequently washed with running water until the excess stain was 
removed, left to dry and viewed by light microscopy (Nikon Eclipse TS100). 
 
3.3.4.2  Oil Red O Staining 
Oil red O (Sigma, UK) (stock of 3.5g/L dissolved in isopropanol) working stain was 
prepared fresh by mixing a 4:6 ratio of double distilled water to oil red O stock. This 
was incubated at room temperature for 10 min on a shaker, before filtering through 
Whatman grade 42 filter paper (Fisher Scientific, UK). Adipogenic cultures and its 
controls were stained with 0.5 ml/well working oil red O solution for 10 min at room 
temperature, with gentle agitation. Wells were subsequently washed with double 
distilled water and then briefly with 60% isopropanol, before washing again with 
double distilled water until the excess stain was removed. Sections were left to dry 
before viewing by light microscopy. 
 
3.3.4.3  Safranin O Staining 
Pellet sections were placed in fast green FCF staining solution (1:5000 dilution of 
0.1g fast green FCF (Sigma Aldrich, UK) in 500ml double distilled water for 5 min 
and washed subsequently in 1% acetic acid. For safranin O staining, the washed slide 
was placed in 0.1% safranin O staining solution (1g/L safranin O, Sigma , UK) in 
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double distilled for 10 min and was subsequently washed in a 95% ethanol-xylene 
mixture (1:1). A cover slip was mounted with a drop of glycerol and fastened with 
nail polish, before viewing by light microscopy. 
 
3.3.5 RT-PCR of DPPC Differentiation 
RT-PCR was performed on 6-well plates for osteogenic and adipogenic 
differentiation cultures and their controls. RT-negative and water negative controls 
were used and actin was used as the housekeeping gene for PCR. The extraction 
of mRNA and RT-PCR were performed as previously described (Section 2.3.5.1). 
PCR primers for osteogenic markers OCN and Runx2 and adipogenic markers 
lipoprotein lipase (LPL) and PPARwere used. In addition, low-affinity nerve 
growth factor receptor (LNGFR or CD271) was examined in each clone prior to 
differentiation. Primer sequences, melting temperatures and product sizes are 
summarised in Table 3.1.  
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Table 3.1: Human differentiation gene markers used for PCR amplification. Β-
actin was used as a housekeeping gene. 
 
 
Gene 
Marker 
 
Primer sequence 
Annealing 
Temperature 
o
C 
 
Cycles 
 
Source 
Osteocalcin F:5'-GCAGGTGCGAAGCCCAGCGGTGCAGAG-3' 
R: 5'-GGGCTGGGAGGTCAGGGCAAGGGCAAG-3' 
62 35 Chi Lee 
Cardiff 
University 
Osteopontin 
(SPP1) 
F:5'- ATCACCTGTGCCATACCA-3' 
R:5'- CATCTTCATCATCCATATCATCCA-3' 
55 35 Maria Stack 
Cardiff 
University 
peroxisome 
proliferator-
activated 
receptor  
F:5'-GCCATCAGGTTTGGGCGGATGCCACAG-3' 
R: 5'-CCTGCACAGCCTCCACGGAGCGAAACT-3' 
62 35 Chi Lee 
Cardiff 
University 
lipoprotein 
lipase 
F:5'-GCTGGCATTGCAGGAAGTCTGACCAATAA-3' 
R:5'-GGCCACGGTGCCATACAGAGAAATCTCAA-3' 
55 35 Chi Lee 
Cardiff 
University 
CD271 
(LNGFR) 
F:5'- CTGCAAGCAGAACAAGCAAG-3' 
R:5'- GGCCTCATGGGTAAAGGAGT-3' 
55 35 Lindsay 
Davies 
Cardiff 
University 
-actin F:5'-AGGGCAGTGATCTCCTTCTGCATCCT-3' 
R:5'- CCACACTGTGCCCATCTACGAGGGGT-3' 
65 35 XQ Wei 
Cardiff 
University 
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3.4 Results 
 
3.4.1 Osteogenic Differentiation 
 
3.4.1.1 Cell Morphology and Alizarin Red Staining 
For clone A31, osteogenic cultures of DPPCs (30PDs) at day 14 were fibroblast-like 
in morphology, but appeared larger and to form clusters in the calcified area (circled) 
(Figure 3.1.A), when compared with the control cultures where cells were narrower 
in morphology and more crowded, (Figure 3.1.B). After 18 days of osteogenic 
culture, at early PD (30PDs), there was strong alizarin red staining with secreted 
mineralised calcium nodules scattered in the cells cultured in osteogenic medium 
(arrowed) (Figure 3.2 A). Mid-point (62PDs) (Figure 3.2 C) and late PD cells 
(75PDs) (Figure 3.2 E) demonstrated less staining. Control cultures with alizarin red 
s, at day 18, did not exhibit any stained cells for the 3 different PDs (Figure 3.2 B, D 
and F).  
 
For clone A11 at early PD (17PDs) there was marked staining of alizarin red 
(arrowed) (Figure 3.3.A), which was similar to clone A31 at 30PDs (early PD) 
(Figure 3.2 A). Control cultures exhibited no staining for alizarin red.  
 
Clone B11 at 25PDs showed minimal staining of alizarin red S (Figure 
3.4.A), which was significantly less than the staining of Clones A31 at 30PDs and 
A11 at 17PDs (Figure 3.2.A and 3.3.A) and without region of big cluster. Control 
culture showed no staining of alizarin red S (Figure. 3.4. B). 
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Figure 3.1.  Exemplar light microscopy of DPPCs (A31 clone at 30PDs) cultured 
in osteogenic medium for 14 days. (A) Cells appeared larger with clustered 
areas (indicated by red circle), when compared with control cultures (B) that 
appeared unclustered. ×10 magnification, Scale bar 100μm. 
 
       
(A) 
 
 
 
(B) 
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Figure 3.2. Light microscopy of osteogenic cultured cells of A31 clone, stained 
with alizarin red. Early PD (30PDs) cultured cells demonstrated higher levels of 
staining with secreted calcium globules at day 18 (A) compared with mid-PD 
(62PDs) which exhibited less calcium globules (C). Late PD (75PDs) cells were 
observed to exhibit the least amount of staining (E). Control cultures exhibited 
no staining at early PD (B), mid PD (D) and late PD (F). ×10 magnification, 
scale bar 100μm. 
 
 
 
A      B 
            
C      D 
            
E      F 
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Figure 3.3.  Light microscopy of A11 at 17PDs osteogenic cultured cells, stained 
red with alizarin red (A) that was similar to what was found in early PD of clone 
A31. no staining was observed with control culture (B). ×10 magnification, scale 
bar represents 100μm. 
 
 
 
(A) 
        
 
 
(B) 
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Figure 3.4. Light microscopy of B11 at 17PDs osteogenic cultured cells, stained 
with alizarin red S without a specific clustered area (A). Control cultures with 
no stain observed (B). ×10 magnification, scale bar represents 100μm 
 
 
 
(A) 
 
 
 
(B) 
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3.4.1.2 RT-PCR for Osteogenic Differentiation 
The RT-PCR for clone A31 late PD (75PDs) of osteogenic cultured cells at day 18 
was negative for the 3 osteogenic markers (Runx2, OCN and OPN) (Figure 3.5). The 
expression of the osteogenic markers was also negative for control cultures at day 18 
(Figure 3.5).-actin housekeeping gene was positive in the all results and RT 
negative showed no bands. 
 
For all the clones (A31 at 30PDs, A11 at17PDs and B11 at 25PDs), RT-PCR 
of the osteogenic cultured cells revealed the presence of osteogenic markers Runx2, 
OCN and OPN at day 18 (Figure 3.6). The day 0 initial culture controls were positive 
for Runx2 but not OCN and OPN. Day 18 control had the same gene expression as 
day 0 where Runx2 was positive and OCN and OPN were negative (Figure 3.6).  
 
Clone A31 at early PD in osteogenic medium revealed the presence of 
osteogeneic markers and high staining of alizarin red which faded gradually with 
cellular ageing. Furthermore, at later PD, cells cultured in osteogenic medium failed 
to express all the osteogenic markers. A11 (17PDs) and B11 (25PDs) clones 
displayed the presence of osteogenic markers in osteogenic culture which was similar 
to clone A31 at early PD (30PDs). 
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Figure 3.5. RT-PCR results showed mRNA expression profiles for clone A31 at 
early (30PDs) and late (75PDs) PDs in osteogenic medium and control culture 
medium at day 18 for Runx2, OCN and OPN. -actin was used as a 
housekeeping gene. Cells at early PD in osteogenic medium expressed the 
osteogenic markers while at late PD did not express any of the osteogenic 
markers. Cells in control culture at early PD only expressed Runx2 while in late 
PD did not express any osteogenic markers. 
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Figure 3.6. RT-PCR results showed mRNA expression profiles for clones; A31 
at 30PDs, A11 at 17PDs and B11 at 24PDs in osteogenic medium and control 
culture medium at day 18 for Runx2, OCN and OPN. -actin was used as a 
housekeeping gene. All cells in osteogenic culture expressed the osteogenic 
markers (Runx2, OCN and OPN). Also, cells in control culture expressed only 
Runx2. 
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3.4.2 Adipogenic Differentiation 
 
3.4.2.1 Cell Morphology and Oil Red O 
For clone A31, adipogenic cultures of DPPCs (62PDs) at day 9 started to secrete fat 
droplets (arrowed) (Figure 3.7.A), when compared with the control cultures (αMEM 
with 20% FCS) where cells started to be over-confluent and stressed, (Figure 3.7.B). 
After 21 days of adipogenic culture, early PD (30 PDs), cells demonstrated small 
amounts of oil red O staining that revealed the lipid droplet within cells (arrowed) 
(Figure 3.8.A). At mid-late PD (62PDs), cells demonstrated large amount of oil red 
O staining present in almost in all the cells revealing the lipid droplet within cells 
(arrowed) (Figure 3.8.C). At late PD (75PDs), many cells appeared to have died but 
the remaining cells, did demonstrate oil red O staining of the fat droplets (arrowed) 
(Figure 3.8.E). Control cultures of A31 clones at the 3 different PD showed no 
specific staining with some cells tend to lift off the plate due to over-confluency 
(Figure 3.8. B, D and F).  
   
For both clones A11 (17PDs) and B11 (25PDs), at day 21 in adipogenic 
culture, no staining of oil red O was observed (Figure 3.9.A. and 3.10.A), along with 
their control cultures (Figure 3.9.B and 3.10.B). 
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Figure 3.7.  Light microscopy of DPPCs (clone A31 at 62PDs) cultured in 
adipogenic medium for 9 days, (A) showed some cells with fat droplet 
(arrowed), while (B), cells in control cultures after 9 days where cells started to 
be over-confluent and wider. ×10 magnification, Scale bar 100μm. 
 
 
       
(A) 
 
 
 
 
(B) 
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Figure 3.8.  Light microscopy of clone A31 adipogenic cultured cells, stained 
with oil red O for early passage (30PDs) cultured cells showed less fat droplet 
staining at day 21 (A) compared with mid (62PDs) (C) and late (70PDs) passage 
(E) which showed more stained fat droplets). No specific stain was observed on 
control cultures at early (B), mid (D) and late PD (F). ×20 magnification, scale 
bar represents 100μm. 
 
 
 
A      B 
            
C      D 
            
E      F 
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Figure 3.9.  Light microscopy of clone A11 adipogenic cultured cells, stained 
with oil red O showed no fat droplets staining at day 21 (A). Control cultures 
had no specific stain of fat droplets observed (B). ×10 magnification, scale bar 
represents 100μm. 
 
 
A      B 
             
 
 
Figure 3.10.  Light microscopy of clone B11 adipogenic cultured cells, stained 
with oil red O showed no fat droplets staining at day 21 (A). Control cultures 
had no specific stain of fat droplets observed (B). ×10 magnification, scale bar 
represents 100μm. 
 
 
A      B 
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3.4.2.2 RT-PCR for Osteogenic Differentiation 
The RT-PCR of the adipogenic cultured cells and the control of clone A31 indicated 
the presence of adipogenic markers PPARat both early (30PDs) and late (75PDs) 
PDs (Figure3.11) at day 21. LPL gene expression was observed at both PDs (early 
and late) in the adipogenic cultured cells at day 21, while in the control cultured 
cells, LPL was negative at early and late PDs (Figure 3.11). Further investigation of 
RT-PCR, demonstrated the cells cultured in adipogenic culture expressed the 
osteogenic marker Runx2 at early PD but did not express at late PD.  Runx2 
expression in the control culture had the same result of the adipogenic culture in both 
PDs (30 and 75PDs) (Figure 3.11). 
 
For both clones A11 (17PDs) and B11 (25PDs), at day 21 in adipogenic 
culture, The RT-PCR was positive for PPARbut not LPL. Similar results of RT-
PCR for these two clones were noted for the control cultured cells at day 21, as 
PPARwas expressed but not LPL (Figure 3.12).-actin housekeeping gene was 
positive in the all results and RT negative showed no bands.  
 
 Clone A31 at early and late PDs in adipogenic medium revealed the presence 
of adipogenic markers which confirmed by staining of oil red O, However the 
staining was much more in the late PD with the expression of LPL more intense in 
the late PD.  Clones A11 and B11 failed to express LPL which support the negative 
staining results of oil red O. Cells cultured as control cultures failed to express LPL 
and were negative for the adipogenic stain.  
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Figure 3.11. RT-PCR results showed an mRNA expression profile of PPAR, 
LPL, Runx2, for clone A31 at early (30PDs) and late (75PDs) in both adipogenic 
and control culture at day 21. -actin was used as a house keeping gene. LPL 
only expressed in the adipogenic culture for both PDs, while Runx2 expressed 
only in early PD for both cultures medium. 
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Figure 3.12. RT-PCR results showed an mRNA expression profile of PPAR 
and LPL for clones; A31 at 30PDs, A11 at 17PDs and B11 at 25PDs in both 
adipogenic and control cultures. -actin was used as a house keeping gene. 
PPAR was expressed in all the clones in both adipogenic and control cultures 
while LPL was only expressed in clone A31 in adipogenic culture. 
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3.4.3 Chondrogenic Differentiation 
After culturing the three different clones (A31, A11 and B11) with the ChondroDiff 
chondrogenic medium, the pellets of cells became rounded after 6 days whereas the 
control cultures remained as pellets adhered to the bottom of the conical tube. During 
the process, these rounded pellets became smaller and more rounded, while the 
control cultures lost their initial pellet appearance and became a mass of cells. At the 
end of the culture period, day 24 chondrogenic culture pellets appeared very small, 
rounded and compact and the control cultures were irregular masses of cells (Figure 
3.13). 
 
3.4.3.1 Safranin O Staining 
After the fixation and sectioning process, clone A31’s pellets were strongly stained 
by Safranin O, while the other two clones had almost no staining observed (Figure 
3.14). Control culture pellets failed to be sectioned because cells did not form a 
rounded tissue as the ChondroDiff chondrogenic medium cultured cells.  
131 
 
Figure 3.13.  Photographs of DPPCs pellets cultured in ChondroDiff 
chondrogenic medium. After 24 days the pellet in chondrogenic medium became 
rounded (A), whilst the control culture remained as an irregular mass cells (B). 
 
 
 
A      B 
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Figure 3.14.  Light microscopy at x10 and X40 magnification of clone A31 (A) in 
chondrogenic cultured cells, stained with Safranin O demonstrated strong 
staining compared with other clones A11 and B11 (B and C) , scale bar 
represents 100μm. 
 
 
 
   Ax10     Ax40                              
               
 
   Bx10     Bx40 
                    
 
   Cx10     Cx40 
                
133 
 
3.4.4 Effects of H2O2 on Osteogenic Differentiation 
Clone A31 showed similar staining of alizarin red at all different concentrations (0, 
50, 100, 200M) (Figure. 3.15) of H2O2. Control culture showed no staining of 
alizarin red S (Figure. 3.16 control). The RT-PCR of the osteogenic cultured cells in 
the 0M concentration of H2O2 was Positive for Runx2, OCN and OPN while cell 
cultured in 200 M did not express OCN or OPN (figure 3.17).   
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Figure 3.15. Light microscopy of A31 osteogenic cultured cells, stained with 
alizarin red after being cultured under different concentrations of H2O2 (0, 50, 
100, 200M). Cells cultured in increasing concentrations of H2O2 expressed 
similar amounts of alizarin red. ×10 magnification, scale bar represents 100μm. 
 
 
 
0M                    50M 
           
 
100M                                                    200M    
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Figure 3.16. The control culture of the previous figure (3.15). No alizarin red 
staining was observed. ×10 magnification, scale bar represents 100μm. 
 
 
 
        0M -control                                   50M -control 
               
 
        100M -control                         200M -control  
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Figure 3.17. RT-PCR for 0 m and 200m concentrations of H2O2 in osteogenic 
culture and in control culture for Runx2, OCN and OPN. OCN and OPN were 
only expressed on 0 m concentration of H2O2 while Runx2 was positive in all of 
them. -actin was used as a house keeping gene. 
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3.4.5 CD271 Expression 
All the clones were investigated for CD271 marker expression prior to 
differentiation.  Clone A31 at 30PDs did not express this marker, while A11at 17PDs 
and B11 at 25PDs did express CD271 (Figure 3.18).   
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Figure 3.18. RT-PCR results showed an mRNA expression profile of CD271 for 
clones; A31 at 30PDs, A11 at 17PDs and B11 at 25PDs. CD271 was expressed by 
clones A11 and B11 but not A31. . -actin was used as a house keeping gene. 
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3.5 Discussion 
This chapter clearly linked the highly proliferative clone, A31 that has a long 
telomere length with the ability to differentiate into three different lineages i.e. 
osteogenic, chondrogenic, and adipogenic. While the low proliferative clones, A11 
and B11, that have short telomere lengths, were more committed and only 
differentiated into osteoblasts. In addition, CD271 marker was only expressed in 
clones A11 and B11, the clones that differentiated into one lineage, indicating 
CD271 expression marker could be used to distinguish between multipotent and 
unipotent clones. Furthermore, in vitro expansion of the clones affected their 
differentiation ability into osteoblasts in favour of adipocyte differentiation. Finally, 
as seen from the previous chapter H2O2 had no effects on clones, it also appears in 
this chapter H2O2 had no effect on ability of clones to differentiate into osteoblasts. 
 
The results of clonal analyses in terms of differentiation potential have been 
discussed extensively in the literature and are supported by the findings of this work. 
Many papers show that clonal populations of DPPCs are able to differentiate into the 
three lineages, but appear to be from a small percentage of overall numbers of 
isolated clones, which is less than 5% of the total population (Halleux et al., 2001; 
Okamoto et al., 2002; Russell et al., 2010). The data in this study demonstrated that 
all three clones (A31, A11, B11) differentiated into an osteogenic phenotype, while 
A31 clone (the highly proliferative clone) alone was able to differentiate into three 
different lineages (osteoblast, chondrocytes, and adipocytes). This is in line with data 
presented by Halleux et al (2001), where 24 designated clones differentiated into 
osteogenic lines, while 17/24 and 18/24 clones differentiated into chondrogenic and 
adipogenic lineages, respectively. The preferable differentiation of these clones into 
osteogenic lineages may be due to their source of origin as pulp cells are indicated to 
express bone markers (Gronthos et al., 2002). It is also worthy to note that although 
these studies perform their experiments on clones, methods of isolation or culture 
medium were different from those described in this study, such as isolation of cells 
based on their stem cell marker expression, and culture of clones in Dulbecco's 
modiﬁed Eagle's medium (DMEM). Whereas here, clones were isolated by 
fibronectin adhesion assay, and alpha minimum essential medium, respectively. 
Indeed, different methods of isolation could result in different population of cells. 
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Cells isolated by enzymatic dissociation showed better differentiation ability into 
osteogenic lines than cells isolated by direct outgrowth (Bakopoulou et al., 2011).  
 
The reason behind the variety of the clones in terms of differentiation ability 
is still not fully understood. Some studies have linked variations to the expression 
levels of cell surface markers such as CD146 (Russell et al., 2010) or CD271 
(Mikami et al., 2011). The reason behind different stem cell marker expression could 
be due to their different locations. DPPCs that express CD146 marker are suggested 
to be from a perivascular niche (Shi and Gronthos, 2003), while DPPCs that express 
CD271 marker suggests that the niche is of a nerve network  origin within the cell-
free zone (Lizier et al., 2012). The relationship between CD146 expression and 
differentiation ability was proportional, while for CD271, differentiation was 
inversely related to the differentiation ability (Russell et al., 2010; Mikami et al., 
2011). In this study, A31 clone, the only clone with multiple differentiation ability, 
was the only clone to not express CD271. Although A11 clone is from the same 
patient as A31 clone, it did express CD271. This may indicate different niches from 
which these clones were isolated. Another theory which supports the reason of the 
variations in both differentiation and proliferation between the clones is asymmetric 
division of the stem cell. Adult stem cells have the ability for self-renewal and 
differentiate into multiple cell lineages, with short life-spans. To achieve self-
renewal capabilities and differentiation functions, stem cells divide slowly and 
symmetrically to produce an identical daughter cell with low proliferative capacity 
and multipotential differentiation. Some of these adult stem cells go on to divide 
asymmetrically and give rise to one identical daughter cell and another progenitor 
cell called a transit amplifying (TA) cell. TA cells have a high proliferative potential 
and low differentiation ability and give rise to more committed progenitors with 
reduced proliferative potential (Figure 1.1), and eventually produce terminal 
differentiated cells (Alison et al., 2002; Ho, 2005). Asymmetrical division could give 
one explanation of the reasons that cause different characteristics between isolated 
clones of DPPCs. Here, clone A31 was the only clone that had both characteristics 
with highly proliferative and multipotential differentiation, probably because of 
asymmetrical division of stem cells that led to this clone to have both populations i.e. 
stem cells and TA cells. While clones A11 and B11 were more committed 
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progenitors with low proliferation capacity and commitment to differentiate only into 
osteoblasts. 
 
For osteogenic differentiation, alizarin red staining was shown in all isolated 
DPPCs clones (A11, A31 and B11). Alizarin red is used to demonstrate the calcium 
deposition nodules (Koch et al., 2007).  In addition, several bone specific genes 
(Runx2, OCN, and OPN) were expressed in these clones after induction in 
osteogenic medium for 18 days. Runx2 controls the expression of many tooth and 
bone related genes and regulate the differentiation of MSCs into osteoblasts (Lian et 
al., 2006). OCN gene expression is recognized to occur at a late stage of osteoblastic 
differentiation (Mizuno and Kuboki, 2001). OPN is a major non-collagenous protein 
produced by differentiated osteoblasts, and BSP is considered as a specific marker 
for osteoblasts (Mizuno and Kuboki, 2001). Runx2 was detected in early passage 
cells in all clones in normal and osteogenic medium, but OCN and OPN were only 
detected in cells cultured in osteogenic medium. As such, the expression of Runx2, 
OCN, and OPN with alizarin red staining, confirmed the osteogenic differentiation of 
all three DPPCs clones.  At late PD, Runx2 was not detected in neither normal nor 
osteogenic cultured medium cells. Therefore, OCN and OPN expression was absent. 
Losing Runx2 with ageing indicated loss of the ability of these cells to differentiate 
into bone, which has been previously reported (Banfi et al., 2000); and may explain 
the deterioration of bone in elderly patients with osteoporosis where Runx2 is 
suppressed by PPAR (Moerman et al., 2004).  
 
Clone A31 demonstrated its differentiation ability into an adipogenic lineage 
by morphological changes and expression of specific adipogenic genes. The main 
morphological change was the accumulation of lipid rich vacuoles within cells which 
is a sign of successful differentiation of MSCs into adipocytes (Pittenger et al., 1999; 
Jaiswal et al., 2000; Huang et al., 2009b). In addition, clone A31 adipogenic 
differentiated cells expressed PPAR the key factor for MSC differentiation into 
adipocytes (Muruganandan et al., 2009). PPAR was shown in all the clones, for 
both adipogenic and control cultures, while LPL was only identified in clone A31 
after culturing in adipogenic medium; which was also the only clone to have the 
positive staining of oil red O. This is due to the fact that adipocytes and osteoblasts 
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share the same origin progenitor cells, while only pre-osteoblastic cells differentiate 
into osteoblast, but not into adipocytes (Shakibaei el al, 2012). Furthermore, LPL is 
downstream from PPAR and so is mainly expressed in mature adipocytes, in order 
to increase the generation of fatty acid (Yoke Yin et al., 2010). This explains the 
presence of oil red O staining with the expression of LPL in the only clone 
differentiated into adipocytes (A31 clone). 
 
It has been reported that in vitro ageing, which means passaging cells during 
cell culture, has greater effects on MSCs, in term of proliferation and differentiation, 
than in vivo ageing (Fickert et al., 2011; Kim et al., 2012b). Due to the need of 
considerable stem cell expansion in vitro for DPPCs to produce sufficient cell 
numbers to characterise these cells and for the therapeutic use in the future 
(Thirumala et al., 2013), an investigation of the effect of in vitro ageing was 
performed. In this study, the highly proliferative clone A31 showed more ability to 
differentiate along the osteogenic pathway and less ability to differentiate into 
adipocytes at early PD. However, A31 lost its osteogenesis ability at late PD in 
favour of adipogenesis. The lack of Runx2 has been shown before that it prevents the 
osteogenic differentiation (Komori et al., 1997), which is similar to what has been 
found in clone A31 at late PD. Comparing this to an in vivo model, osteoblasts and 
adipocytes are derived from mesenchymal stem cells in bone marrow (Bianco et al., 
2001), based on two main transcription factors; Runx2 for osteogenic differentiation 
and PPARfor adipogenic differentiation (Kim et al., 2012b). PPARacts as 
suppressor of Runx2 and osteoblast phenotype. With ageing, the expression of 
PPARincreases which leads more MSCs to terminally differentiated adipocytes, 
rather than osteoblasts. These results may explain the reason of the appearance of 
fatty marrow with advancing age (Moerman et al., 2004). Furthermore, decreases in 
the differentiation capabilities with ageing seem to co-ordinate with the loss of the 
stem cell marker expression that has been shown in chapter 2. It is noteworthy to 
point that what is consider as early PDs in this thesis could not be the same in other 
studies such as in  Deng et al., ( 2001) where early PD was at passage 2. 
 
For the chondrogenic differentiation clones, highly proliferative clone A31 
showed high potential to differentiate into cartilaginous tissue by using chondrogenic 
143 
 
medium in 3D culture, in the form of pellet culture (Johnstone et al., 1998). The 
specimens were stained with Safranin O to stain proteoglycans, which are major 
proteins in cartilage (Schmitz et al., 2010). In addition the transcription factor, Sox9, 
is also a major component of the cartilage (Shirasawa et al., 2006), was detected in 
this clone. Low proliferative clones (A11 and B11) showed almost no ability to 
differentiate into cartilaginous tissue. This again may be due to the origin of these 
clones, as described previously.  
 
H2O2 is used to accelerate cellular senescence at concentrations that are non-
lethal to cells. As oxidative stress-induced senescence had no effects on the telomere 
lengths, H2O2 did not have an effect on the differentiation capacity of the highly 
proliferative clone A31 in terms of mineralisation, which was shown by Alizarin red 
staining and the expression of gene marker, Runx2. However, the expression of OCN 
and OPN were negative only in the highest concentration, 200m. This proves that 
the expression of these two markers does not co-ordinate with mineralisation, in line 
with previous studies (Beck et al., 1998; Addison and McKee, 2010). Even though 
Runx2 is considered as a regulator for OCN and OPN, however it is not the only 
regulator of these genes, which means that H2O2 may have an effect on other 
regulators that lead to OCN and OPN not being expressed, such as homeodomain 
proteins, exogenous phosphate or ascorbate could react with H2O2 (Goralczyk et al., 
1998; Hassan et al., 2004). Oxidative stress via H2O2 has been linked to loss of bone 
density with ageing in both men and women (Basu et al., 2001), but it did not show 
that in this study. This may be due to the time exposure of H2O2 was not enough to 
cause effects on the mineralisation process. 
 
In conclusion, this chapter has demonstrated that only the highly proliferative 
clone (A31) was able to differentiate into osteogenic, chondrogenic and adipogenic 
lineages, which makes it the likeliest candidate for tissue engineering. Although, 
clone A11 is from the same patient as A31 but it did not show the same results as 
A31. This could be due the different niche where these clones arise from or what 
stage of development these cells are as shown in figure 1.1 Given their low levels in 
dental pulp cell populations, this means finding better ways to isolate and 
characterise these clones is a crucial step before using these MSC clones for 
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therapeutic applications.  Furthermore, in vitro expansion of the cells has its effect on 
the clone differentiation ability, which could explain the differences that occurs in 
humans during ageing, such as increase of fat in bone marrow, at the expense 
mineralised of bone status.  
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Chapter 4: 
Identification of Clonal Dental Pulp Variations Using Raman Spectroscopy 
 
 
4.1 Introduction 
There are ever-increasing demands on the therapeutic usage of mesenchymal stem 
cells (MSCs), which means further investigation regarding cell characteristics and 
behaviour is needed (Pijanka et al., 2010). This is because MSCs have no specific 
markers and their behaviour differs, based on the species, site of origin and maturity. 
However, to analyse these cells, this may require fixation, staining and drying steps 
that damage cellular characteristics, or structural features and does not provide the 
real-time chemical information from living human stem cells. This calls for 
investigations to develop non-destructive applications to characterise cells. One of 
these methods is Raman Spectroscopy (Moody et al., 2010).      
 
Raman spectroscopy is a biochemical characterisation method based on the 
inelastic scattering of monochromatic light. When the incident light is scattered from 
a molecule or crystal, most photons are elastically scattered. Only a very small 
fraction of photons (approximately 1 in 10
7
 photons) are scattered inelastically, i.e. 
with a frequency different from that of the incident photons. This inelastic scattering 
is called the Raman effect (Advanced physics Laboratory, 2006). The 
monochromatic light that is used in Raman spectroscopy is a laser, whose 
wavelength can vary from the visible to the infrared region of the electromagnetic 
spectrum. The theoretical physics behind Raman spectroscopy is that photons scatter 
at the same angle as the incident angle, due to the vibration of the molecules and 
atoms. When the wavelength of the scattered Raman photon is lower than that of the 
incident photon, it is termed anti-Stokes scattering. In contrast, when the wavelength 
of the scattered Raman photon is higher than that of the incident photon, so-called 
Stoke scattering occurs (Figure 4.1). There are many Raman band assignments that 
have been identified for human cell components. Table 4.1 shows some of these 
bands (Chan et al., 2009). The energy difference between the incident and scattered 
photons is numerically calculated as Raman shift in wave numbers (cm
-1
), through 
the following equation: V = 1/incident -1/scattered   where  is the wavelength in cm.  
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Figure 4.1. Energy level diagram for Raman scattering. (a) Stokes scattering 
and (b) anti-Stokes scattering. (Image taken from Advanced Physics 
Laboratory, 2006). 
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Table 4.1 Raman peak wavenumbers and their assignments 
 
 
Wavenumber 
cm
-1 
Assignment 
3328 Amide A: N–H and O–H stretching vibrations of 
polysaccharides, proteins 
3129 Amide B: N–H stretching vibrations of proteins 
3015 Olefinic =CH stretching: unsaturated lipids, cholesterol 
esters 
2960 CH3 antisymmetric stretching: lipids, protein side chains 
2920 CH2 antisymmetric stretching: mainly lipids 
2875 CH3 symmetric stretching: protein side chains, lipids 
2850 CH2 symmetric stretching: mainly lipids 
1720–1745 C=O stretching vibrations of lipids (triglycerides and 
cholesterol esters) 
1710–1716 C=O antisymmetric stretching: RNA and purine base 
1705–1690 C=O antisymmetric stretching vibrations: RNA, DNA 
1654 Amide I: C=O (80%) and C–N (10%) stretching, N–H 
(10%) 
bending vibrations: proteins a-helix 
1630–1640 Amide I: C=O (80%) and C–N (10%) stretching, N–H 
(10%) 
bending vibrations:proteins β-structure 
1610, 1578 C4-C5 and C=N stretching in imidazole ring of DNA, RNA 
1515 Aromatic tyrosine ring 
1540–1550 Amide II: N–H (60%) bending and C–N (40%) stretching 
vibrations: proteins α-helix 
1530 Amide II: N–H (60%) bending and C–N (40%) stretching 
vibrations: proteins β-structure 
1467 CH2 bending vibrations: lipids and proteins 
1455 CH3 bending and CH2 scissoring vibrations: lipids and 
proteins 
1370–1400 COO– symmetric stretching and CH3 bending vibrations: 
lipids, proteins 
1330–1200 Amide III: proteins 
1230–1244 PO2
 −
 antisymmetric stretching vibrations: RNA, DNA and 
Phospholipids 
1090-1080 PO2 
−
 symmetric stretching vibrations: RNA, DNA 
996 RNA stretch and bend ring of uracil 
 
 Table is adapted from Aksoy and Severcan, 2012. 
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Vibrational investigation of the biomedical properties of specimens has been 
applied before using infrared (IR) absorption spectroscopy (Miura and Thomas, 
1995). However, water is a strong IR absorbing medium. The advantage of Raman 
spectroscopy over IR spectroscopy is that the Raman peak of water is far from the 
fingerprint region (600-2000cm
-1
) of most of living biological systems (Thomas, 
1999). Other advantages of Raman spectroscopy are its ability to examine samples at 
different physical states, (solutions, suspensions, precipitates, gels, fibres, etc.) and 
its non-destructive and label-free nature (Thomas, 1999). On the other hand, one of 
the disadvantages of Raman spectroscopy is the weakness of the Raman signal. For 
this reason, improvements to Raman spectroscopy techniques are being sought, such 
as sample preparation, illumination or scattered light detection (Kachynski et al., 
2008).  
 
4.1.1 Applications of Raman Spectroscopy 
Raman spectroscopy has been used to identify and measure the cellular responses, 
such as cell-cell interaction, cell-matrix interaction, cell metabolism and senescence 
(Notingher, 2007). For example, it is possible to identify cell death based on the 
cellular response to toxic agents that produce distinct biochemical fingerprints in the 
Raman spectra of cells. This fingerprint is related to the intrinsic molecular 
composition of the cell. Ricin and sulphur mustard were used as the toxic agents and 
Raman spectroscopy showed high sensitivity to damaged cells with 99% accuracy 
(Notingher, 2007). 
  
The uniqueness of the Raman fingerprints of cells and tissues  is beneficial in 
different biomedical applications, such as the analysis of chemical composition 
(DNA, RNA, lipids and proteins), molecular markers, the measurement of biological 
functions (enzymatic activity and lipid intake), diagnosis of diseases (cancers) and in 
vivo endoscopies (Wachsmann-Hogiu et al., 2009). Most structurally informative 
bands occur in the range between 500-1800cm
-1
, such as protein and nucleic acid 
with the exception of the hydrogenic stretch molecules which generates 
wavenumbers at 2400-3600cm
-1
 Raman interval (Thomas, 1999). Figure 4.2 shows 
the Raman spectrum of P22 virus by using Raman Spectrum excited by argon laser at 
514.5nm. Water has been used as a buffer at its wavelength between 3000-3700cm
-1
. 
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Figure 4.2. Raman spectrum at 514.5nm excitation of P22 virus in H2O buffer at 
20
o
C. Bottom trace showed the complete spectrum, including H2O solvent 
(3000–3700cm-1) and aliphatic C -H stretch modes of viral protein and DNA 
(~2900cm
-1
). Most of the bands occurred in the 600-1800cm
-1
, including DNA 
backbone range between 830 and 1039cm
-1
. The figure is adapted from 
(Thomas, 1999). 
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Raman spectroscopy has also been used to distinguish between different 
types of cells. It has been reported that human embryonic stem cells (hESCs) show a 
higher Raman intensity in the lipid region (peaks at 2920, 2850 and 1740cm
-1
), when 
compared to human MSCs (Pijanka el al, 2010). This difference could help 
distinguish between multipotent and pluripotent stem cells, based on their lipid 
contents. This suggests Raman spectroscopy can separate stem cells from their 
derivatives, based on DNA and RNA contents, because their levels drop significantly 
during stem cell differentiation. The decrease of RNA to protein ratio was clearly 
shown in in murine neural stem cells during differentiation to glial cells (Ghita et al., 
2012). Another benefit of Raman spectroscopy in stem cells therapy is the detection 
and avoidance of teratomas by successful separation of stem cells from their 
derivatives. This is because with uncharacterised stem cells, there is a possibility of 
having mixed populations containing different types of cell, especially during the 
necessary culture expansion that led some of these cells to undergo differentiation. 
This type of heterogeneous population may cause teratoma and cancer (Chan et al., 
2009; Downes et al., 2011). 
 
Data analysis forms a very important part of Raman spectroscopy. One of the 
most commonly used statistical analyses with high potential to separate signals that 
have different intensities in the Raman spectra is Principal Component Analysis 
(PCA) (Hasegawa et al., 2000). PCA is a multvariate statistical analysis method 
based on non-parametric data that converts a collection of observations of probably 
connected variables into a group of values of linearly unconnected variables, called 
principal components (Massart et al., 1998). PCA is mathematically defined as “an 
orthogonal linear transformation that transforms the data to a new coordinate system 
such that the greatest variance by any projection of the data comes to lie on the first 
coordinate (called the first principal component), the second greatest variance on the 
second coordinate, and so on” (Jolliffe, 2002). PCA has been broadly used in Raman 
spectroscopy to distinguish between different tissues, especially between normal and 
diseased tissues, such as non-diseased skin tissue and basal cell carcinoma (Martin et 
al., 2004), to identify T and B lymphocytes of normal and leukemic patients (Chan et 
al., 2008); and to discriminate between live and apoptotic cells, such as in human 
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gastric cancer cells (Yao et al., 2009). However, PCA does not provide any chemical 
information, but only reveals differences between samples (Ong et al., 2012). 
 
4.2 Aims 
Characterisation of adult stem cells is vital to regenerative medicine. As it has been 
shown in the previous chapters, clones isolated from dental pulp behave differently 
according to the different methods of characterisation used, such as stem cell marker 
expression, population doubling level (PD), differentiation ability and telomere 
length. However, these methods are time consuming, which might also be destructive 
for the stem cells. 
 
For this reason, Raman spectroscopy was used to investigate if it could be 
used as a quick non-invasive method to characterise dental pulp progenitor cells 
(DPPCs) prior to their use in stem cell-based therapies. Raman spectroscopy was also 
used to investigate if the biochemical signatures of DPPCs are different from their 
successors following differentiation into chondrocytes. 
 
4.3 Material and Methods 
 
4.3.1 Cell Source 
Cultures of the isolated DPPC clonal populations at early PD (A31 at 18PDs, A11 at 
8PDs and B11 at 7PDs) in addition to mid-late A31 PD at 60PDs were thawed from 
liquid nitrogen and prepared for Raman spectroscopy by washing first in -MEM 
medium and subsequently in PBS. Cells were centrifuged at 1,800 rpm (Labofuge 
400, Thermo Scientific, USA) for 5 min to form a pellet, and further 1 ml of 90% 
industrial methanol solution (IMS) was added and left overnight at -80
o
C.   
4.3.2 Raman Spectroscopy 
 
4.3.2.1 Experimental Raman Set Up 
The Raman Microspectroscope used in this chapter was built by Dr. Elisabetta 
Canetta at Cardiff School of Bioscience (Figure 4.3). The microscope of the Raman 
system is an Eclipse Ti-U inverted microscope Nikon equipped with a 20x (NA = 
0.75) dry objective. The laser source is a diode pumped solid-state (DPSS) laser, 
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operating at 532nm and with a maximum power of 50mW (Lasever, Ningbo, China). 
The laser beam passes through a clean-up filter (Semrock-Laser 2000, Ringstead, 
UK) which transmits 90% of the laser beam at 532nm, in order to remove any 
optical noise from non-lasing (i.e. plasma) lines and spontaneous emissions. To fulfil 
the back-aperture (4.37mm) of the 20x (NA 0.75) objective of the microscope, the 
nominal laser beam size 1/e2 of 2mm was expanded 3 times. At this size, a 1:3 beam 
expander composed of two visible achromat lenses of focal lengths f = +75mm 
(Thorlabs, Ely, UK) and f = -25mm (Thorlabs, UK) was used along with a scan lens 
of f = 100mm (Thorlabs, UK), as the tube lens focal length for Nikon microscopes is 
~200mm. The laser beam is reflected from a dichroic beam splitter (Semrock-Laser 
2000, UK) and focused onto the sample by an objective lens.  
 
The Raman scatter from the sample was collected by the same objective lens 
and transmitted through the same dichroic beam splitter. It then passed through a 
Steinheil triplet achromat lens with a magnification of 1:1 and f = 50mm (Edmund 
Optics, York, UK), followed by a confocal slit that can open up to 6mm (Thorlabs, 
UK) and another Steinheil triplet achromat lens 1:1. The confocal slit was kept open 
to its maximum (i.e. 6mm) and confocality achieved using the slit of the 
spectrometer. A bi-convex lens of f = 25mm (Thorlabs, UK) was placed in front of 
the confocal slit in order to image the sample onto the grating of the spectrometer. 
 
Before entering the spectrometer the Raman scatter, passed through a long-
pass filter (Semrock-Laser 2000, UK), in order to reject any Rayleigh scatter 
travelling with the Raman scatter, so that only the latter enters the spectrometer. The 
spectrometer is an iHR550 Jobin Yvon (Horiba, Kyoto, Japan) equipped with a 600 
grooves/mm grating (spectral resolution 4 cm
-1
) and a spectroscopy CCD camera 
(model Newton, Andor, USA). The Raman system is entirely enclosed for safety 
reasons. 
 
4.3.2.2 Raman Sample Preparation 
The sample chamber used in the Raman experiments was made using a 80-μm deep 
vinyl spacer between a quartz slide (1 mm in thickness) and a quartz coverslip (200 
μm in thickness) (UQG, Cambridge, UK). Cell suspensions (20μl) were placed inside 
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the chamber and the cells allowed to sediment onto the inverted quartz coverslip for 
∼30 min, before commencing the Raman experiments. 
 
4.3.2.3 Raman Experiments 
Single cell standard spectra were acquired from 20 fixed cells from each clone and 
measured over a range of 600cm
−1
 to 1800cm
−1
. Ten spectra were measured from the 
central region of the cells (nucleus) and another ten spectra were measured from the 
peripheral region of cells (cytoplasm and membrane), to obtain average spectra 
representing each cell type. The background spectra were also acquired at a 20x 
objective (N.A. =0.7). The laser power on the sample during signal acquisition was 
∼36mW with each spectrum collected in the range from 500 to 2100cm−1 (grating 
150 grooves/mm) with an integration time of 60 s. The laser beam, during 
acquisition, was focused on the cell nucleus. At the beginning of each Raman 
session, the dark current of the Andor camera was measured. 
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Figure 4.3. Raman Microspectroscopy setup used in this study (built by Dr. 
Elisabetta Canetta). 
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4.3.3 Data Analysis 
 
4.3.3.1 Calibration of the Spectrometer Using a Neon Lamp 
To convert the Raman spectra acquired from pixels to wavenumbers, the 
spectrometer needed to be calibrated. For this, a clear neon lamp (RS, Corby, UK) 
was used. The neon lamp was inserted inside the condenser of the Ti-U Nikon 
microscope, in order to achieve a homogenous illumination of the sample area. Neon 
spectra were taken at centre wavelength positions of 600nm (Figure 4.4).  
 The neon spectra in pixels were compared with neon spectra in wavelength 
found in literature. The pixel–wavelength experimental data were fitted with a linear 
fit (Figure 4.5). 
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Figure 4.4. Neon spectrum obtained at a 600nm wavelength position of 
the iHR550 spectrometer, using a 150 grooves/mm grating. 
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Figure 4.5.  Linear fit of the neon spectra pixel data versus wavelength. 
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4.3.3.2 Spectral Analysis 
The Raman spectra were analysed using Origin v. 7 (OriginLab, Northampton, 
USA). The average of the 20 Raman spectra for each individual cell and the dark 
current was subtracted from each average. The same procedure was adopted for the 
background spectra. The average background was then subtracted from the average 
Raman spectrum of the samples for fluorescence suppression. The main peaks of the 
Raman spectra for each clone were assigned by comparing them to the reference 
peaks based on (Notingher, 2007). 
 
4.3.3.3 Multivariate Statistical Analysis 
 To achieve clonal classification, the Raman spectra were investigated using PCA. 
PCA extracts the relevant information from the original data and generates a new set 
of variables, called principal components (PC). This has been  used to build an 
algorithm, based on the PCA scores to relate the Raman spectra findings, where the 
PC are related to the most important variation that occurs in all spectra, in this study 
they were PC3 and PC4. This was achieved by using prcomp function in the R 
package. 
 
4.4 Results 
 
4.4.1 Comparisons between Dental Pulp Progenitor Cell's Clones 
Raman spectroscopy allowed vibrational characterisation of 3 clones; A31 at 18PDs 
and 60PDs, A11 at 8PDs and B11 at 7PDs, without staining. All spectra had been 
normalised to the area of the peak at 1450cm
-1
, to enable the direct comparison of 
data (Chan et al., 2009). Figure 4.6 shows the Raman spectra of these clones in the 
spectral range 600 to 1800cm
-1
. The spectra contains the typical Raman peaks 
assigned to DNA nucleic acids at 729, 789, 834, 858, 1092, 1167cm
-1
, those assigned 
to proteins at 1245 and 1680cm
-1
; and CH deformation at 1450cm
-1
. Differences 
were found at 1056cm
-1
 assigned to RNA ribose C–O vibration, which was only 
visible with the clone A31 at 18PDs; and 958cm
-1
 assigned to phenylalanine. 
Comparing the different Raman spectra showed that the spectral intensity of A31 at 
18PDs was much higher than A31 at 60PDs and the other clones (Figure 4.6). Table 
4.2 shows in detail the bands present in each clone and Table 4.3 shows the 
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percentage of intensity of each band of A31 at 60PDs, A11 at 8PDs and B11 at 
7PDs, compared with A31 at 18PDs. Taking selected band which are responsible for 
cell growth (Figure 4.7), it is clear that clone A31 at 18PDs has higher intensity 
peaks compared with the other clones.  
 
PCA discriminated Raman spectra of DPPCs clones. In particular, PC3 and 
PC4 were used because they captured the most significant variance among the clones 
(Figure 4.8). The scatter plot using scores of PC3 and PC4 of the Raman spectra of 
the 3 DPPCs clones (A31 18PDs, A11 8PDs, B11 7PDs), in addition to A31 at 
60PDs (Figure 4.9), demonstrates that A11 and B11 overlap almost exactly 
indicating that their Raman fingerprints are similar. A31 at 18PDs and A31 at 60PDs 
did not overlap at all, indicating a large difference in their fingerprints. Furthermore, 
both A31 populations are widely spread and do not overlap with A11 and B11, 
further confirming difference in their signatures. 
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Figure 4.6. Mean Raman spectra obtained from three clones (A31 at 18PDs, A11 
at 8PDs and B11 at 7PDs) in addition to Raman spectra obtained for A31 at 
60PDs. These spectra are displayed in the fingerprint range from 600 to 
1800cm
−1
. All data was detected as relative intensities in arbitrary units (a.u.). 
The strongly dominated bands have been highlighted and the corresponding 
wavenumbers given. The regions 1-5 are the main regions where the main 
differences  between the clones were observed. All spectra have been 
normalised to the area of peak (1450cm
-1)
 to enable fairer, robust- comparisons 
of data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
60P
Ds 
18P
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8PD
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7PD
s 
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Table 4.2. Highlights of the dominating peaks with their assignments from 
Figure 4.6. The major differences with the high proliferating A31 clone at 
18PDs were the presence of phenylalanine (958cm
-1
) and RNA (1054cm
-1
) which 
were not visible in A31 at 60PDs; or clones A11, and B11. 
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Table 4.3. The percentage of intensity of major bands of A31 at 60PDs, A11 at 
8PDs and B11 at 7PDs, compared with A31 at 18PDs, with their assignments. 
1054 and 958cm
-1
 bands were only detected in A31 at 18PDs. 
 
 
Wavenumbers 
(cm
-1
) 
Assignment Difference percentage compared 
to A31 at 18PDs 
 
729 
Adenine 
(DNA) 
A31 at 60PDs ~ 6% lower 
A11 at 8PDs ~ 40.3% lower  
B11 at 7PDs ~ 39.9% lower  
 
789 
 
DNA 
A31 at 60PDs ~ 10.2% lower 
A11 at 8PDs ~ 46.4% lower  
B11 at 7PDs ~ 31.3% lower 
 
1092 
 
DNA 
A31 at 60PDs ~ 4.8% lower 
A11 at 8PDs ~ 30.2% lower  
B11 at 7PDs ~ 21.4% lower 
 
1167 
 
Isoleucine 
A31 at 60PDs ~ 23.6% lower 
A11 at 8PDs ~ 25.7% lower  
B11 at 7PDs ~ 39.2% lower 
 
1245 
 
Amide III 
(-sheet) 
A31 at 60PDs ~ 23.8% lower 
A11 at 8PDs ~ 44.2% lower  
B11 at 7PDs ~ 45.4% lower 
 
1402 
 
Thymine 
A31 at 60PDs ~ 48.3% lower 
A11 at 8PDs ~ 41.5% lower  
B11 at 7PDs ~ 35.8% lower 
 
1450 
 
Proteins and 
Lipids 
A31 at 60PDs ~ 5.6% lower 
A11 at 8PDs ~ 31% lower  
B11 at 7PDs ~ 32.2% lower 
 
1629 
 
Serine 
A31 at 60PDs ~ 40.2% lower 
A11 at 8PDs ~ 41.1% lower  
B11 at 7PDs ~ 51% lower 
 
1680 
 
Amide III 
A31 at 60PDs ~ 15.2% lower 
A11 at 8PDs ~ 40.7% lower  
B11 at 7PDs ~ 39.3% lower 
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Figure 4.7. Highlights of the intensity of peaks responsible for cell growth, 
derived from Figure 4.6. Clone A31 had higher intensities for all of these peaks, 
compared to A11 and B11 clones. 
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Figure 4.8. (A) PC3 and (B) PC4 of the Raman spectra showed the Raman 
contribution inter-sample variation, attributed to the cellular changes that 
distinguish the samples. 
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Figure 4.9. PCA dot plots were widely spread and showed three clearly 
distinguishable areas depicted as red and green (B11 and A11), blue (A31 at 
18PDs) and orange (A31 at 60PDs). 
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4.4.2 Comparisons between A31 Clone and Its Derivatives (Chondrocytes) 
Raman spectroscopy also allowed the vibrational characterisation of clone A31 at 
18PDs, before and after differentiation into chondrocytes. All spectra were 
normalised to the area of the peak at 1450cm
-1
, to enable a fairer comparison of the 
data (Chan et al., 2009). Figure 4.10 shows Raman spectra of A31 and its derivative 
in the spectral region 600 - 1800cm
-1
. The spectra show differences, where some 
peaks are present only in the progenitor (788cm
-1
 and 1095cm
-1
), while other peaks 
were only observed in differentiated cells (chondrocytes). These included 945,1466, 
1560, 1616 and 1730cm
-1
. Table 4.4 shows in detail the presence of each band in 
each clone and to which biochemical compounds it refers.  
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Figure 4.10. Mean Raman spectra obtained for clone A31 at 18PDs and after 
chondrogenic differentiation. These spectra are displayed in the fingerprint 
range from 600cm
−1
 to 1800cm
−1
. All data were detected as relative intensities in 
arbitrary units (a.u.). The strongly dominated bands have been highlighted with 
their numbers. All spectra were normalised to intensity of peak 1450cm
-1
 to 
enable direct comparison of data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
168 
 
Table 4.4. Dominating peaks with their assignments from Figure 4.10. The 
major differences with undifferentiated clone A31 at 18PDs were the presence 
of DNA bands at 788 and 1094cm-
1
, while chondrogenic differentiation showed 
the presence of protein bands at 945, 1466, 1560, 1616 and 1730cm
-1
. 
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4.5 Discussion 
For the first time, the differences between the DPPCs clones isolated from the same 
tissue is confirmed in term of intensity of peaks at specific waves number by Raman 
spectroscopy. These wavenumbers were based on DPPCs biochemical features 
which will help to discriminate between MSCs clones to identify best clones to use 
in tissue engineering.  
 
 The clinical use of stem cells in tissue engineering needs to develop criteria 
for distinguishing the best MSCs from other cells to be used for stem cell therapy. 
Currently, identification of MSCs needs an extensive in vitro expansion that may 
affect the behaviour of these cells (Harkness et al., 2012). Raman spectroscopy is a 
non-invasive, rapid and sensitive technique that has been used to investigate stem 
cell characteristics (Chan and Lieu, 2009; Downes et al., 2010). In this study, the 
possibility of using Raman spectroscopy as a sensitive method for quick 
identification of different clonal DPPCs has been investigated. Differences in 
spectral peak intensities were been observed between the clones. 
 
Cell components consist mainly of water, proteins, nucleic acids, lipids and 
carbohydrates (Cooper, 2000). Differences in one or all of these components between 
cells may provide further evidence of their behaviour and ability to proliferate and 
differentiate. Cells can contain more than 1000 various molecules. These molecules 
include different sugars, amino acids, fatty acids, proteins and nucleic acids, where 
each one will have a specific fingerprint spectrum in the wavenumber range 400-
1800cm
−1
. This range contains virtually all of the basic vibrational information on a 
protein or nucleic acid molecule, which gives a promising potential to detect the 
different between clones in the shortest, non-invasive way possible (Thomas, 1999; 
Dukor, 2002; Swain and Stevens, 2007). These fingerprints may also probe chemical 
compositions and structural changes in tissues and cells in real-time. This could also 
help to discriminate ageing cells and dead cells (Chan et al., 2008). 
 
In general, the results (Figure 4.6) showed that the Raman spectrum of each 
clone contains many bands, where each band represents a distinct molecular 
vibration. Over the range of Raman shifts shown, characteristic peaks  include those 
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representing essential amino acids, such as adenine group vibrations around 729cm-1 
,tryptophan around 765cm
-1
, tyrosine at 843cm
-1
, isoleucine at 1167cm
-1
 , arginine at 
1402cm
-1
 and serine at 1629cm
-1
; which  have all been found in the clones, including 
the later PD for clone A31. The existence of all these amino acids in each clones 
confirms that they are fundamental factors in building the cell components, such as 
DNA, RNA and proteins (Alberts et al., 2008). Little is known about the precise 
function of these amino acids on MSCs behaviour, such as proliferation and 
differentiation, but it appears that all the mentioned amino acids have a function on 
stem cell proliferation (Higuera et al., 2012). However, the intensity of these peaks 
was different between the clones (Table 4.3), which indicates different 
concentrations of these amino acids. These differences would appear to reflect 
differences in their proliferation. For example, serine was almost double in clone 
A31 at 18PDs compared to the other clones or the same clone at later PD. It has been 
found, that cells with higher serine content are also more active, as serine regulates 
cell proliferation in progenitor cells (Saito et al., 2012). Changes in the Raman 
spectra that can be accredited to differences in the proliferative status of the cells are 
clearly evident in Figure 4.6. These conclusions are supported by the results in Table 
4.3, which demonstrated that for clone A31, the highly proliferative clone, a higher 
DNA content was observed, compared with the low proliferative clones, A11 and 
B11. Furthermore, Figure 4.7 highlighted the bands that may be involved in cell 
growth. It was clear that clone A31 has higher peaks than the other clones. It has 
been observed in rat liver cells that increasing DNA synthesis will stimulate cell 
proliferation (Abanobi et al., 1982). Furthermore, cells at later PD showed less DNA 
content than earlier PD for clone A31, to confirm DNA damage or loss in cells with 
ageing (Beckman and Ames, 1998).   
 
Only the high proliferating clone A31 at early PD showed the presence of 
tyrosine at 1111cm
-1
. Tyrosine was found in different wavenumbers as it exists in 
different isoforms. This finding was interesting as the role of tyrosine in stem cells 
has been suggested to maintain the undifferentiated state and the proliferation of 
progenitor cells (Anneren, 2008). As such, tyrosine could possibly be used as a 
marker for highly proliferative clones. In addition, phenylalanine was only found in 
the highly proliferative clone in both early and late PDs. Although the role of 
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phenylalanine has been described as inhibiting cell proliferation (Oberdoerster et al., 
2000), phenylalanine is a precursor for tyrosine. This may indicate that phenylalanine 
is only converted to tyrosine in early DPPCs by phenylalanine hydroxylase, but not 
in later DPPCs. (Hernández et al., 2010; Müller et al., 2012). These findings could be 
linked to the decreased proliferation of late PD of clone A31, as oxidative stress 
increases with age and leads to defects in phenylalanine hydroxylase (Brouilette et 
al., 2003). For example, the disease called phenylketonuria, results from an increase 
of phenylalanine in the blood due to a defect in phenylalanine hydroxylase, which is 
accompanied with a increase in oxidative stress, and reduction in antioxidant defence 
(Vargas et al., 2011). Another notable difference was the representative Raman 
markers for RNA (1054cm
-1
), which was only visible in A31 at early PD but not at 
later PD, and not shown at all in clones A11 and B11. This Raman marker may 
indicate the ability of a cells differentiation capacity, as only clone A31 at early PD 
underwent differentiation into 3 different lineages. As such, RNA delivers amino 
acids and is shown to have an influence in inducing differentiation of stem cells (Tan 
et al., 2011). 
 
PCA was used to compare spectral features of the clones. It showed a 
separation between the highly proliferative clone (A31) and low proliferative clones 
(A11 and B11). PCA also demonstrated a separation between clone A31 at early PD 
and later in higher order PCAs (PCA3 and PCA4). This was apparent in (Figure 4.9), 
where clones A11 and B11 overlapped almost exactly suggesting that their Raman 
fingerprints are similar, even if they were isolated from 2 different patients.  In 
contrast, clone A31 at early PD and late PD did not overlap at all, suggesting large 
differences in their fingerprints. Moreover, A31 at early late PD did not overlap with 
A11 and B11 clones, further confirming differences in their signatures. It is 
noteworthy that all clusters are reasonably compact, indicating good level of 
homogeneity in the data sets (i.e. Raman spectra of each data set are quite similar to 
each other). This method of characterization was compared with the population 
doublings and differentiation data from previous chapters to confirm that PCA can be 
effectively used as a quick, non-invasive method to discriminate between DPPCs and 
possibly other MSC sources.   
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Raman spectroscopy was also used to study the signature differences between 
the progenitor cells and their derivatives. In this case, chondrocytes were compared 
to their undifferentiated form for clone A31. Changes in the Raman spectra were 
observed. Results demonstrated that the protein level was higher and DNA level was 
lower in chondrocytes, compared to the undifferentiated progenitor cells. This was 
observed in the Raman spectra (Figure 4.10) by the presence of prominent protein 
bands in the chondrocytes including amide I (around 1660cm-
1
), CH2 (around 
1466cm-
1
) and a-helix (935cm
-1
) (de Mul et al., 1984; McManus et al., 2011), in 
addition to presence  of prominent DNA bands in progenitor cells at 788cm
-1
 and 
1095cm
-1
 peaks (de Mul et al., 1984). These results confirm that the relative amount 
of protein is higher following chondrogenic differentiation (McManus et al., 2011). 
This means that this technique can be used to confirm DPPCs differentiation. 
 
This study showed that Raman spectroscopy is a quick method which can 
discriminate between clones, based on their biochemical features to select of the 
ideal clone for tissue engineering as several recent studies have demonstrated that 
Raman activated cell sorting is achievable (Chan et al.,2009). The PCA technique 
was also successful in achieving clonal classification, which matches with the results 
of other methods in the previous chapters. In addition, the results presented here 
show that Raman spectroscopy can be used to detect biochemical changes that occur 
as a result of changes in differentiation, which make it easier to distinguish between 
MSCs and their derivatives, especially that there are no specific markers to sort these 
cells out from their neighbours.  
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Chapter 5: 
Type I Collagen Gel Interaction with DPPCs 
 
 
5.1 Introduction 
The extracellular matrix (ECM) plays a critical role in regulating stem cell functions 
that includes proliferation, migration, and differentiation into different lineages 
(Campbell et al., 1985; Flaim et al., 2005; Kihara et al., 2006). ECM remodelling is 
regulated through synthesis and degradation. ECM components play an important 
role in regulating mechanical properties of the ECM, and consists of intrinsic matrix 
proteins such as collagen (e.g. types I, II, III and IV), glycoproteins (fibronectin and 
laminin), proteoglycans (aggrecan, decorin, and biglycan), and elastin (Jean et al., 
2011). Collagen type IV is essential for basement membrane stability (Pöschl et al., 
2004). The dental pulp contains a progenitor stem cell population that is vital for the 
repair of the tissue. Dental pulp progenitor cells (DPPCs) exist within and interacts 
with the ECM. Many studies however, investigate the potential of cultured 
progenitor cells in vitro without considering the ECM role during 
expansion. Collagen gel could provide a unique way to study the interaction of 
DPPCs with the ECM such as the effect of collagen contraction and its influence on 
cell proliferation and morphology, which is not possible in routine cell culture 
surfaces. The collagen status (attached and detached) is found to have important roles 
in fibroblast proliferation (Butt et al., 1995; Riddle et al., 2005; Yamamoto et al., 
2005; Stops et al., 2010), chondrogenic differentiation (Steward et al., 2013), and 
controlling fibroblast shape and alignment (Eastwood et al., 1998). The ECM 
interacts with cells physically and functionally via cell surface receptors such as 
integrins, which provide the ECM-cell link (Desgrosellier and Cheresh, 2010). These 
integrins can also activate matrix metalloproteinases (MMPs) that have major roles 
in ECM remodelling (Deryugina et al., 2001). Such ECM remodelling plays an 
important role in disease progression (Messent et al., 1998). Seeding DPPCs in 
collagen gels will hopefully contribute towards a better understanding of the 
behaviour of DPPCs during different environmental conditions, such as quiescent 
conditions within the niche, or pulpal inflammation. 
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5.1.1 Collagen 
Collagens are the most abundant family of proteins in the human body and the major 
structural element in connective tissues. They provide strength and structural 
integrity for tissues. Collagen is composed of a triple helix of three polypeptide 
chains. Each of the 3  chains forms an extended left handed helix, supercoiled 
around a central axis in a right handed manner and stabilised by interchain hydrogen 
bond. The amino acid composition of the three  chains is either identical or 
different, depending on collagen type. Each  chain is 300nm in length and contains 
approximately 1000 amino acids, which is characterised by repetitious polypeptide 
chains, glycine-X-Y, where X and Y position is often occupied by proline and 
hydroxyproline (Gelse et al., 2003).   
 
There are 28 types of collagens which have been identified in the human body so far. 
Types I, II, III and V collagen are the main types that compine the essential collagen 
components in bone, cartilage, tendon, skin and muscle (Smith and Rennie, 2007). 
Collagen type I is the most well-known type of collagen. It is the major form of 
organic mass in bone and the main types of collagen in tendon, skins, ligaments, 
cornea and other tissues. In bone, it provides load bearing, tensile strength and 
stiffness (Gelse et al., 2003). Collagen type I is the major fibrous component in the 
dental pulp with addition to collagen type III (Linde, 1985). Furthermore, collagen 
type I regulates dental pulp cells gene expressions. e.g. it down-regulate dentin 
matrix protein-1 (Dmp-1) and up-regulates osteocalcin mRNA levels ( Mizuno et al., 
2003). 
 
 Culturing cells in collagen gel is not a novel idea. In 1972, Elsdale and Bard 
cultured fibroblast cells in a model of collagen matrices (Elsdale and Brad, 1972). 
These 3D collagen gels induced morphological changes in the fibroblasts that 
mimicked cell morphology in vivo. Since then, collagen gels became the favourite 
choice to provide possibly the most physiological and biomimetic environment in 
which stromal cellular function can be studied (Lee et al., 2011). Other advantages of  
collagen gel: biocompatibility, adhesion, suturable, highly porous, combination with 
other material such as demineralised bone powder, transuded by fluid pressure,  
(Glowacki J, Mizuno, 2008) and collagen fibrous network, allows researchers 
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excessive use in tissue engineering. In addition, with the surrounding medium fluid, 
cells are permitted to migrate and interact with each other naturally as they would 
within the ECM (Lee et al., 2011). Collagen gels have already been approved for use 
as tissue engineered skin in clinics (Trent and Kirsner, 1998). Additionally, cultured 
MSC's collagen gels enhanced osteogenic differentiation, showing better result than 
fibrin glue and alginate as substrate (Oh et al., 2012). In this chapter, collagen type I 
gel will be utilised for the culture and assessment of DPPCs in term of cell 
morphology and matrix metalloproteinases (MMPs) production.   
 
 Cell characteristics such as morphology, signalling and proliferation, within 
collagen matrices, vary depending on the physical state of collagen such as 
mechanical stress. Fibroblasts within stressed collagen develop isometric tension and 
contract once the gels are detached, which provides a similar model to wound 
contraction. In contrast, fibroblasts in attached, stressed gels tend to proliferate, 
whereas cells in relaxed gel became quiescent which may be explained by reducing 
signalling through  extracellular-signal-regulated kinase (ERK) (Cukierman et al., 
2002). 
 
5.1.2 Matrix Metalloproteinases (MMPs) 
ECM remodelling plays a vital role in many cellular events, such as cell migration, 
proliferation and development. It also plays a role in the pathological events, such as 
inflammation and wound healing (Vargova et al., 2012). ECM degradation occurs 
through the actions of different groups of proteolytic enzymes, classified based on 
their structure and catalytic mechanism. These enzymes are MMPs, serine 
proteinases, cysteine proteinases and aspartic proteinases, which are produced by 
many types of cells (Barrett et al., 1998).  Although collagen is resistant to most 
proteolytic enzymes and has a long half-life in vivo, MMPs produced by many cells 
such as fibroblasts and odontoblasts in many events such as participate in dentin 
matrix organisation or even dental caries that leads of degrading collagen type I 
(Hannas et al., 2007; Sabeh et al., 2009). MMPs are a family of zinc-dependent 
enzymes which collectively can degrade almost all major ECM components (Kähäri 
and Saarialho-Kere, 1997) . There are over 24 members of the MMP family 
recognised in humans (Lee and Murphy, 2004). All MMPs members have a pro-
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domain and a catalytic domain. MMPs are generally secreted as inactive enzymes 
until the propeptide has been removed by proteolysis. During proteolytic activation, 
the pro-domain is first cleaved generating an MMP intermediate, which is followed 
by cleavage of the remnants of the prodomain by the MMP intermediate itself, or by 
other active proteinases, generating the fully active MMP (Lee and Murphy, 2004). 
 
 MMP activation and inactivation is regulated by a number of factors, such as 
the expression of inflammatory cytokines, growth factors and tissue inhibitors of 
MMPs (TIMPs) (Dasu et al., 2003). Mechanical force also plays a role in the 
regulation of MMP expression, where a relationship between actin cytoskeletal 
organisation and MMP-2 activation has been found through the regulation of the 
membrane-tethered metalloenzyme (MT1-MMP) (Sanka et al., 2007). Collagenases 
(MMP-1, MMP-8 and MMP-13) together with gelatinases (MMP-2 and MMP-9) can 
degrade collagen, in addition to being able to activate growth factors and other MMP 
zymogens (Shiomi et al., 2010). Like all MMPs, gelatinases need to be activated by 
proteolytic removal of the N-terminal proenzyme domain. For pro-MMP-9, 
activation occurs by cleavage through soluble proteinases, such as MMP-3 and 
plasmin, while pro MMP-2 is converted to its active form by a mechanism mediated 
by TIMP-2 and MT1-MMP (Ries et al., 2007). Human MSCs travel from their niche 
in response to different stimuli, such as injury, via type I collagen. Invasion of 
collagen is performed by secreting MMP-2 that is activated by MT1-MMP (Lu et al., 
2010). 
 
5.2 Aims  
The objective of this chapter was to determine whether collagen matrices will act as 
a native ECM environment for DPPCs by assessing proliferation, morphology and 
MMPs production by seeded high and low proliferative DPPCs. 
 
5.3 Materials and Methods 
 
5.3.1 Preparation of Gelatinase-Free, Foetal Calf Serum 
Gelatinases, MMP-2 and MMP-9, were removed from foetal calf serum. Briefly, 
gelatin Sepharose 4B (GE Healthcare, Amersham, UK), was added to foetal calf 
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serum at a ratio of 1:5; and mixed for 18 h at 4
o
C. Following centrifugation at 
(1000g/5 min), supernatants were removed from the gelatin Sepharose pellet and 
sterilised through 0.22m membrane filter (Elkay, Basingstoke, UK) (Azzam and 
Thompson, 1992). 
 
5.3.2 Preparation of 3D Collagen Matrices and Culture 
 Equal volumes of αMEM (Invitrogen, Paisley, UK) were added to the same amount 
of type I rat tail collagen (First Link, Wolverhampton, UK) to make up 1mg/ml 
concentration of collagen. This solution was neutralised by the drop wise addition of 
5M sodium hydroxide until a change of colour (yellow to pink). Subsequently, 1ml 
of the collagen mixture was poured into each well of 12-well plate and left at 37
o
C, 5% 
CO2 for 45 min for the collagen matrices to solidify. After detachment, DPPCs 
clones (A31, A11) at different population doubling levels (PDs) were suspended in 
αMEM, containing 20% gelatinase-free, foetal calf serum. Cells at 5x104/ml 
gelatinase-free, αMEM were added to the collagen matrices that already were made 
in the 12-well plates. For detached collagen gels, collagen was detached using a filter 
tip. 
 
 The degree of lattice contraction was quantified from 3 separate lattice 
diameter measurements performed on each of the 3 replicate samples, at days 1, 2, 4, 
6, and 12.  The average collagen contraction values obtained were expressed as % 
reduction in matrices diameter, compared to the matrices diameters, at 0h.  
Conditioned medium surrounding the matrices was also collected from each 
individual well for the analysis of gelatinase production and activity at the same 
time-points as the matrices measurements. 
 
5.3.3 Cell Morphology Using Light and Fluorescence Microscope 
Cellular morphology was compared in different types of culture conditions (plastic 
surface attached collagen and detached collagen) by light microscopy with serial 
images captured using a digital camera (Canon PC1234, Japan). The actin 
cytoskeleton of cells was stained with phalloidin-FITC (Sigma-Aldrich, Poole, UK) 
to determine cellular morphology. The cells were washed with phosphate buffered 
saline (PBS) and fixed with 1ml/well 4% paraformaldyhyde (PFA, Santa Cruz, 
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Dallas, USA) and incubated for 10 min at room temperature. The PFA was aspirated 
and washed twice with 1ml/well PBS at 5 min interval. The PBS was aspirated 
before the cells were treated with 1ml/well 0.3% Triton-X100 (Sigma-Aldrich) for 
30min, with gentle shaking at room temperature. The Triton-X100 was aspirated and 
the cells washed twice with Tris-buffered saline (TBS, pH7.5). The cells were 
blocked with 1ml/well of 1% fraction V bovine serum albumin (BSA, Fisher 
Scientific, Loughborough, UK) in TBS (1% BSA-TBS) for 1 h at room temperature 
with gentle shaking. The blocking buffer was removed before the addition of 
1ml/well Phalloidin-FITC (20g/mL, Sigma-Aldrich) in 1% BSA-TBS; and 
incubated for 1 h at 4°C with gentle shaking and under darkness. The stain was 
aspirated and cells washed twice with 1ml/well TBS at 5 min interval. Images were 
captured using an ultra violet (UV) microscope (Olympus AX70 with a Digital 
Eclipse DXM1200 digital camera attachment, Tokyo, Japan). The images were 
captured using the Automatic Camera Tamer (ACT-1) control software (Nikon 
Digital, Tokyo, Japan) at 373nm/456nm (FITC). 
 
5.3.4 Scanning Electron Microscopy (SEM) 
The morphology of the collagen scaffolds was captured in collaboration with Nafiseh 
Badiei (Swansea University) using a Hitachi S4800 Scanning Electron Microscope 
(Hitachi, Japan) operated at 10kV. To prepare the sample for SEM, collagen gels 
were fixed with 2.5% glutaraldehyde (Agar Scientific, Stansted, UK) in 0.1M 
Cacodylate buffer for 2 h at room temperature and then washed 3 times with 0.1M 
Cacodylate buffer. The fixed samples were dehydrated in a graded ethanol series: 
30%, 50%, 70%, and 100% for 15 min each and finally allowed to dry overnight. 
The dried hydrogels were sputter-coated and SEM images were taken at multiple 
locations across the sample. 
 
5.3.5 Determination of Cell Numbers Within Collagen Lattices 
DPPCs were recovered at days 1, 2, 4, 6 and 12 from 4 collagen matrices by 
enzymatic degradation as previously described by Stephens et al. (1996). Lattices 
were solubilised by incubation for 120 min at 37ºC with 400 L of PBS containing 2 
mg/mL Collagenase A.   This was followed by incubation with 100 L of 0.05% 
(w/v) Trypsin/0.53mM EDTA for 20 min at 37ºC.  The cells were recovered by 
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centrifugation and viable cell numbers determined using a 0.02% (w/v) Trypan Blue 
solution, and a direct counting was undertaken in a Neubauer haemocytometer. 
5.3.6 Assessment of Matrix Metalloproteinase Activity 
To measure the relative amount of pro- and active- MMP-2 and -9 produced by 2 
different DPPCs clones at early and late PDs, gelatin zymography was performed 
(Stephens et al., 2004). Equal volumes (25l) of conditioned medium mixed with 
same volume of loading buffer (Table 5.1) were separated by SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE) on pre-cast 10% gelatin zymography gels (Ready 
Gel 10% Gelatin Zymogram Gels, Bio-Rad Laboratories Ltd, Hemel Hempstead, 
UK). The gel was run at 20mA (Bio-Rad Mini-Protean 3 Electrophoresis Cell). SDS 
was removed from gels by washing in 2.5% Triton X-100 solution (Sigma), at room 
temperature, for 1h. MMPs were activated by incubation in Activation buffer (Table 
5.1), at 37
o
C overnight. Gels were stained with 0.05% Coomassie Blue (Table 5.1), 
destained in Destaining solution (Table 5.1) and gel images captured by using a 
Scanjet 3300c (Hewlett-Packard, USA). The relative amounts of pro- and active-
MMP-2 and MMP-9 was confirmed by the appearance of clear bands at comparable 
molecular weights to MMP-2 and MMP-9 standards. 
 
5.3.7 MMPs Data Analysis 
To convert the intensity of each band of MMPs into quantitative data (numbers), the 
gel zymography images were opened using image J software. Each band was 
selected and then density of the band was calculated. Each process was performed on 
3 separate occasions. The average values and standard error of mean (SE represented 
as ±) were determined using Microsoft Excel. Samples were compared using analysis 
of variance (ANOVA). p-values below 0.05 were considered statistically significant 
at a 95% confidence interval by using GraphPad InStat3 software. 
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Table 5.1. Gelatin Zymography Solutions 
 
 
 
Running Buffer (x5, stock 
solution; 2000mL) 
Adjust pH to 8.3 with HCl.  When 
required, stock solution was diluted 1:5 
with ddH2O. 
Reagent    Amount 
Tris (Sigma)   30.2g 
Glycine (Sigma)   188g 
SDS (Sigma)   10g 
ddH2O    2000mL 
Loading Buffer (200mL) 
Adjust to pH 6.75 with HCl.  Dilute to 
200mL with ddH2O. 
Reagent    Amount 
Tris (Sigma)   1.15g 
Glycerol (Sigma)   20mL 
ddH2O    35mL 
SDS    4g 
Bromophenol Blue (Sigma) 0.002g 
Activation Buffer (1000mL) 
Adjust pH to 7.8 with HCl. 
Reagent    Amount 
Tris (Sigma)    6.06g 
Calcium Chloride (Sigma)   0.74g 
Sodium Chloride (Sigma)   8.8g 
ddH2O     1000mL 
Coomassie Blue (stock solution; 
500mL) 
Reagent    Amount 
Methanol (Fisher Scientific) 250mL 
ddH2O    250mL 
Coomassie Blue (Sigma)  1.25g 
Coomassie Blue (working 
solution; 250mL) 
 
Reagent                                         Volume (mL) 
Coomassie Blue stock solution           50 
Methanol (Fisher Scientific)               88 
Glacial acetic acid (Fisher Scientific) 24 
ddH2O                                                 88 
Destain solution (1000mL) 
 
Reagent               Volume (mL) 
Methanol (Fisher Scientific)               50 
Glacial acetic acid (Fisher Scientific) 75 
ddH2O                                                 875 
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5.4 Results 
 
5.4.1 Cellular Proliferation  
The average values gained for DPPCs clonal (A11 at 17PDs and A31 at 30PDs and 
80PDs) proliferation upon culture over 12 days for cells cultured in attached collagen 
(Attached), detached collagen (Detached) and on the surface of 12-well plates 
(Monolayer), are shown in Figure 5.1. For attached collagen, all the DPPC’s clones 
had similar numbers of cells for the first 4 days, approximately 7x10
4
 cells/well. 
After 4 days, A31 cells at 30PDs and A11 at 17PDs began to proliferate until they 
reached approximately 20 x10
4
 by day 6. At day 12, both A31 (30PDs) and A11 
(17PDs) cells decreased in number, with A11 showing a greater tendency to decrease 
than A31 (30PDs). A31 (80PDs) did not show proliferation during the 12 day culture 
period.  On detached collagen gel, A11 and A31, both at early and late PDs, did not 
show a significant increase in cell number during the 12 day period. In monolayer 
culture, the three progenitor clones showed similar trends of cell number as with the 
attached collagen, with the exception that A31 (30PDs) at day 12 remained nearly 
the same as the cell number at day 6. Further investigation using ANOVA (Table 
5.2) showed that a significant differences on cell numbers of clone A31 early PD 
(30PDs) and late PD (80PDs) when cells cultured on monolayer and or on attached 
collagen with p value <0.05 after 6 days of culture while there were no significant 
differences between the different clone (A11 and A31), (p value > 0.05).  
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Figure 5.1.  Number of clonal cells (A11 at 17PDs, and A31 at 30PDs and 
80PDs) on A) attached collagen, B) detached collagen, and C) monolayer, over 
12 days in culture (N=3, average  SE). After 4 days, cell numbers on A and C 
started to increase while B demonstrated no change in cell number over 12 days 
in culture. 
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Table 5.2. Sums of significant p values for cell numbers from Figure 5.1. 
comparing clone A31 at 30PDs in 3 different culture (monolayer, attached and 
detached collagen gel) with clone A31 at 80PDs and clone A11 at 17PDs in the 
same culture condition over 12 days. * = p<0.05, non-significant (ns) = p>0.05. 
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5.4.2 Cellular Morphology 
For cell morphology, A31 (30PDs) and A11 (17PDs) cells in attached and detached 
collagen did not exhibit any morphological differences, compared to cells in 
monolayer (Figure 5.2). There were also no morphological differences between cells 
cultured in monolayer surface and the attached collagen, following staining with 
phalloidin-FITC (Figure 5.2A and B, respectively). Cells under both conditions 
exhibited very clear actin filaments with fibroblastic appearance, while cells cultured 
on detached collagen appeared to lose the fibroblast appearance with less prominent 
actin filaments (Figure 5.2C). 
 
 The microscopic structure of acellular collagen gels obtained by SEM 
showed a fibrillar network consisting of cross-linked fibers (Figure 5.3). The SEM 
analysis of A31 (30PDs) cells on collagen gels obtained showed that these cells 
attached to the collagen fibre at day one (Figure 5.4A) and showed better 
representative example of cells interacting with collagen matrices after 12 days, by 
demonstrating entanglement of matrix fibrils with cell extensions and putting out 
pseudopodia-like outgrowths (arrowed)  (Figure 5.4B). 
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Figure 5.2. Phalloidin-FITC actin cytoskeletal staining for clone A31 at 30PDs 
in monolayer culture (A), attached collagen (B), and detached collagen (C). ×10 
Magnification. Scale bar 500μm. 
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Figure 5.3.  SEM images of control acellular collagen gels. The collagen fibrillar 
meshwork is clearly visible. Images are shown in different magnifications (A) 
x1100, (B) x4000, (C) x10,000 and x (D) 15,000). 
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Figure 5.4. SEM images of clone A31 30PDs seeded in collagen gel after 1 day 
(A) and 12 days (B). pseudopodia-like outgrowths arrowed. Images are shown 
in different magnifications. 
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5.4.3 Collagen Gel Contraction  
Collagen gel contraction images for clone A31 (30PDs) over 12 days in culture are 
shown in Figure 5.5.  Average collagen gel contraction values, expressed as % 
reduction in gel diameter, for DPPCs clones for 12 days period are shown in Figure 
5.7. As expected, cells from all clones in attached collagen did not show any 
contraction (data not shown), as the collagen remain attached to the well during the 
12 day period. Cells in detached collagen showed variable contraction rates, which 
increased over time. For both clones A11 (17PDs) and A31 at early PD (30PDs), 
cells displayed gradual contraction from day 1 to day 4, where clone A31 (30PDs) 
displayed more contraction (54% left of its original size) than A11 (65% left of its 
original size). At day 6, when cell numbers increased, collagen continued to shrink 
with A11 showing more contraction at this point than A31 (30PDs). By day 12, 
collagen reduced in size to 29% and 34% from their original size at day 0 for clone 
A11 and A31 (30PDs), respectively. In contrast, clone A31 at late PD (80PDs) 
displayed almost no shrinkage over the first 6 days and the collagen size reduced to 
only 74% from its original size by day 12 (Figure 5.6). Further investigation using 
ANOVA (Table 5.3) showed a significant difference in collagen contraction between 
early PD and late PDs of clone A31 with p value < 0.001 while no significant 
difference observed between the different clones (A31 and A11), with p value > 
0.05. 
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Figure 5.5.  Example of detached collagen contraction of clone A31 at 30PDs 
that can be easily visualised over 12 days in culture. 
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Figure 5.6.  Average type I collagen lattice contraction (N=3, average  SE), 
expressed as % reduction in lattice diameter, upon culture in detached collagen 
for clones A11 (17PDs) and A31 (30PDs and 80PDs). 
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Table 5.3. Sums of significant p values for collagen lattice contraction from 
Figure 5.6. comparing the contraction of collagen of clone A31 at 30PDs with 
clone A31 at 80PDs and clone A11 at 17PDs over 12 days in culture. ** = 
p<0.01, *** = p<0.001, non-significant (ns) = p>0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  A11 17PDs A31 80PDs 
Day1 A31 30PDs ns *** 
Day2 A31 30PDs ns *** 
Day4 A31 30PDs ns *** 
Day6 A31 30PDs ns *** 
Day12 A31 30PDs ns ** 
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5.4.4 Dental Pulp Progenitor Cells and Matrix Metalloproteinase Synthesis 
 MMP gelatin zymography analyse of conditioned media collected from clones A11 
(17PDs), A31 (30PDs) and A31 (80PDs) in detached collagen and monolayer culture 
over a 12 days period, are shown in Figure 5.7. MMP zymography analysis from the 
band intensity demonstrated that pro-MMP-2 was detectable in all clones under all 
conditions. It also demonstrated that active-MMP-2 was only detectable in detached 
collagen after day 4. Clone A31 at 80PDs showed less MMP activity, compared with 
other clones. MMP-2 expression for all the clones in different environments 
increased gradually over time (Figure 5.8 A,B and C). MMP-9 was detected only in 
clone A31 at later PD (80PDs), with more MMP-9 activity at later PD than earlier 
PD (30PDs) in monolayer culture. Furthermore, conditioned medium from clone 
A31 (30PDs) in detached collagen showed more MMP-9 activity over time than in 
monolayer culture (Figure 5.9).  
 
 By determining p-values for the production of pro-MMP-2 (Table 5.4), it was 
clear that a significant difference between all the clones in monolayer was evident, 
with p values < 0.001 from day 2 until day 12. In detached collagen, there was a 
significant difference in clone A31 between early PD (30PDs) and late PD (80PDs) 
over the 12 days period. However comparing clone A31 at 30PDs with clone A11 at 
17PDs showed significance different only at day 4 and 6 when active-MMP-2 started 
to be produced. 
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Figure 5.7. Zymography gels showed pro-MMP-2 running at molecular weight 
(Mw) 72kDa, active-MMP-2 running at Mw of 62kDa and MMP-9 enzymes 
running at Mw of 92kDa, obtained from clones A31 (30PDs and 80PDs) and 
A11 (17PDs) from detached collagen and monolayer conditioned medium, over 
12 days in culture. 
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Figure 5.8.  Quantitative analysis of pro-MMP-2 bands of the zymography gel 
obtained from conditioned medium of monolayer and detached collagen of A) 
A11 (17PDs), B) A31 (30PDs) and C) A31 (80PDs) (N=3, average SE). * = 
p<0.05, ** = p<0.01, *** = p<0.001, non-significant (ns) = p>0.05. 
 
 
 
 (A)   A11 (17PDs) 
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  (B)   A31 (30PDs) 
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    (C)   A31 (80PDs) 
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Figure 5.9.  Quantitative analysis of MMP-9 bands of the zymography gel 
obtained from conditioned medium of monolayer clone A31 (30PDs and 80PDs) 
and detached collagen of A31 (30PDs). (N=3, average SE). * = p<0.05, ** = 
p<0.01, *** = p<0.001, non-significant (ns) = p>0.05. 
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Table.5.4 Sums of significant p values for pro-MMP-2  from Figure 5.7. 
Compares  pro-MMP2 synthesis from clone A31 at 30PDs in 2 different 
conditions (monolayer and detached collagen gel) with production of pro-MMP-
2 in clones A31 at 80PDs and A11 at 17PDs, in the same conditions over 12 days 
in culture. ** = p<0.01, *** = p<0.001, non-significant (ns) = p>0.05. 
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5.5 Discussion 
This chapter illustrated that collagen gels, attached and detached, could potentially 
mimic the basic niche of DDPCs in different conditions, quiescent and proliferative 
respectively. Cells in attached collagen gel tend to proliferate the same as on a plastic 
surface, where active MMP-2 was not synthesised. On the other hand, DPPCs on 
detached collagen did not proliferate, and synthesised active MMP-2. For this reason, 
detached gel could mimic the quiescent stage in the dental pulp, while attached 
collagen gel could mimic the pulp in response to stimuli such as inflammation. The 
collagen gel interaction with DPPCs will help in understanding cell responses to 
ECM components, which is proved to play an important role in cell differentiation 
and tissue mineralisation (Kim et al., 2012a; Coyac et al., 2013). This work sheds 
light on collagen gel, which may be an intriguing material to use as a scaffold in 
tissue engineering. 
 
 The PD data showed differences in proliferation of DPPCs between culturing 
on plates compared to culturing these cells on collagen gels. There was also a clear 
difference when comparing the behaviour of DPPCs on floating collagen gels, 
compared to attached gels.  Currently, there is much evidence that cells respond 
differently when cultured in collagen constructs in comparison to  cell culture plates 
which has been credited to the similarities of collagen environment with the natural 
ECM (Butcher and Nerem, 2004). Mechanical forces, such as gravity, tension and 
fluid shear stress, influence the behaviour of cells under physiological and 
pathological conditions. In addition, the force generated by the cells themselves may 
influence many biological processes of stem cells, such as proliferation and 
differentiation (Wang and Thampatty, 2008). It has been shown that mechanical 
loading is essential for differentiation of fibroblasts into myofibroblasts (Arora et al., 
1999) and mechanical forces can induce the differentiation of MSCs into functional 
osteoblasts, by enhancing alkaline phosphatase (ALP) activity and the mRNA 
expression of other osteogenic marker genes (Zhao et al., 2008). 
 
 In attached collagen gels, cells developed isometric tension by forming actin 
prominent stress fibers and demonstrated cell extensions attached to matrix fibrils 
and began to put pseudopodia-like outgrowths to help in their movement or 
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attachment on the collagen (Gabbay et al., 2006). DPPCs have also shown the ability 
to proliferate on the attached collagen, due to mechanical stresses in line with other 
findings (Riddle et al., 2005; Yamamoto et al., 2005; Stops et al., 2010). The 
proliferation for both clones A11 and A31 at early PDs began after a lag period of 
approximately 4 days, following which they proliferated rapidly. The cell number 
began to decrease after 12 days, possibly due to cells reaching the maximum 
numbers to survive in the collagen gel, suggesting cells were over-confluent. Clone 
A31 at late PD only exhibited no or low proliferation as was expected at this stage of 
PD as cells were senescent. Cells cultured on detached collagen showed minimal or 
no proliferation during the 12 day period for clones A11 and A31, in line with other 
findings (Rosenfeldt  and Grinnell, 2000; Hadjipanayi et al., 2009). Said studies 
showed that fibroblasts do not proliferate in floating collagen as they are arrested in 
G0 phase of the growth cycle. Both clones, A31 and A11, when in monolayer 
revealed the same pattern of proliferation rate on attached collagen.  The main reason 
cells tend to proliferate on attached collagen and tend to be quiescent in floating 
collagen is still not fully understood. It could be explained by signalling through the 
extracellular signal-regulated kinases (ERK pathway). ERK or MAP kinases 
belonging to a group of proteins that are activated in response to a number of stimuli, 
such as growth factors, neurotransmitters and environmental stresses such as heat 
shock (Pages et al., 1993) or mechanical stresses (Ruwhof and van der Laarse, 2000). 
These control cell growth, as ERK kinase seems to be essential during G1 
progression for triggering entry into the S phase of the cell cycle (Pages et al., 1993). 
A study had shown that ERK signalling decreases in detached collagen (Fringer and 
Grinnel, 2001). This decrease was linked with the absence of isometric tension which 
results in the lack of actin stress fibers as shown by Phalloidin-FITC staining. It is 
also worth mentioning that in monolayer, the ERK pathway is regulated mostly by 
growth factors, such as platelet-derived growth factor (PDGF), and cell adhesion 
(Fringer and Grinnel, 2001). Taken together, the attached collagen could mimic the 
phase of injury when cells of granulation tissue proliferate under isometric tension, 
as in skin wounds (Clark, 1993; Grinnel et al., 1999). This could explain what 
happens to the DPPCs in response to injury in the tooth. Upon injury, DPPCs are 
recruited from their niche where they are engrafted in high numbers at the wound 
site, and stimulate a cascade of complex and as yet unclarified events (Mitsiadis et al., 
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2011). Furthermore, cells in detached collagen could mimic the quiescent phase of 
cells on their microenvironment which is a common stem cell niche feature (Ema and 
Suda, 2012).  
 
 Cellular functions within tissues are firmly regulated by the tissue 
microenvironment, which consists of an extracellular matrix that is metabolised 
potentially by MMPs (Shiomi et al., 2010). These proteolytic enzymes play an 
important role in many cellular events, such as cell proliferation and migration 
(Vargova et al., 2012). Furthermore, hMSCs, in response to signalling cascades, tend 
to mobilise from their niche to penetrate the affected host site and subsequently 
differentiate into the appropriate specific type of cells (Lu et al., 2010). Several 
MMPs are expressed in human dental pulp including MMP-2 and MMP-9, where 
they are involved in dentine matrix organisation during dentinogenesis and also 
during pathological conditions, such as dental caries where MMP-2 and MMP-9 
contribute to degradation of the organic matrix of teeth (Palosaari et al., 2003; 
Mazzoni et al., 2007). The natural ability of DPPCs to remodel their ECM 
environment by activating proteolytic enzymes (MMP-2 and MMP-9) was evaluated 
by gelatin zymography (Toth et al., 2012). There are many resemblances in MMP-2 
and MMP-9 in structure and substrates, but they differ in terms of regulation and 
activation. For example, MMP-2 is activated by MMP-1, MMP-7, MMP-13, MMP-
14, MMP-15, MMP-16, MMP-17, MMP-24 or MMP-25, while MMP-9 activated by 
MMP-2 itself or by MMP-1 (Visse and Nagase, 2003). In general, MMP-2 is 
produced in a wide range of cell types, including fibroblasts, endothelial cells, 
keratinocytes, and macrophages, while MMP-9 is produced mainly in leukocytes and 
other cell types in response to stimuli, such as inflammation (Whatling et al., 2004; 
Xue and Jackson, 2008). For example, human lung fibroblasts do not produce MMP-
9 in monolayer or in collagen gels, but only produce MMP-9 when stimulated by 
cytokines (Kamio et al., 2010).  Controversially, cell stress has been shown to be one 
of the factors that upregulate and downregulate MMP gene expression (Mudera et 
al., 2000; Sternlicht and Werb, 2001; Karamichos et al., 2007). Therefore, a 
relationship could be established between cell proliferation, which is also affected by 
cell stress, and MMPs production. The relationship appeared to be an inverse one 
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between the cell proliferation rate and the presence of the MMP inhibitor, as in the 
fibroblast (Bott et al., 2010). 
 
 Data from this study has shown that the physical state of the collagen gel 
influences cell proliferation. It also demonstrated the physical state regulated MMP 
production, which caused collagen shrinkage over time. In monolayer culture, there 
was an expression of pro-MMP-2 by both clones (A11 and A31) that increased 
gradually over time, especially after day 4, suggesting the increase was related to cell 
number. In monolayer culture no expression of active-MMP2 was detected, while in 
detached collagen active-MMP-2 was detected, which indicated that MMP-2 
activation was induced by the ECM, collagen type I. The amount of pro-MMP-2 
produced by cells in detached collagen gels was much higher than in monolayer 
cultures. This could be because cells in detached collagen have less tension than in 
monolayer and it has been found that a decrease in cell tension may lead to an 
increase in the expression of MMP-2 (Howard et al., 2012).  MSCs function has been 
shown to be regulated by MMP activity (Kasper et al., 2007; Glaeser et al., 2010; Lu 
et al., 2010; Lozito and Tuan, 2011).  Human bone marrow mesenchymal stem cells 
have been found to constitutively produce MMP-2 in vitro to organise the basement 
membrane (Ries et al., 2007). hMSCs that have MMP-2 gene knock-down lose their 
invasion ability into affected site (Ries et al., 2007). This may explain the reason why 
cells of both clones reduced in number in late PD as cells also tend to lose their 
stemness by age (Stolzing et al., 2008) as demonstrated in chapter 2. Furthermore, 
MMP-9 production was only detected in clone A31 in both monolayer and in 
detached collagen. In detached collagen gels, the production of MMP-9 remained 
constant during the 12 day period, while it increased gradually in monolayer culture. 
MMP-9 production by clone A31 in detached collagen gel was greater than in 
monolayer, which could be due to the cell numbers. However, comparing early PD 
(30PDs) with late PD (80PDs) of clone A31, found that late PD produced more 
MMP-9 even when it had less cell numbers. Another explanation why the expression 
of MMP-9 was highest at the late PD, was that cells were almost senescent, which 
confirms the link between MMP-9 and cell senescence (Cao et al., 2013). 
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 This chapter has demonstrated that detached collagen gels appear to be 
regulated by MMP-2 only and not MMP-9. Also demonstrated was increased type I 
collagen lattice contraction, which was mediated by increased pro-MMP-2 
expression/activity whereby active-MMP-2 started to appear (Azzam and Thompson, 
1992; Gilles et al., 1997; Theret et al., 1999; Rupp et al., 2008). This regulatory 
mechanism could be important for MSCs to keep them in their quiescent state in 
their physiological stem cell niche and to activate their differentiation in the case of 
injury (Kasper et al., 2007). MMP-9 was only expressed in the highly proliferative 
clone, which could be connected to what stage of commitment these cells are in as 
described in chapter 2. Furthermore, it is known that hMSCs express very low level 
of MMP-9 under normal conditions (Ries et al., 2007), which may suggest that they 
are linked to the clonal variation. However, more investigation is needed such as 
examining the expression of MMP-2 and MMP-9 at a gene level and expression of 
tissue inhibitor of metalloproteinases (TIMPs), especially as MSCs from bone 
marrow express high levels of TIMPs (Lozito and Tuan, 2011). Therefore, it is 
important in the future to study TIMPs expression levels in monolayer, attached 
collagen and detached collagen.  
 
 Overall, the objective of this chapter was to determine whether collagen 
matrices will act as a native ECM environment for DPPCs, by assessing DPPCs 
proliferation, morphology and MMPs production. However, the initial data showed 
that the physical state will play an important role in these properties. The attached 
collagen seems to be successful to obtain cell proliferation and morphology of these 
cells, but not detached collagen. Recently, a study on DPPCs seeded on collagen gel 
found that culturing these cells on collagen will enhance their differentiation ability. 
However, in order to do so, the collagen was compressed to make it resemble to the 
natural matrix environment (Coyac et al., 2013). This means further investigations 
are needed to compare between all these different physical states of the collagen and 
their subsequent effects on cell morphology and cell differentiation to allow 
clinicians to benefit from the combination of DPPCs with collagen gels for the 
clinical repair of osseous and dental defects. 
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Chapter 6: 
Discussions 
 
 
6.1 General Discussion 
This thesis set out to better identify dental pulp progenitor cells (DPPCs) clones most 
efficient for tissue engineering. Previous studies have showed the existence of 
different mesenchymal stem cells (MSCs) clones only in terms of proliferation ability 
and differentiation capacity, without demonstrating possible reasons for clonal 
variation; despite identical gene expression of selected MSCs (CD29, CD44, CD90, 
CD105, and CD166) (Gronthos et al., 2002; Mareddy et al., 2007; Jeon et al., 2011). 
In addition, use of heterogeneous stem cell populations is likely to produce an 
unpredictable biological activity such as inefficiency of differentiation into specific 
lineages or differentiation into undesirable cell types (Roy et al., 2006; Müller et al., 
2010). Thus, from efficacy and safety points of view, ability to identify homogenous 
MSCs clones will be more beneficial for clinical application. Hereon, a highly 
proliferative clone (A31) was identified, and for the first time the highly proliferative 
clone was linked with other preferable properties for tissue engineering. These 
properties include long telomere length, higher resistance to H2O2 with delayed 
senescence, ability to differentiate into three different lineages (i.e. adipogenic, 
osteogenic, and chondrogenic), absence of tumor suppression genes (p53 and 
p16
INK4a
) and of neural marker CD271. On the other hand, low proliferative clones 
(A11 and B11) were linked with short telomere length, less resistance to H2O2 and 
cell senescence, ability to differentiate only into osteogenic lineage, and expression 
of tumor suppression genes (p53 and p16) and marker CD271. As such, generating 
well-defined cell populations from stem cells will advance tissue engineering 
therapies (Karystinou et al., 2009). In order to reach this goal to identify such a 
desirable clone, extensive in vitro expansion was needed. Such expansion altered 
DPPCs stemness by loss of stem cell markers, loss of telomere length, differntial 
differentiation ability (favouring adipogenesis over osteogenesis), and eventual 
replicative senescence. The process of expansion is also costly and time consuming. 
For this reason, a different method was investigated to identify clonal differences. 
Raman spectroscopy was used to identify a quick and non-invasive method to 
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discriminate between clones, based on their attributed DNA, RNA, and amino acid 
contents, relative to proliferation and differentiation status. Raman spectroscopy 
successfully showed that the highly proliferative clone (A31) had a completely 
different fingerprint, based on biochemical features, compared with low proliferative 
clones. Lastly, the behaviour of high and low proliferative clones on type I collagen 
was assessed. DPPCs in detached collagen caused collagen contraction irrespective 
of clonal type, by synthesising active MMP-2, which is not expressed on a plastic 
culture surface. In addition, DPPCs in detached collagen did not proliferate, which 
may mimic a quiescent state in the dental pulp. On the other hand, DPPCs in attached 
collagen gel tended to proliferate, which may mimic the pulps response to stimuli 
such as inflammation. MMP-9 expression was only seen in the highly proliferative 
clone, and expression level was the same on both collagen and plastic environments. 
This expression level of MMP-9 increased at late PDs, which may indicate an MMP-
9 role in cell senescence, and distinguish such an advantageous clone from others 
less so. Thus collagen gel is an intriguing material to assess DPPCs behaviour in 3D 
culture, for use in cell-therapy. 
 
 It is now well-acknowledged that individual mesenchymal stem cells (MSCs) 
colonies, from the same tissue including dental pulp, exhibit different behaviour and 
differentiation capacities (Gronthos et al., 2002; Guilak et al., 2006; Karystinou et 
al., 2009). However, none of these previous studies compared isolated colonies from 
the same tissue or the same donor and subsequently linked proliferative capacity with 
differentiation ability and telomere length. In this thesis, three clones were isolated 
from wisdom teeth of the same patient A11, A31, and A51, and another clone from 
different patient, B11. Only one clone, A31 proliferated for more than 80PDs while 
others only proliferated for less than 40PDs (Figure 2.3).  For this reason, clone A31 
was taken forward with another clone from the same patient (A11), with the other 
clone from the second patient (B11), to address the reasons behind these differences. 
In addition, the subsequent impact of such variations in proliferative capabilities on 
clonal differentiation and regenerative potential were also examined. The highly 
proliferative clone showed the ability to differentiate into three different lineages: 
osteoblasts (Figure 3.2), adipocytes (Figure 3.8) and chondrocytes (Figure 3.14), 
while the low proliferative clones (A11 and B11) were only differentiated into 
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osteoblasts (Figure 3.3 and Figure 3.4). The reasons behind the ability of clone A31 
to differentiate into the three different lineages could be down to the asymmetric 
division of the stem cell as will described in the next paragraph. 
 
  Adult stem cells are capable of self-renewal and differentiation into multiple 
cell lineages, with short life-spans. To achieve self-renewal capabilities and 
differentiation functions, stem cells divide slowly and symmetrically to produce an 
identical daughter cell with low proliferative capacity and multipotential 
differentiation. Some of these adult stem cells go on to divide asymmetrically and 
give rise to one identical daughter cell and another progenitor cell called a transit 
amplifying (TA) cell. TA cells have a high proliferative potential and low 
differentiation ability and give rise to more committed progenitors with reduced 
proliferative potential (Figure 1.1), which eventually produce terminal differentiated 
cells (Alison et al., 2002; Ho, 2005). Asymmetrical division could give one 
explanation of the reasons that cause different characteristics between isolated clones 
of DPPCs. Here, clone A31 was the only clone that had both characteristics with 
highly proliferation and multipotential differentiation, probably because of 
asymmetrical division of stem cells that led to this clone to have both populations i.e. 
stem cells and TA cells. This hypothesis supports the telomere data presented here as 
clone A31 had longer telomeres throughout culture, while at later PD it showed a 
long smear band indicative of the existence of two populations, possibly showing 
stem cell with longer telomeres and TA cells with shorter telomeres. In addition, the 
clones A11 and B11 were unipotent and displayed less division potential and shorter 
telomere lengths, possibly as they could be considered to be the more committed 
progenitor cells. Another result that supports this theory is the expression of 
senescence marker p53. This marker was expressed in short telomere clones which 
suggested that clone A11 is a later stage version of clone A31 as they are from the 
same patient (Hao et al., 2013). One of the differences between the clones is the 
expression of p16 gene that was expressed only in the low proliferative clones, which 
gives support to the asymmetrical stem cell division theory by way of explanation for 
the differences between clones. The expression of p16 gene could be another 
beneficial way to help researchers distinguish between high and low proliferative 
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colonies, as it has been shown that enhancing expression of p16 leads to a decrease 
in the proliferation capacity of stem cells in mice (Molofsky et al., 2003).  
 
Another theory that could explain the differences between the clones, is the 
niche in which DPPCs reside. DPPCs  are proposed to be  located in different niches 
within the pulp, such as the perivascular region (Huang et al., 2009b), within 
capillaries and nerve networks of the cell free zone (Lizier et al., 2012), or 
subodontoblastic cell-rich layer of the dental pulp (Hosoya et al., 2012). This might 
bestow different characteristics such as different stem cell gene expression profile. In 
this study, expression of the selected stem cell markers was the same for all the 
clones except the expression of the CD271 gene. CD271 was expressed in low 
proliferative clones (A11 and B11), which suggests that low proliferative clones 
were derived from the nerve networks in cell free zone within the dental pulp, as 
CD271 is considered a neural tissue marker (Lizier et al., 2012) . More stem cell 
markers gene expressions need to be investigated for A31, A11 and B11 clones for 
their respective expression profiles, such as CD146 that is linked to progenitor cells 
raised from the perivascular niche (Shi and Gronthos, 2003). Such experimentation 
will help to investigate if such genes could be linked to either highly proliferative 
clone (A31) or low proliferative clones (A11 and B11). Moreover, CD271 has 
conflicting results in terms of it's expression in MSCs, based on the tissue it is raised 
from. MSCs with positive expression of CD271 from bone marrow differentiate into 
osteogenic, adipogenic and chondrogenic lineages, while MSCs from umbilical cord 
do not show an indication of any differentiation (Watson et al., 2013). Furthermore, 
CD271 is found to inhibit differentiation of deciduous dental pulp stem cells 
(Mikami et al., 2011). In line with the data presented here, the only clone that did not 
show expression of CD271 marker was the multipotent clone, A31. This means that 
clones which express CD271 isolated from dental pulp could be excluded from use in 
tissue engineering. Finally, another consideration is the epigenetic regulation of stem 
cells, which is deeply involved in their development and differentiation (Liu and 
Xiao, 2011). Chromatin-modifying activities, including methylation and 
phosphorylation organise the suppression or activation of gene expression, such as 
Runx2, SOX9 and PPARγ, which control the stem cell differentiation along 
osteogenic, chondrogenic and adipogenic lineages, respectively. These regulatory 
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mechanisms suggest that epigenetics might provide an important role in stem cell 
differentiation (Kelly and Jacobs, 2010; Li et al., 2010). 
 
The differences between the three clones were supported by the data from the 
Raman spectroscopy ( Chapter 4). Indeed, the initial results displayed that highly 
proliferative clone (A31) had a completely different fingerprint based on their 
biochemical features compared with low proliferative clones (A11 and B11). The 
low proliferative clones also had very similar fingerprints with one other. The only 
peaks found in clone A31 were 1111cm-1 and 958cm-1, which corresponds to tyrosine 
and phenylalanine, respectively. These two peaks could be used as markers in Raman 
spectroscopy to distinguish between high proliferative and low proliferative clones. 
Raman spectroscopy data was analysed by the principal component analysis (PCA), 
where low proliferative clones overlapped each other while clone A31 had a 
completely distinguishable and separate area (Figure 5.7). Raman spectroscopy was 
also used as a marker of chondrogenic differentiation for clone A31, which may help 
in distinguishing stem cells from their derivatives. Spectra from chondrocytes 
highlighted bands that were characteristic of proteins that included amide I (1616cm
-
1
) and C=O ester (1730cm
-1
). While non-differentiated cells highlighted a band 
characteristic of DNA, the C5’-O-P-O-C3’ phosphodiester bonds in DNA (788cm
-1
) 
(Table 4.4). Successful separation of stem cells from their derivatives will help to 
isolate a pure population for tissue engineering, by avoiding a heterogeneous 
population that is indicated to lead to teratoma and cancer (Chan et al., 2009; 
Downes et al., 2011). 
 
 In order to use DPPCs in cell therapy, in vitro cell expansion is needed. This 
expansion may have an effect on the quality of the cells eventually obtained. It has 
been reported that MSCs lose their multipotentiality, proliferation ability and 
capability to differentiate to bone during expansion in vitro (Banfi et al., 2000; Min 
et al., 2011). MSCs have a finite proliferative life-span, which means they will 
undergo replicative senescence during long-term culture in vitro. Replicative 
senescence is characterised by gradual reduction in proliferation rate, morphological 
changes, loss of function and reduction in their telomere length (Bonab et al., 2006). 
There are many studies into the effects of in vitro expansion of MSCs (Banfi et al., 
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2000; Stenderup et al., 2003; Bonab et al., 2006; Brandl et al., 2011; Kim et al., 
2012b).  None of these studies however, look at the long term and simultaneous 
effects on proliferation, differentiation, telomere length, stem cell marker expression, 
cell senescence and H2O2 senescence on DPPCs. Indeed, this thesis showed the 
effect of long term in vitro culture on DPPCs from different aspects. Firstly, the stem 
cell population doubling levels (PDs) decreased following 280 days culture  for clone 
A31, and less than 100 days for the other clones (A11, B11, and A51) (Figure 2.5). 
Secondly, the expression of embryonic and mesenchymal stem cell markers was 
gradually lost with increasing PDs, until they completely disappeared in all clones 
(Figure 2.6). Despite the loss of stem cell markers, clones were still capable of 
proliferation. Previous work shows that DPPCs loss their mesenchymal stem cell 
markers as early as twenty-five passages (Kerkis et al., 2006). The loss of these 
markers during in vitro culture is still not fully understood, but it may be due to cells 
not having the same environment as they have in their original niche, which leads 
cells undergoing spontaneous differentiation followed by senescence (Patel et al. 
2009). Thirdly, DPPCs lost their ability to differentiate into an osteogenic lineage at 
late PD (Figure 3.2), in favour of an adipogenic lineage (Figure 3.8), which was 
supported by decreased Runx2 bone gene expression and increased PPAR 
adipogenic gene expression. A study by D'Ippolito et al (1999) found that MSCs 
from bone marrow lose their capacity to differentiate into osteoblasts during aging. 
MSCs from bone marrow tend to differentiate into adipocytes, much like when bone 
marrow is partially replaced by adipocytes in human aging, which is believed to 
cause some forms of osteoporosis whereby Runx2 is suppressed by PPAR 
(Moremen et al., 2004; Fehrer and Lepperdinger, 2005). Finally, the other effect of in 
vitro expansion on DPPCs was replicative senescence. Replicative senescence was 
witnessed by morphological alterations (Figures 2.9, 2.10, 2.11), positive staining of 
-galactosidase enzyme (Figure 2.14), and shortening of the telomere length (Figure 
2.15); which was also supported by absence of human telomerase reverse 
transcriptase (hTERT) of these cells (Figure 2.7). In addition to telomere shorting, 
DNA damage accumulation could be another mechanism supporting replicative 
senescence (Gharibi and Hughes, 2012). Little is known however about replicative 
senescence in MSCs. Telomere shortening and accumulation of DNA damage leads 
to activation of tumour suppressor p53 and its downstream p21, and induction of the 
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cyclin-dependent kinase inhibitor p16
INK4a
 (reviewed in Sperka et al., 2012). p53 and 
p16
INK4a
 were expressed at early PD in low proliferative clones (A11, B11) but not in 
the highly proliferative clone (A31) (Figure 2.8). These findings lend support to the 
theory of asymmetric division whereby clone A11 is later-stage MSC of clone A31. 
Overall, this thesis reported a link between replicative senescence, reduction in 
stemness related genes, loss of MSCs self-renewal, and loss of differentiation 
potential, as reported in other type of MSCs (Liu et al., 2004; Alves et al., 2010; 
Cheng et al., 2011), and a link between tumour suppression gene markers (p16 and 
p53) with the differences between the isolated clones. 
 
The stem cell environment changes widely during stem cell lifespan and has 
an effect on stem cell behaviour and shape (Hao et al., 2013). ECM contributes to 
stem cells behaviour because cells that attach to a substrate have been shown to exert 
contractile forces, resulting in tensile stresses in the cytoskeleton. The relationship 
between cells, environment and mechanical stiffness or elasticity of this ECM have a 
major influence on cell activities such as migration, apoptosis and proliferation 
(Guilak et al., 2009). For this reason, an investigation of the effect of an artificial 
type I collagen ECM, was conducted. Results demonstrated that DPPCs in floated 
collagen did not proliferate. This may represent the quiescent stage of stem cell in 
vivo, while DPPCs in attached collagen proliferate in similar way when on the 
surface of a flask. This may represent the state of stem cells when they respond to 
stress, such as an inflammation. Stem cells rest in their quiescent stage for most of 
their lifespan in vivo (Fehrer and Lepperdinger, 2005) and are activated through 
signals, such as the ERK pathway in response to stimuli such as inflammation (Pages 
et al., 1993), in order to endorse repair and regeneration process (Fehrer and 
Lepperdinger, 2005). In response to the ERK signalling pathway, MSCs mobilise 
from their niche into an affected site by penetrating the ECM, which includes 
collagen type I, via increased matrix metalloproteinase (MMP) expression (Lu et al., 
2010). Indeed, this thesis showed that active MMP-2 is only demonstrated in cells 
cultured in floating collagen, which underwent contraction, unlike cells cultured on a 
plastic surface (Figure 5.8). This confirms that MMP-2 activity plays an important 
role in matrix remodelling by DPPCs, and possibly in migration as shown by MSCs 
from bone marrow (De Becker et al., 2007). MMP-9 was only detected in clone A31, 
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which might be linked to the clonal variation. This MMP-9 did not increase with 
time in detached collagen as MMP-2 did, which suggests that only active MMP-2 
had a role in collagen organisation by DPPCs. MMP-9 expression also was higher 
expressed in late PD (80PDs) than in early PD (30PDs), which suggests that MMP-9 
has role in cell senescence (Cao et al., 2013). 
 In conclusion, this thesis identified key reasons behind variations in DPPCs 
clones. The data confirmed clonal variations in DPPC proliferative capacity and the 
onset of senescence, identified by reductions in PD, altered morphology, increased 
senescence associated β-galactosidase staining and senescence marker (p53/ 
p21
WAF1
/p16
INK4A
) expression.  Highly proliferative clone was capable of >80PDs in 
vitro, while low proliferating clones only achieved <40PDs.  Although it was shown 
that hTERT expression is not responsible for clonal variation in proliferative 
capabilities, this study is the first to identify that highly a proliferative clone can 
possess inherently longer telomeres (>15kb, by Telomere Restriction Fragment 
Length analysis) than low proliferative clones, which maintains stem cell marker 
(CD73, CD90 and CD105) expression for longer.  Early senescence and stem cell 
marker loss in low proliferative clones further leads to impaired osteogenic and 
chondrogenic lineage differentiation at earlier PD, unlike highly the proliferative 
clone.  Therefore, the preferred highly proliferative/regenerative DPPC clones  could 
be exploited for tissue repair/regeneration purposes. These findings with the addition 
of Raman spectroscopy results, will ultimately help into developing methods for the 
selective screening/isolation of highly proliferative/regenerative clones from whole 
dental pulp, thereby permitting greater cellular expansion for in vitro/in vivo 
assessment and eventual clinical use. 
 
6.2 Future Works 
The work described in this thesis has begun to explore the use of Raman 
spectroscopy as a quick non-invasive tool for the selective screening and isolation of 
highly proliferative clones from dental pulp for therapeutic use. Raman spectroscopy 
however, is to be considered an additional supporting method, as the isolation of 
such a desirable clone is likely to require several techniques. A number of 
approaches could be used as quick way to identify highly proliferative clones. For 
example, single telomere length analysis (STELA) is one of these approaches.  
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STELA is a novel PCR-based technique for the analysis of telomere length from 
single chromosome ends.  The exquisite sensitivity of this technique allows the 
detection and characterisation of single telomeric molecules, thereby revealing the 
full spectrum of telomere lengths (including ultra-short telomeres).  Importantly, 
STELA only requires small numbers of cells (500+), and thus can determine 
telomere length very early (≈5PDs) in the proliferative lifespan of cells. Another 
example relies on proposed genes involved in DPPC proliferation and senescence
 
(Mehrazarin et al., 2011); of which there are many genes critical to stem cell function 
not yet characterized. Here differences in the expression of CD271 in DPPCs clones 
were seen. A plethora of other genes however need to be investigated such as CD146 
(proposed stem cell niche marker), and BMI-1 (regulator of tumour suppression 
genes p16 and p53; as found here in low proliferative clones). For this reason use of  
Affymetrix Microarrays, a quartz chip for analysis of DNA microarrays (Perez-
Iratxeta et al., 2005), will permit quick scanning for the presence of particular genes 
in a biological sample (Perez-Iratxeta et al., 2005). Such microarrays could complete 
clonal characterisation and identify candidate genes for enhanced/reduced 
proliferation and regenerative potential. 
 
The work in this thesis on the interaction of DPPCs with type I collagen gel is 
only a stepping stone for further investigation of the role of ECMs in regulating 
DPPCs function. Future works need to be done in this area firstly includes, 
investigating whether cells penetrate collagen vertically by using confocal 
microscopy to confirm that this environment is truly a 3D culture model. Secondly, 
investigation of 3D culture to enhance differentiation ability of cells, by measuring 
expression of specific markers at protein level using Western blot. Finally, an 
important focus is the MMP-9 role in the highly proliferative clone, by inhibiting 
expression of MMP-9 via TIMP-1, and the potential effect upon DPPC behaviour on 
collagen and plastic surfaces. 
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